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ABSTRACT 
Reem Hasan 
Vaginal bleeding in early pregnancy: 
Patterns, predictors, and association with miscarriage 
(Under the direction of Donna Baird and Andrew Olshan) 
 
 First-trimester vaginal bleeding is common in pregnancy; however, few data 
have described the distribution, characteristics, and predictors of early bleeding 
episodes. The relationship between bleeding and miscarriage is not well understood.  
 Data from Right From the Start (RFTS), a prospective, community-based 
pregnancy cohort were used for all analyses. We used descriptive statistics to 
characterize first-trimester bleeding episodes and logistic regression to identify 
predictors of bleeding. Bleeding characteristics (such as heaviness, duration, timing, 
and color) predictive of miscarriage were identified using classification and 
regression trees. The relationship between bleeding and miscarriage was modeled 
using discrete-time hazard models. We compared retrospectively collected bleeding 
reports from the first trimester interview with prospective data from a daily diary to 
obtain sensitivity, specificity, and kappa statistics. Log-linear models were used to 
identify predictors of agreement. In all analyses, we removed bleeding episodes that 
ended within four days of miscarriage. 
 Approximately one-fourth of participants reported bleeding in early pregnancy, 
mostly spotting or light bleeding episodes. Most episodes lasted fewer than 3 days, 
and most occurred between gestational weeks 5 and 8. Heavy episodes, reported by 
about 2% of women, were more likely to be painful, of longer duration, and red in 
 iv
color. Predictors of bleeding were age (particularly between 28 and 34), increasing 
education, nulliparity, and menstrual cycle length less than 27 days or greater than 
33 days. Maternal conditions (diabetes, fibroids), prior pregnancy outcomes 
(miscarriage, induced abortion), reproductive tract infections, smoking, and alcohol 
intake were also predictive of bleeding. Women who reported heavy bleeding had 
nearly three times the risk of miscarriage compared to women without bleeding (OR 
3.0, 95% CI 1.9, 4.6). Spotting and light bleeding episodes were not related to 
miscarriage. Bleeding episodes and characteristics were reported with high levels of 
agreement in the diary and interview. No predictors of agreement were identified in 
this analysis. 
 To summarize, we found that vaginal bleeding was a common first-trimester 
symptom. However, the majority of episodes were spotting or light bleeding 
episodes, which did not confer an increased risk for miscarriage. Although few 
women reported heavy bleeding, heavy bleeding was more strongly related to 
pregnancy loss. 
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CHAPTER 1 : INTRODUCTION AND SPECIFIC AIMS 
 
A. INTRODUCTION 
 Miscarriage is a common, and poorly understood, adverse pregnancy 
outcome. Understanding the nature of common biologic processes, symptoms, and 
behavioral changes that occur during early pregnancy may contribute to increased 
knowledge of miscarriage risk factors. The relationship between vaginal bleeding, 
occurring in an estimated 20% of all pregnancies, and miscarriage remains unclear. 
Although vaginal bleeding occurs commonly in early pregnancy and may mark a 
miscarriage event, it is not always associated with imminent pregnancy loss. 
Characterization of the timing and frequency of bleeding in early pregnancy will 
provide useful information that will increase understanding of the role of this 
symptom in pregnancy. It may also give some insight into the extent of errors in 
gestational age dating, which may occur when early pregnancy bleeding is confused 
for the last menstrual period. 
 The goal of this project was to better understand vaginal bleeding symptoms 
occurring in early pregnancy and its association with miscarriage. The timing, 
duration, heaviness, and pain associated with bleeding episodes was described. 
Maternal characteristics that predict the presence of bleeding were investigated. 
This was followed by an analysis of the association between bleeding and 
miscarriage. Prospectively collected bleeding data from a small subset of women 
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were used to validate bleeding episode information obtained from the first trimester 
interview.  
 Data from Right From the Start (RFTS), a prospective pregnancy cohort, were 
used to meet the aims of this project. RFTS enrollment is community-based, and 
occurs in early pregnancy. Data from this cohort will answer critical questions related 
to early pregnancy symptoms, an important topic from the perspective of patients, 
clinicians, and researchers. 
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B. SPECIFIC AIMS 
 Vaginal bleeding is a common and alarming symptom during early pregnancy. 
It has been estimated to affect 7 to 24% of all pregnancies.1-3 Several reports 
suggest that bleeding is associated with an increased risk of various adverse 
pregnancy outcomes, including preterm birth and low birth weight.4-6 Many of these 
studies are limited by their choice of study population and bleeding assessment. 
Furthermore, the relationship between episodes of bleeding and miscarriage is not 
well characterized. Although vaginal bleeding often occurs as a result of miscarriage, 
we focus on other prior bleeding episodes that do not immediately result in 
miscarriage. There are no large-scale descriptions of the usual patterns of bleeding 
in a pregnant population to provide a context in which to consider bleeding 
symptoms in early pregnancy. It is not clear whether a bleeding episode in itself, or a 
host of other factors, are important in predicting later miscarriage. It is also unclear 
what mechanism operates to relate bleeding to adverse pregnancy outcomes.  
 One reason for the paucity of information in this area of research relates to 
the difficulty of studying early pregnancy. The outcome of interest in this analysis, 
miscarriage, occurs prior to the completion of 20 weeks of pregnancy, and frequently 
occurs prior to clinical recognition of pregnancy. Studies of this early pregnancy 
period are limited by issues related to early/pre-pregnant recruitment, incomplete 
case ascertainment, recall bias, and generalizability. In order to ideally examine 
factors related to miscarriage, a representative group of women recruited before 
pregnancy or during early pregnancy should compose the study population, and 
information about exposures and symptoms during pregnancy should be collected 
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soon after enrollment. Such a population, with some limitations, is present in the 
Right From the Start (RFTS) cohort. Some attractive characteristics of this cohort 
include 1) comprehensive bleeding episode assessment; 2) longitudinal data 
obtained on >4000 pregnancies over an 8 year period (2000-2008); and 3) 
ascertainment of early pregnancy outcomes, including over 500 miscarriages. A 
comprehensive first trimester interview is conducted for all RFTS participants, which 
collects bleeding episode information. A subset of women completes prospective 
daily diaries, providing information about pregnancy symptoms and exposures prior 
to pregnancy and throughout the first trimester. Bleeding information collected at the 
first trimester interview will be compared to the diary reports for this subset.  
 This cohort is well designed to answer a broad range of hypotheses related to 
miscarriage risk factors. This analysis will focus on the relationship between first 
trimester bleeding and miscarriage. In undertaking this analysis, we hope to learn 
more about bleeding patterns in early pregnancy, as well as determine the 
association between various maternal characteristics and bleeding. We hypothesize 
that sporadic, light bleeding is a common occurrence of early pregnancy. Heavy 
bleeding associated with reports of pain or cramping will be more strongly 
associated with miscarriage. Finally, we hypothesize that retrospective reports of 
bleeding will contain fewer reports of light spotting and bleeding compared to the 
prospective diary. These hypotheses will be explored under the following specific 
aims: 
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1. Determine the usual patterns and characteristics of vaginal bleeding in 
pregnancy, including details regarding timing, frequency, heaviness, color, 
and pain associated with bleeding. Identify the maternal characteristics that 
predict bleeding in early pregnancy, including maternal age, maternal 
comorbidities, prior birth outcomes, and cycle characteristics. 
 
2. Evaluate the association between patterns of bleeding in early pregnancy 
and the occurrence of miscarriage. 
 
3. Evaluate the extent of agreement between bleeding episodes from 
retrospective first trimester interviews and prospectively collected data from 
daily diaries. 
 
 Descriptive analysis, logistic regression, discrete-time hazard models, and 
log-linear models will be used to answer these study aims. The results of these 
analyses will be useful to patients, providers, and researchers who wish to 
understand the context in which to evaluate early pregnancy bleeding symptoms. 
 
 
 
 
 
 
CHAPTER 2 : BACKGROUND AND SIGNIFICANCE 
 
A. MISCARRIAGE 
 Because miscarriage is difficult to study, few reports describing its causes 
and preventive factors exist. A review of the existing literature describing the current 
state of knowledge related to miscarriage, including epidemiology and risk factors, 
follows.  
 
Epidemiology  
 Pregnancy loss is the most common adverse pregnancy outcome. 
Approximately one-third of implanted embryos are lost prior to live birth.7,8 Between 
20% and 40% of losses are pre-clinical losses, occurring prior to the first missed 
menstrual period.8,9 Miscarriage is defined as the loss of a clinically detected 
pregnancy prior to twenty completed weeks of gestation. These losses, accounting 
for about 15% of all clinically recognized pregnancies,10 can be categorized as early 
or late losses, depending on whether the loss occurs in the first or second trimester, 
respectively.11 In addition to the pre-clinical and clinically recognized pregnancy 
losses discussed herein, it should also be noted that an unknown number of occult 
losses occur, comprised of conceptions that fail to implant. These conceptuses, 
which do not survive more than a few days after conception, are undetectable due to 
the absence of an easily accessible, specific marker for the pre-implantation 
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embryo.7 The total number of conceptions that are spontaneously lost before twenty 
weeks gestation may be as high as 70%.7 
 
Embryonic and endometrial characteristics associated with miscarriage 
 The causes of miscarriage remain unclear. About half of early losses are 
thought to be due to fetal chromosomal abnormalities leading to non-viability.12,13 
Chromosomal abnormalities result from nondisjunction in gamete formation, 
resulting in early errors in zygote cell division and subsequent complications with 
blastocyst differentiation.11 Genetic abnormalities also stem directly from the 
maternal or paternal genotype, as in the case of unbalanced translocations that are 
passed on from the sperm or egg.11,14 Genetic factors may lead to structural or 
developmental aberrations in the embryo, slowing growth and progress towards 
subsequent stages in development, such as implantation. Because the endometrial 
environment is dynamically changing throughout the cycle, if processes such as 
implantation are delayed substantially, the endometrial environment may not 
adequately support the embryo. A larger proportion of embryos that undergo late 
implantation (more than nine days after ovulation) are subsequently lost.15 
Furthermore, a chromosomally abnormal embryo that implants successfully may not 
express necessary factors or respond to signaling molecules at appropriate times 
during development, eventually leading to fetal demise. 
 An interplay between the chromosomal makeup of the embryo and the 
endometrial environment contributes to the occurrence of pregnancy loss. Factors 
affecting endometrial receptivity, particularly the uterine environment around the time 
of implantation, account for a proportion of those pregnancy losses that cannot be 
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directly related to genetic abnormalities.13 Defects in the early processes of 
implantation, invasion into the myometrium, or access to the uterine vasculature may 
contribute to pregnancy loss weeks or months after the event.13 Later complications, 
such as pre-eclampsia, may also result from similar early insults and abnormalities 
in placental growth and differentiation.16 The site of implantation in the uterus also 
plays a role in pregnancy viability, with implantations occurring in the middle and 
lower regions of the uterus more likely to miscarry.17  
 To summarize, the events and environment of very early pregnancy influence 
the eventual outcome of the pregnancy. From an epidemiologic and clinical 
perspective, it is difficult to assess the extent to which these early, often 
unobservable, events predispose to an outcome like miscarriage. Because of this, 
the majority of epidemiologic studies of the causes of miscarriage have focused on 
maternal characteristics that confer an increased risk of miscarriage, rather than 
assessments of embryonic genetic makeup or markers of endometrial receptivity. 
 
Maternal characteristics associated with miscarriage 
 Studies of maternal factors have uncovered a variety of characteristics 
associated with miscarriage. In general, miscarriage risk increases with increasing 
maternal age and number of prior miscarriages.18-20 These trends may be the result 
of an increased frequency of age-related errors in DNA replication, other aspects of 
oocyte and embryo quality, or a uterine environment that is less amenable to the 
development of the embryo.19 Other maternal factors thought to affect the risk of 
miscarriage include structural uterine anomalies, such as bicornuate uterus, or 
benign tumors, such as fibroids. These structural malformations physically interfere 
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with the ability of the conceptus to implant or grow in the uterus due to their space-
occupying effect.11,18,21,22  
 Maternal comorbidities have also been investigated, particularly in 
populations of women with recurrent miscarriage. Women with thyroid disturbances, 
autoimmune diseases, thrombophilic defects, and other systemic disorders such as 
polycystic ovarian syndrome have an increased risk of miscarriage and decreased 
fertility.11,23,24 Similarly, maternal obesity and poorly controlled diabetes have also 
been linked to miscarriage.25-28 Other hormone alterations may also be related to 
miscarriage,29,30 including luteal phase defects. This condition is characterized by 
low progesterone production by the corpus luteum, resulting in miscarriage or 
reduced fertility due to an inability to maintain pregnancy.31-33 These factors 
contribute to a suboptimal uterine environment and decreased endometrial 
receptivity.33 
 Menstrual cycle length and regularity may be related to pregnancy loss. 
Specifically, long cycles have been associated with miscarriage.34-37 Short cycles 
and irregular cycles have also been associated with miscarriage.34,35 These 
relationships may be modified by other systemic factors, such as obesity.38 
 Maternal infection may also play a role in miscarriage, although this has not 
been investigated extensively. Asymptomatic bacterial vaginosis may be associated 
with second trimester miscarriage,39,40 and some evidence also indicates that oral 
infections and placental inflammation may be related to late miscarriage.41,42  
 In addition to medical conditions that may be related to miscarriage risk, 
maternal behaviors and occupational factors have also been suggested to increase 
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the risk of miscarriage. Work schedule, particularly working at night or working 
overtime during the first trimester, has been associated with increased risk of 
miscarriage.43 Work-related stress and stress due to acute or chronic stressors have 
also been found to be related to a higher risk of miscarriage.44-48  
 Both active smoking and exposure to environmental tobacco smoke have 
been associated with miscarriage.49,50 This may result from both reduced maternal 
fertility and altered endometrial receptivity; in a population of women undergoing in-
vitro fertilization, heavy smokers were less likely to achieve pregnancy.51 Maternal 
dietary exposures, including alcohol and caffeine exposure, have also been 
associated with increased risk of miscarriage, although some of the evidence is 
equivocal.52-56 Additionally, some studies found an increased risk of miscarriage for 
caffeine exposure that occurred prior to pregnancy, regardless of consumption 
during pregnancy.57 Certain medication exposures have also been thought to 
increase the risk of miscarriage, including non-steroidal anti-inflammatory drugs58,59 
and some classes of anti-depressants.60,61  
 
Paternal characteristics associated with miscarriage 
 A smaller literature outlines the relationship between paternal characteristics 
and miscarriage. Because the sperm contributes half of the genetic make-up of the 
embryo, a substantial proportion of genetic abnormalities related to miscarriage 
likely derive from paternal factors. Paternal factors may affect chromosomal and 
structural abnormalities in the sperm.14 Additionally, some investigators have found a 
link between paternal age and miscarriage, likely mediated by sperm quality.62 
Paternal environmental exposures and behaviors are also thought to play a role.56,63 
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B. VAGINAL BLEEDING 
Epidemiology 
 
 Large, systematic, population-based descriptions of bleeding symptoms in 
early pregnancy that are not restricted to women having a live birth have not been 
undertaken. More studies focusing on later pregnancy bleeding, associated with 
placental abruption or placenta previa, exist.64-70 However, anecdotal knowledge 
suggests that bleeding is relatively common in early pregnancy, and some evidence 
indicates that if it occurs, it increases the risk of adverse pregnancy outcomes.4 
Studies which attempt to link early pregnancy bleeding with pregnancy outcomes 
have reported a range of prevalence estimates for bleeding in early pregnancy, 
ranging from 7 to 24%.1-3  
 
Previous studies 
 Three reports attempt to describe early pregnancy bleeding patterns in a 
pregnant population, by Yang et al,1 Harville et al,71 and Axelsen et al.3 Most 
participants were enrolled in conjunction with clinical care.1,3 These studies are 
limited by retrospective data collection,1,3 second-trimester recruitment from prenatal 
clinics,1,3 and small sample size.71 Although these studies contribute important 
knowledge, there are no reports describing the bleeding patterns in a large, 
population-based study that is not limited by a long time to recall or inadequate 
follow-up time.  
 The Yang analysis was based on a clinic-based population of pregnant 
women (n=2800) who reported their early pregnancy bleeding patterns at the end of 
the second trimester (26 to 30 weeks of pregnancy).1 This study found that 25% of 
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women reported vaginal bleeding during pregnancy, with peak incidence during the 
first completed month of pregnancy. Because bleeding assessment occurred in a 
telephone interview conducted around the 28th week of gestation, the extent to which 
these results are affected by recall error is unclear. The timing of bleeding was not 
assessed in detail, with episodes reported in monthly intervals. Additionally, only 
those women whose pregnancies continued to the mid/late second trimester (20 to 
26 weeks) were included, eliminating all women who had a miscarriage. This study 
focused on later pregnancy outcomes such as preterm birth. 
 The Harville analysis focused on the reports of 14 women (9% of total n = 
151) who prospectively reported bleeding symptoms during the first eight weeks of 
pregnancy.71 Twelve of the fourteen women with bleeding continued to live birth; 
bleeding was not associated with miscarriage in this study. This study also found no 
evidence for the presence of implantation bleeding. Although the details obtained 
from this study are useful, this study is limited by the small numbers of participants 
and data collection only through the eighth week of gestation. This study is the only 
prospective, longitudinal description of daily bleeding patterns in very early 
pregnancy.  
 The Axelsen study analyzed a group of Danish women in prenatal care.3 
About 20% of participants (n=1091) reported bleeding in a 16 week questionnaire. 
The median week of first occurrence of bleeding was eight weeks, and two-thirds of 
all women did not report pain in association with their bleeding symptoms. Although 
this study is population-based (97% of women in their area receive care at the 
prenatal clinics) and has ~6800 participants, the analysis only includes data from 
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women whose pregnancies progress to live birth, lacking a complete ascertainment 
of all pregnancies in the population (such as those ending in miscarriage or fetal 
death). The focus of this study is primarily on the relationship between recalled 
bleeding and later outcomes such as preterm birth. 
 Two additional studies published over 30 years ago provide some descriptive 
information about the incidence and patterns of vaginal bleeding in early 
pregnancy.72,73 These studies describe the timing of bleeding and maternal 
characteristics associated with increased bleeding occurrence. One of the studies 
found that approximately 27% of pregnancies with vaginal bleeding result in 
miscarriage.73 Unfortunately, neither of these publications contains a complete 
methods section; no details regarding data collection procedures or sample 
recruitment are provided, making it difficult to assess the validity of their results.  
 Based on this review of the identified early pregnancy bleeding literature, it is 
clear that little data exists that would be relevant for miscarriage as an outcome. The 
prevalence of bleeding reported by these studies is wide (7-25%).1-3 This basic 
information needs to be clarified before undertaking additional analyses of the 
relationship between bleeding symptoms and pregnancy outcomes such as 
miscarriage or preterm birth.  
 
Predictors of bleeding  
 Few publications have outlined the maternal and pregnancy characteristics 
associated with bleeding, most of which have evaluated predictors using unadjusted 
analyses. Only one previous study has systematically investigated the maternal 
predictors of bleeding in a general obstetric population.1 This research found that 
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women of advanced maternal age, with passive smoking exposure, prior preterm 
birth, multiple prior elective terminations and prior miscarriages were more likely to 
experience intense vaginal bleeding, as measured by several characteristics 
including heaviness, duration, and index of total blood loss. 
 Another recent study of emergency department visits for vaginal bleeding 
found that Hispanic and younger (ages 20-29) women had higher rates of 
Emergency Department visits than other subpopulations studied. This analysis was 
based on a national database of Emergency Department visits, and may reflect 
national patterns in access to care.74  
 Other studies have also reported unadjusted associations with increasing 
maternal age, minority race/ethnicity, prior obstetric outcomes (induced abortion, 
miscarriage, stillbirth, preterm delivery), or use of assisted reproductive 
technologies.5,75,76  
 
Sources of vaginal bleeding in early pregnancy  
 A bleeding episode in pregnancy may have several sources. Most 
superficially, bleeding may result from vaginal or cervical pathology. This could be 
due to a local lesion, inflammation, or a polyp.77,78 Bleeding may also be related to a 
uterine fibroid.79 Very early bleeding may also be related to physiological changes 
associated with implantation,80 or with usual cycles of menses.81 
 Bleeding may also occur due to low levels of progesterone. Presence of 
sufficient levels of progesterone during pregnancy is required for pregnancy 
maintenance.82 Decreasing progesterone levels are the trigger for the onset of 
menses during the usual menstrual cycle. If progesterone levels decrease during 
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pregnancy, it is conceivable that bleeding episodes may occur, by a mechanism 
similar to what triggers the onset of menses.82 More details about the potential role 
of progesterone can be found in “Biologic Mechanisms.” 
Bleeding may also occur in areas where the placenta and fetal membranes 
detach from the uterine wall, similar to the process underlying placental abruption in 
later pregnancy. Potential mechanisms underlying the detachment are outlined in 
“Biologic Mechanisms”. This separation can result in subchorionic bleeding, which 
may be observable on ultrasound as a subchorionic hematoma (SCH). SCH are 
found in approximately 20% of patients who present to a hospital with vaginal 
bleeding,80,83,84 and are rare in general obstetric populations.85 SCH have been 
associated with alterations in serum markers of fetal well-being.86 It has been 
hypothesized that clinically recognized vaginal bleeding is the result of subchorionic 
bleeding that escapes into the cervical canal.87  
 Studies have found associations between the presence of a SCH and 
adverse obstetric outcomes, such as miscarriage, preterm birth, and fetal growth 
restriction.88-90 The interplay between SCH, vaginal bleeding, and miscarriage has 
also been investigated, with some findings that presence of vaginal bleeding alone 
(without evidence of SCH) is an independent risk factor for miscarriage.85,91 On the 
other hand, some studies have found that the presence of a SCH does not adversely 
affect obstetric outcome, particularly for SCH detected in the first trimester among 
women with bleeding.83,92-95 Some studies concluded that SCH are common and 
insignificant sonographic findings in women with vaginal bleeding.83,94  
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 Specific characteristics of SCH, such as size, location, and gestational age at 
formation, have also been associated with certain outcomes. Specifically, large-
volume SCH have been associated with poor obstetric outcome,91,96 while other 
reports suggest that the location of SCH is more important in determining pregnancy 
outcome.90 Studies of the size of SCH must be interpreted with caution, however, as 
the size of a SCH is determined by the amount of bleeding in the subchorionic space, 
as well as the amount of external vaginal bleeding that has occurred.85 The time at 
which the ultrasound is conducted in relation to symptoms may bias SCH size.  
 Although SCH are found in a substantial proportion of women who present 
with vaginal bleeding, SCH are not found in all women who experience vaginal 
bleeding, likely due to the fact that the blood has not accumulated internally for 
visualization.83 It is possible that the origins of these cases of vaginal bleeding are 
similar to the physiologic processes underlying the development of SCH.  
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C. BLEEDING AND PREGNANCY OUTCOMES 
 
 Although the underlying source of bleeding episodes remains unclear, the 
relationship between bleeding symptoms in pregnancy and various pregnancy 
outcomes has been investigated.4,85 Studies of adverse outcomes in both early and 
late pregnancy are briefly reviewed. 
 
Miscarriage 
 Women who present to the clinic or emergency department with early 
pregnancy bleeding are usually considered to have a ‘threatened abortion’. 
Approximately 35 - 66% of women hospitalized with threatened abortion proceed to 
miscarriage.76,97-99 Women with threatened abortion and ultrasound-detected fetal 
cardiac activity have a lower risk of miscarriage, ranging from 5 to 23%.100-103 These 
reports of the risk of miscarriage are based on clinical populations whose symptoms 
and outcomes are collected retrospectively in obstetric clinics or emergency 
departments.  
 Nine previous studies have been identified that examined the relationship 
between vaginal bleeding and miscarriage.5,76,98,99,104-107 These are summarized in 
Table 2.1. Most studies have reported some relationship between early pregnancy 
bleeding and miscarriage. Gracia and colleagues found that a complaint of bleeding 
was associated with miscarriage in their study population recruited in an urban 
emergency department (OR 7.4, 95% CI 5.7, 9.4).104 Weiss et al. conducted a 
similar analysis among women presenting for prenatal care in several sites 
throughout the country and reported an OR of 2.5 (95% CI 1.5, 4.3) for the 
relationship between light bleeding and miscarriage and an OR of 4.2 (1.6, 10.9) for 
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heavy bleeding and miscarriage.5 A less stable estimate of the OR was also 
provided by Chung et al., who reported that vaginal bleeding similar to menses was 
associated with miscarriage (OR of 10.5; 95% CI 1.5, 74.4) when compared to light 
bleeding.98 This study was conducted among 1000 consecutive bleeding cases 
presenting to a university hospital. Tongsong et al. reported a risk ratio (RR) of 2.9 
(95% CI 1.1, 8.0) for the relationship between first trimester threatened abortion and 
miscarriage.105 Strobino and Pantel-Silverman published a report showing that 
moderate or heavy bleeding was related to pregnancy loss of both a normal (OR 3.6; 
95% CI 2.1, 6.2) and abnormal karyotype (OR 4.9; 95% CI 2.1, 11.6).76 However, 
slight bleeding was only associated with a miscarriage of a normal karyotype (OR 
2.7; 95% CI 2.0, 3.6).76 Bennett et al. found that the risk of miscarriage more than 
doubled when bleeding occurred in the first eight weeks of pregnancy, compared to 
later episodes of bleeding.91 The remaining studies describing the relationship 
between bleeding and miscarriage used unadjusted tabular analyses to report the 
risk of miscarriage among those who reported bleeding and those who did 
not.99,106,107 Additional details about these studies are listed in Table 2.1.  
 However, these studies have important limitations. No uniform definition of 
bleeding has been used in the literature; some studies focused on bleeding 
quantified by number of pads used and other studies included light spotting in their 
bleeding definition. Most studies were prenatal clinic- or hospital/emergency 
department-based studies of pregnant women seeking care. Recruitment only from 
prenatal clinics is especially difficult for studies of miscarriage because many 
miscarriages occur before entry to prenatal care. Additionally, recruitment in a 
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hospital setting only captures the most serious episodes of bleeding that occur as a 
direct consequence to miscarriage. Thus, to have complete ascertainment of all 
women experiencing bleeding during pregnancy, a community- or population-based 
recruitment design is preferred, permitting enrollment of participants very early in 
pregnancy, before entry to prenatal care.   
 Another drawback of the published literature is that presence of vaginal 
bleeding was an eligibility criterion in almost all of these studies. Because only 
women with bleeding were assessed, the conclusions that can be drawn from these 
studies are limited. These studies do not have an appropriate comparison group to 
which the risk of miscarriage can be compared. Many miscarriages are not 
associated with any symptoms of bleeding. Some of the studies categorized different 
‘types’ of bleeding (such as light, heavy, etc.) in order to create different groups for 
comparison. The study by Weiss and colleagues was the only analysis that used a 
general clinic-based population of pregnant women, rather than focusing only on 
those with bleeding symptoms.5 This study enrolled participants between 10 and 14 
weeks of pregnancy, not accounting for pregnancy losses occurring prior to that time. 
The reported results are for the relationship between bleeding in the month prior to 
enrollment and second trimester miscarriage and the overall focus of the study is 
primarily on the effect of bleeding and later pregnancy outcomes. A case-control 
study by Strobino and colleagues likewise only reports on the relationship between 
first-trimester bleeding and second-trimester fetal loss (defined as loss occurring up 
to 28 weeks of gestation).76 
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Later pregnancy outcomes 
 Vaginal bleeding in early pregnancy has also been related to a variety of 
outcomes that occur later during pregnancy. Studies have focused on preterm 
birth,2,108-110 small-for-gestational age births,109,111 low birthweight,2,75,112 placental 
abruption113 and rate of Caesarean section.114,115 This literature has been 
systematically reviewed.4 It is clear that vaginal bleeding is of interest not only with 
regards to early pregnancy outcomes, but also for later outcomes. Proper 
characterization of this symptom is essential as an initial step towards understanding 
its role in pregnancy. 
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D. BIOLOGIC MECHANISMS 
 A bleeding episode in pregnancy may be associated with a variety of 
pregnancy outcomes, including miscarriage. Evidence from the basic science 
literature provides some insight into biologic mechanisms that may underlie the 
association between bleeding and miscarriage. 
 
Miscarriage as a disorder of placentation 
 A hormonally functional placenta begins to produce sufficient amounts of 
progesterone to support the pregnancy around the 7th week of gestation.82,116 
Progesterone plays a vital role in maintaining pregnancy, by preventing uterine 
contractility, maintaining the endometrium, and altering the maternal immune 
response to prevent rejection of the embryo.117 If sufficient amounts of progesterone 
are not produced, miscarriage may result.82 
 Some evidence also suggests that during the first ten weeks of gestation, the 
fetus develops in a largely hypoxic environment.118,119 The gestational sac serves as 
a barrier to prevent oxygen transfer to the fetus, whose metabolism is largely 
anaerobic during this time.120 Additionally, extravillous trophoblastic cells of the fetus 
migrate to the edge of the intervillous space during most of the first trimester to plug 
the spiral arteries and seal off the intervillous space. This creates a trophoblastic 
shell that protects the fetus from the maternal blood supply.121 Furthermore, at this 
time, the spiral arteries are narrow, high-resistance vessels that inhibit blood flow.122 
These barriers between the maternal and fetal circulation create a physiologically 
hypoxic environment during early pregnancy. Early onset of maternal-fetal circulation 
may expose the fetus to high levels of oxidative stress. Specifically, free oxygen 
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radicals interact with lipids, proteins, and DNA, to destroy membranes and contribute 
to cellular dysfunction and cell death. Overall, oxidative stress damages fetal tissues, 
disrupts organogenesis, and affects other developmental processes during this 
critical period of pregnancy.120,123  
 At about ten weeks of gestation, the plugs located at the periphery of the 
placenta begin to disintegrate, and maternal-fetal circulation begins in the intervillous 
space.123 The spiral arteries of the placenta transform into low-resistance vessels to 
accommodate increased blood volume. By fourteen weeks of pregnancy, maternal 
blood flows freely into the placenta, permitting the exchange of nutrients and other 
essential factors.16 By this time, fetal antioxidant enzymes are functional, providing 
the fetus with additional defense mechanisms to maintain the balance of oxidative 
factors.124 
 A proportion of miscarriages may result from premature onset of maternal 
blood flow and fetal exposure to oxidative stress.16,118 Due to defective placentation, 
the trophoblastic shell may be fragmented and inadequately prevent the entry of 
maternal blood into the intervillous space.121,125 Premature onset of circulation 
exposes the fetus to the damaging effects of free oxygen radicals. Markers of 
oxidative stress were increased in miscarriage tissues compared to controls.126 
Bleeding into the intervillous space may also lead to subchorionic bleeding, which 
may be clinically observed as vaginal bleeding or observed on ultrasound (see 
“Sources of vaginal bleeding in pregnancy”). Subchorionic bleeding has been 
associated with increased production of free oxygen radicals, and may exert a 
mechanical space-occupying effect that interferes with fetal presence in the 
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uterus.127 Furthermore, subchorionic bleeding may cause a chronic inflammatory 
reaction and uterine contractions that directly lead to miscarriage.127 Extra-cellular 
matrix degradation may also destabilize and weaken fetal membranes, increasing 
the likelihood of pregnancy loss.125 These defects in placentation probably originate 
very early in gestation; the processes described may relate to anomalies of 
implantation or early fetal cell organization.121 
 
Miscarriage and bleeding associated with other physiological changes 
 Bleeding could also lead to a cascade of other events that may be involved in 
the pathophysiology of miscarriage. A hematoma may result in an inflammatory 
reaction, leading to uterine contractions and loss of pregnancy.127 Some studies 
have described links between cytokine imbalances and bleeding and 
miscarriage,128,129 while this has been disputed by other authors.130 Little is known 
about the role of the immune response predisposing to early pregnancy loss. 
Previous work suggested that a Th2-biased immune response may be characteristic 
of women with miscarriage or threatened abortion;128 however, this paradigm has 
recently become controversial due to new data describing the role of previously 
uninvestigated cytokines and other immune cells in early pregnancy loss.131 Overall, 
immune and inflammatory mediators may be altered during threatened abortion, 
although no definitive conclusions exist.  
 Infection may mediate the relationship between bleeding and miscarriage.132 
Infection during pregnancy has been implicated as a factor underlying a variety of 
adverse outcomes, including preterm birth,133 and may predispose to some of the 
previously mentioned immune alterations. Investigations of the role of infection in the 
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manifestation of bleeding symptoms have concluded that bleeding in pregnancy may 
be the only symptom related to a concurrent underlying infection of the reproductive 
tract.104,134 On the other hand, early pregnancy bleeding may also result in infection 
by opening access to areas of the reproductive tract that were previously 
inaccessible to pathogens. 
 Endocrinologic changes occurring in early pregnancy may also be associated 
with bleeding and loss. Alterations of levels of hormones and metabolic factors 
among women with miscarriage compared to women whose pregnancy continues 
have been found in studies of women with vaginal bleeding. The central role of 
progesterone in maintaining pregnancy has been previously discussed.117 
Differences in the levels of human chorionic gonadotrophin,104,135,136 thyroid 
hormones,136 and endocannabinoids137 have been reported for women with 
miscarriage compared to women with continuing pregnancy. Although these 
differences may simply be representative of the overall health of the pregnancy, it is 
noteworthy that different hormone levels have been documented by miscarriage 
status among women with bleeding. Some studies also contain an external control 
group of women who did not experience any vaginal bleeding. In these comparisons, 
lower levels of human chorionic gonadotrophin135 and higher levels of thyroid 
hormone136 were found among women with bleeding. There may also be a 
relationship between alterations of thyroid hormone levels and immune function.136 
All in all, it is clear that endocrinologic changes occur within the maternal system in 
response to miscarriage and also in response to an episode of bleeding. Whether 
these events are causally related remains unclear. 
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E. CONCEPTUAL FRAMEWORK 
 
 This project seeks to increase understanding of the implications of a bleeding 
episode in early pregnancy. We hypothesize that a bleeding episode during early 
pregnancy may indicate one of the following processes: 
1) a marker of pregnancy loss (e.g., bleeding may be related to infection, or 
abnormal placentation, which is the actual causative agent);  
2) the result of pregnancy loss (e.g., fetal demise may have occurred days or 
weeks prior to the onset of bleeding, where bleeding is merely a symptom of 
an event that has already occurred);  
3) a physiological phenomenon of early pregnancy (e.g. implantation 
bleeding).  
  
 Figure 2.1 summarizes some of the mechanisms underlying the relationship 
between vaginal bleeding and miscarriage, which were discussed in the previous 
section. In this analysis, we eliminate episodes that immediately precede pregnancy 
loss, so as to focus our efforts on understanding (1) and (3). 
 Although this model depicts potential mechanisms by which some pregnancy 
losses occur, it does not explain why so many women with symptoms of vaginal 
bleeding do not have a miscarriage. Variations in bleeding intensity or timing may be 
related to differences in outcomes. Many of the processes depicted in the figure are 
unmeasured in this study. As a beginning step, characterization of the patterns of 
bleeding and related maternal characteristics will provide a foundation for future 
studies in this area. 
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F. PUBLIC HEALTH SIGNIFICANCE 
 
 Although vaginal bleeding may be associated anecdotally with pregnancy 
loss (perhaps due to the fact that bleeding is often a primary symptom of loss), 
understanding the characteristics and distribution of first trimester bleeding will 
clarify its role in predicting adverse outcomes. This project will evaluate the 
relationship between vaginal bleeding experienced by some women in early 
pregnancy and miscarriage. Based on the review of the identified literature on 
this topic to date, it is evident that there is little solid data in this area and that an 
analysis of RFTS data can contribute a great deal of knowledge to this field. This 
research will inform future studies of early pregnancy, as the timing, frequency, 
or intensity of symptoms may provide clues of the gestational/developmental 
stages at which bleeding may be most relevant. Clinically, any research that 
gives insight to the processes and mechanisms operating during early pregnancy 
is useful. This time period in pregnancy is not well understood, despite the fact 
that the most common adverse outcome of pregnancy, miscarriage, frequently 
occurs during this time.  
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Table 2.1. Previous studies of vaginal bleeding and miscarriage. 
 
 
 
 
Author 
(year) n Setting Eligibility 
Bleeding 
ascertainment Relationship examined Effect (95% CI) 
Gracia et 
al. 
(2005)104 
2,026 Case-control study in an 
Emergency Department 
Philadelphia, PA 
Patients presenting with pelvic 
pain or vaginal bleeding in the 
first trimester, before definitive 
diagnosis 
Information obtained 
at time of presentation 
Any bleeding and 
miscarriage versus no 
bleeding 
OR 7.4 (5.7, 9.4) 
Weiss et al. 
(2004)5 
16,506 Prospective, multicenter 
cohort, objective is to 
examine first- and 
second-trimester serum 
and ultrasound markers 
to assess Down 
syndrome risk, 14 
centers in USA 
Unselected obstetric population Interview at 10-14 
weeks gestation, 
bleeding in 4 weeks 
prior to enrollment 
only 
Light bleeding and 2nd 
trimester miscarriage 
versus no bleeding; 
heavy bleeding and 2nd 
trimester miscarriage 
versus no bleeding 
Heavy bleeding: 
OR 4.2 (1.6, 10.9) 
 
Light bleeding: 
OR 2.5 (1.5, 4.3) 
Chung et al. 
(1999)98 
739 Cohort study of 1000 
consecutive women in a 
university teaching 
hospital 
Hong Kong 
 
Pregnant patients presenting 
with a history of bleeding in the 
past 24 hours 
All symptomatic, 
bleeding assessed at 
time of presentation 
Heavy bleeding and 
miscarriage versus light 
bleeding; increasing 
bleeding and miscarriage 
versus decreasing 
bleeding 
Heavy bleeding:  
OR 10.5 (1.5, 74.4) 
 
Increasing bleeding:  
2.3 (1.3, 4.1) 
Everett 
(1997)99 
626 Rural community study  
United Kingdom 
Pregnant women with hospital 
discharge summaries indicating 
bleeding, or who complained of 
bleeding in a visit to the 
ultrasound, antenatal, or midwife 
clinic 
Charts and discharge 
summaries reviewed 
for bleeding before 20 
weeks of gestation 
Descriptive analysis Bleeding occurred in 21% of 
pregnancies. 
 
Miscarriage occurred in 12% 
of pregnancies 
Bennett et 
al. (1996)91 
516 Retrospective chart 
review of clinic patients 
with bleeding 
Boston, MA 
Patients with vaginal bleeding, a 
subchorionic hematoma, a single 
gestational sac with identifiable, 
regular heart beat on ultrasound  
All symptomatic; 
bleeding occurring at 
6-13 weeks of 
gestation 
Compared miscarriage 
among early bleeding (≤8 
weeks) versus later 
bleeding (>8 weeks) 
Bleeding ≤8 weeks: 
13.7% risk of miscarriage 
Bleeding >8 weeks: 
5.9% risk of miscarriage 
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Tongsong 
et al. 
(1995)105 
255 Case-control study, 
patients seeking care for 
threatened abortion in a 
hospital 
Thailand 
Threatened abortion with visible 
heart beat 
All cases were 
symptomatic, controls 
were not asked about 
bleeding episodes 
Comparison group was 
265 uncomplicated 
pregnancies undergoing 
ultrasound for size 
measurements 
Study group had a 
miscarriage rate of 5.5% 
compared to miscarriage rate 
of 1.9% in comparison group 
Strobino et 
al. (1987)76 
889 Case-control study, 670 
chromosomally normal, 
219 chromosomally 
abnormal losses 
compared to 3089 
controls from a general 
obstetric population 
New York City, NY 
Women with fetal losses after 14 
weeks of gestation composed 
the case groups. 
 
Interview at time of 
loss (cases), during 
2nd trimester 
(controls); bleeding in 
first trimester, info on 
number of episodes 
and date of 
onset/severity of the 
first episode only 
Bleeding in the first 
trimester was compared 
between cases and 
controls, who were 
selected from a general 
obstetric population 
Heavy bleeding associated 
with both chromosomally 
normal (OR 3.6 [2.1-6.2]) and 
abnormal (OR 4.9 [2.1, 11.6]) 
loss. 
 
Light bleeding: OR 2.7 (2.0, 
3.6) for chromosomally normal 
loss, but not with 
chromosomally abnormal loss 
(OR 1.1, [0.7, 1.9]) 
Evans et al. 
(1970)107 
3082 Prospective cohort of 
prenatal clinic patients 
Australia 
All pregnant prenatal patients 
were asked about bleeding 
Interview at first 
prenatal visit, less 
than 13 weeks of 
gestation, and follow-
up questions at every 
subsequent visit 
Descriptive Incidence of miscarriage was 
5.6%, two-thirds of cases not 
preceded by bleeding 
Johannsen 
(1970)106 
266 Prospective cohort of a 
hospitalized population 
with bleeding 
Denmark 
Bleeding episode requiring 
admission to hospital  
All symptomatic; 
bleeding occurring 
prior to 20 weeks 
gestation 
Descriptive 50.8% of patients miscarried 
*OR: odds ratio;  CI: confidence interval     
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Figure 2.1. Conceptual model outlining the relationship between bleeding and 
miscarriage, Right From the Start. 
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CHAPTER 3 : METHODS 
 
A. RIGHT FROM THE START  
Right From the Start (RFTS) is a multi-phase and multi-center cohort 
study of early pregnancy. The study is referred to colloquially by participants and 
the community as Right From the Start; however, different grants provide funding 
to allow different phases of the study to focus on unique exposures occurring in 
early pregnancy. The different phases of the study are referred to by the 
research team, and in this proposal, by the order in which the phase was funded 
(RFTS 1, 2, 3). The phases of the study are united by similar study 
activities/protocols, recruitment methods, and questionnaires, with slight 
modifications in the timing of some study activities. Data from all phases of the 
study will be used for this project. 
 
RFTS Background and Eligibility 
 RFTS 1 began recruitment in 2000 in three areas of the United States: the 
Raleigh/Durham region of North Carolina, Galveston, Texas, and Memphis, 
Tennessee. This first phase was funded by the American Water Works 
Association Research Foundation to study the effects of water disinfection 
byproducts on birth outcomes in three cities of the United States. In 2004, RFTS 
1 ended, and recruitment began for RFTS 2, continuing only in North Carolina. 
RFTS 2 focused on the presence of fibroids and change in fibroid size during 
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pregnancy. In Spring 2007, RFTS 3 began recruitment. RFTS 3 and RFTS 2 
recruitment occurred simultaneously (see Table 3.1 for differences in eligibility 
criteria). RFTS 3 obtained a detailed, prospective assessment of non-prescription 
medication use and other pregnancy symptoms in early pregnancy. RFTS 2/3 
expanded to Nashville, TN in the summer of 2007, leading to a brief period of 
overlap in recruitment between the North Carolina and Tennessee sites. In late 
2007, recruitment stopped in North Carolina, and active recruitment continued 
only in Tennessee. RFTS 2 and 3 are funded by the National Institute of Child 
and Human Development. Figure 3.1 highlights the main events occurring on the 
timeline of RFTS study activities. 
 Despite a shift in focus with each phase of the study, the bulk of participant 
questionnaires and participant activities remained the same. All questions 
required for this project have remained the same throughout the eight year period 
under study. Eligibility criteria for the study are listed in Table 3.1.  
Notable changes in eligibility criteria between the phases of the study are 
highlighted in Table 3.2, which also includes other unique characteristics of each 
study phase. The main alterations in eligibility are summarized in these two 
points: 
 
1. RFTS 1 allowed recruitment up to the twelfth week of pregnancy by 
self-reported last menstrual period (LMP) at time of enrollment, while 
RFTS 2 and 3 required women to be less than 9 weeks pregnant by self-
reported LMP. 
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2. RFTS 3 had the additional eligibility criteria of only enrolling women 
prior to pregnancy and requiring participants to have daily access to the 
Internet. However, since RFTS 2 and 3 were enrolling participants 
concurrently and shared the same protocol, those participants without 
Internet access or who were already pregnant were enrolled in RFTS 2, 
lessening the concern for selection bias into this study phase. Other 
eligibility criteria and study activities remained the same for the two 
phases of the study. 
 
 Beyond these differences, the study activities and procedures for each 
phase of the study remained virtually the same, as described in ‘RFTS protocol.’  
 
RFTS Recruitment 
The RFTS study team builds on nearly ten years experience recruiting and 
enrolling participants during early pregnancy. Recruitment has always occurred in 
close collaboration with community organizations, including private obstetric clinics, 
university obstetric groups, health departments, and through the use of other 
recruitment methods such as bus advertisements, mailings to new homeowners, 
mass emails, flyers and information placed in pharmacies and other local points of 
interest. Although the study is not a random population-based sample, the goal of 
RFTS recruitment strategies has been to enroll a group of women that is more 
representative than a standard prenatal clinic-based sample. A strictly clinic-based 
sample has been previously shown to yield biased participant characteristics, 
potentially affecting results.138 Additionally, when studying miscarriage, basing a 
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study on a clinic-based population could lead to lower ascertainment of miscarriage 
since many women do not enter prenatal care until later in the first trimester. Table 
3.3 depicts the similarities and differences between characteristics of the RFTS 1 
Raleigh cohort and characteristics of all births in the Raleigh enrollment area, as 
obtained from 2001 Vital Statistics data. Maternal characteristics in the RFTS 1 
cohort and the general population were similar, with the exceptions that RFTS 1 
participants were, on average, more highly educated and less likely to be Latina. 
Strong efforts to remediate some of these dissimilarities have been undertaken in 
subsequent phases of RFTS, with a focus on minority recruitment. 
Table 3.4 summarizes the average gestational age at various stages of the 
study; women enroll in the study, on average, at a very early stage of pregnancy. 
Women who are not yet pregnant, but have been trying to become pregnant 
for no more than six months (RFTS 2) or three months (RFTS 3) are eligible to pre-
enroll in RFTS. Formal enrollment occurs when they become pregnant. All RFTS 3 
women are pre-enrolled; these women are also required to provide daily information 
about common symptoms and exposures via a web-based diary during the pre-
pregnancy period and during the first trimester. Based on current data, about 56% of 
pre-pregnant enrollees become pregnant within 6 months and formally enroll in the 
study.  
 By the end of November 2007, RFTS has screened 8026 women for eligibility 
to participate in the study. Sixty-one percent (n=4916) of these women were eligible 
and agreed to participate in the study. After enrollment, some women (1.9%, n=95) 
formally withdrew their consent to participate in the study. Reasons for withdrawal 
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include time constraints, health status changes, concern about pregnancy, too many 
study activities/demands, and an unwillingness to share personal/medical 
information. 
 Surveys among RFTS participants suggest that many reasons motivate 
women to participate in RFTS.139 The most common reasons include the free 
ultrasound and pregnancy test kits (for pre-enrolled participants). Many women also 
comment on their desire to contribute to knowledge about pregnancy complications 
and a sense of altruism.  
 
RFTS Participants 
Because of the multi-site nature of the study and some differences in 
recruitment strategies employed by each site, the study population differs slightly at 
each site (Table 3.5). For instance, the Galveston site successfully recruited many 
women from its local health department. As a result, the study population in 
Galveston has a greater proportion of minority and low-income women. Additionally, 
almost 30% of participants from the Memphis and Galveston sites were obese, a 
higher proportion compared to women recruited in North Carolina. The North 
Carolina population is highly educated and more white, reflecting the demographics 
of the cities where many participants enrolled. This population also has a higher 
consumption of alcohol during pregnancy. Table 3.5 summarizes the differences in 
study populations by site for variables of interest to pregnancy studies. Minority 
enrollment has also been a priority for RFTS. In an effort to enroll women with a 
wide range of characteristics, the study devoted special efforts to recruitment of 
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African-American and Latina women. Up to August 2007, 16.1% of subjects enrolled 
in RFTS 2 and 3 were African-American and 8.3% were Latina.  
 
RFTS Protocol 
Women are eligible to enroll in the study once they report a positive 
pregnancy test. During the enrollment process, a brief intake interview is conducted 
and an ultrasound is scheduled. Signed, informed consent is obtained from 
participants prior to the ultrasound.  
Differences among RFTS phases were previously highlighted. Figure 3.2 
outlines participant activities. Recruitment of a diverse, representative study 
population has been a focus of RFTS since its inception (see ‘RFTS Recruitment’ for 
details). Collaboration with public and private obstetric clinics, community coalitions, 
and direct mailings were used to achieve a representative sample of the source 
population. A toll-free study telephone number and website (www.mom2be.org) is 
provided on all recruitment materials, facilitating communication and dissemination 
of information about the study. Recruitment is not targeted to participants with 
specific concerns about miscarriage or specific exposures associated with 
miscarriage, but rather more generally towards all pregnant women, in order to 
increase the representativeness of the RFTS study sample. 
 Study activities are concentrated in the first trimester. At enrollment, 
participants complete a brief baseline intake interview, focusing on demographic 
information and symptoms and behaviors of early pregnancy, such as nausea and 
vomiting, alcohol intake, and cigarette smoke exposure.  
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An ultrasound is scheduled as soon as possible after the fifth week of 
pregnancy. The ultrasound serves as an incentive for participants to join the study 
and assesses fetal viability and gestational age. With the inclusion of ultrasounds 
into the study protocol, RFTS gestational age estimation is of highest possible 
quality. All study sonographers have at least five years experience prior to joining 
the study, specialize in early pregnancy ultrasounds, and are trained to conduct 
study ultrasounds. A previous validation substudy of ongoing pregnancies in RFTS 1 
found that self-reported LMP, on average, estimates gestational age to be 0.8 days 
(SD 8.0, median 0) longer than ultrasound-based estimates for live births in this 
cohort.140 Proportions of births classified as preterm based on ultrasound and LMP-
based methods were similar, and the overall conclusion was that self-reported LMP 
is a reliable indicator of gestational age in RFTS.140 In a miscarriage analysis, 
reliance on self-reported LMP estimates is necessary because restricted early fetal 
growth among miscarriages may systematically affect ultrasound-based dating of the 
pregnancy.141,142 Our use of LMP-based estimates is further justified by the high 
quality LMP dates provided by our participants.  
A comprehensive telephone interview takes place at the end of the first 
trimester (no later than 16 6/7 weeks of pregnancy) for RFTS 2 and 3. In RFTS 1, an 
initial interview was conducted during the first trimester, and a follow-up interview 
was completed around 20 weeks of pregnancy. Similar questions were asked during 
both interviews. This computer-assisted telephone interview (CATI) obtains detailed 
information about a broad range of information about important covariates, including 
details about demographic characteristics (race, education, income level), comorbid 
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conditions (diabetes, hypertension, thyroid dysfunction), maternal behaviors 
(caffeine intake, smoking status, alcohol use, nutritional exposures), and other 
maternal characteristics (height, weight, reproductive history). This interview also 
collects a great deal of information regarding the early pregnancy period, from which 
bleeding data and associated symptoms will be obtained.  
The rich amount of information collected from RFTS participants at this early 
stage of pregnancy makes it an ideal dataset for exploring questions related to 
exposures and symptoms of the early pregnancy period. The average gestational 
age of completion for each of these components of the study is displayed in Table 
3.4. An overview of the type and extent of data collected in RFTS is found in Table 
3.6. First trimester CATIs are conducted by staff at the Batelle Memorial Institute, a 
research organization which is subcontracted by RFTS. This organization maintains 
rigorous training and quality control activities for its interviewers and has been 
working with the study since its inception.  
Women who are not yet pregnant are eligible to pre-enroll in the study. Pre-
enrolled participants receive free monthly pregnancy test kits to encourage early 
pregnancy recognition. Pre-enrolled women must have been attempting pregnancy 
for fewer than six months (RFTS 1 and 2) or fewer than three months (RFTS 3) to be 
eligible, in order to avoid bias associated with enrollment of a study population of 
infertile or sub-fertile women.  
Pre-enrolled participants in RFTS 3 complete an initial interview and submit 
daily web-based diaries during the pre-pregnant period and throughout the first 
trimester. The diary is designed to take less than two minutes to complete and 
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queries common symptoms and exposures of the early pregnancy period. The diary 
format for collection of data is preferred in this situation not only because of the ease 
with which data can be collected and compiled on a daily basis, but also because 
questions of a sensitive nature (sexual intercourse, vaginal bleeding, use of alcohol 
while pregnant) may be more accurately and feasibly collected using a diary 
format.143,144 Additional questions documenting presence of spotting/bleeding 
episodes are included in the diary for the validation component of the study.  
 The web-based interface is available in English to individuals with a valid 
username and password, and all information submitted via diary is time-stamped 
and transmitted in an encrypted format. Study staff send reminders to participants 
who do not complete their diary entry within 48 hours of availability.  
 A 2005 pilot study of 40 RFTS women overwhelmingly suggested that a web-
based diary is a feasible and acceptable data collection tool. More than 95% of 
eligible diary entries were completed in this pilot study. The diary captured more 
reports of symptoms and medication use compared to a telephone interview several 
weeks later. The daily diary has now been in use for at least twelve months in the 
RFTS study population. More information about exposure assessment and validation 
will be provided in the following sections of this chapter. 
Once pre-enrolled women report a positive pregnancy test, participants 
formally enroll in the study. After formal enrollment, the pre-enrolled sub-group of 
women continues to provide daily diary information throughout the first trimester. 
Beyond these activities unique to the RFTS 3 cohort, this group completes all other 
study activities in the same manner as other RFTS participants.  
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RFTS Data Management 
A rigorous system for managing data and maintaining quality control has 
been in place since the start of RFTS. The data management system contains many 
internal checks to assure the integrity of the data. The database draws on data 
obtained from several sources (Battelle first-trimester CATIs, diary data, intake 
interviews, ultrasound and medical records information) and does not allow entry of 
implausible values or values that do not fulfill logic check parameters. Regular 
checks of vital variables (such as gestational age at end pregnancy) are conducted 
to ensure that all values are within an acceptable range. Reports of relevant metrics 
(recruitment, enrollment, outcomes) are regularly distributed to the study team and 
data management issues and inconsistencies are discussed and resolved at 
investigators meetings. Error detection, correction, and tracking procedures are 
monitored by study staff. In addition to these built-in data checks, careful cleaning of 
the data is conducted prior to beginning any analyses. Any implausible or unrealistic 
data are discussed within the study team to determine the most efficient and 
appropriate way to move forward. 
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B. EXPOSURE ASSESSMENT 
 
Data on vaginal bleeding and spotting were obtained in the first trimester 
interview. Specific questions regarding vaginal bleeding are listed in Appendix 1. 
Appendix 2 highlights additional questions asked specifically of women with a loss, 
available for RFTS 2 and 3. The wording of these questions is slightly modified for 
women who have had a miscarriage (for example, instead of “since you got 
pregnant,” the interviewer asks, “during your recent pregnancy,”). Detailed 
information, including timing, duration, heaviness, color, and pain associated with 
each episode, was obtained for all participants.  
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C. OUTCOME ASSESSMENT 
 
Participants are asked to complete a pregnancy outcome form when a live 
birth, miscarriage, or other pregnancy outcome occurs. For participants who do not 
self-report an outcome, several alternate mechanisms exist to obtain this information. 
Early losses are detected in Section A of the first trimester interview, which is 
completed by all participants who have not yet submitted a pregnancy outcome form. 
Additionally, linkage to North Carolina birth certificates and fetal death certificates 
captures outcome information about live births and fetal deaths occurring after 20 
weeks gestation. This data is up-to-date through 2008. Medical records are 
requested for all participants.  
RFTS consent includes a HIPAA Authorization form and consent for release 
of medical records. All records pertaining to the RFTS pregnancy are abstracted, 
including records from the prenatal care site, records from emergency department or 
hospital visits, as well as discharge summaries from time of delivery. Trained study 
staff supervise and conduct all abstraction activities.  
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D. COVARIATE ASSESSMENT 
 
Data on other variables used in these analyses are self-reported by 
participants during the first trimester interview, with the exception of fibroid status. 
The presence of fibroids is assessed using the early pregnancy ultrasound. Variable 
specification was based on substantive considerations and the distribution of 
observations in relation to the outcome, with the objective being to specify each 
variable parsimoniously while retaining the ability to distinguish important subgroups 
of the population. 
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E. HYPOTHESES AND ANALYTIC APPROACH 
 
Overall Approach and Variable Definitions 
 Univariate and bivariate analyses were initially used to describe the 
distribution of covariates. Stratified analyses were conducted to increase 
familiarity with all possible categorizations of the data prior to multivariate 
modeling. These steps are essential to ensure that the summarizations and 
smoothing produced by the modeling process are valid and that assumptions are 
upheld.  
 Covariates and outcomes were stratified by bleeding status for descriptive 
analysis of the data. Exploratory analyses of continuous variables were undertaken 
in order to determine the most appropriate way of modeling continuous variables. 
Continuous variables were modeled as splines, and, if appropriate, as categorical 
variables, with category cutpoints determined by a priori knowledge and informed by 
the patterns observed in the data, with the intent of achieving a precise and stable 
estimate for the relationship between each category and the outcome. Similar 
strategies guided collapsing of multi-category variables into fewer categories.  
 Potential covariates were included in models based on a priori relationships 
identified on a directed acyclic graph, strength of association in stratified analyses, 
or based on substantive area knowledge. Inclusion of covariates in predictive 
models was determined by a likelihood ratio test comparing nested models, with an 
alpha of 0.15. 
 The full dataset was restricted to observations that are not missing or 
uncertain for essential values such as last menstrual period and gestational age at 
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outcome or loss to follow-up. Because some women enroll in RFTS more than once, 
only the first pregnancy for which data exists was used for this analysis. Ectopic 
pregnancies were excluded from the analysis. Women who had induced abortions 
were included in the analysis and censored at the time of induced abortion. 
Participants who did not complete the first trimester interview were not included in 
the analysis. Additionally, women for whom the last menstrual period occurred less 
than twenty weeks since the creation of the dataset were not included in the analysis. 
 Bleeding was analyzed according to several definitions. A dichotomous 
variable was created based on the response to whether any bleeding occurred 
during pregnancy (Appendix 1, question H8a). As appropriate, a multi-category 
variable was also used in some analyses, with categories of no bleeding, spotting 
only, light bleeding, or heavy bleeding, based on responses to question H10a 
(Appendix 1). The duration of an episode, color, and associated pain, were also 
incorporated into the definition or used as further stratification variables (Appendix 1, 
questions H9, H10, H11). Episodes of bleeding that terminate within four days of a 
reported date of miscarriage were not included in the bleeding definition, as these 
episodes may overlap with symptoms of miscarriage. Sensitivity analyses were 
conducted as part of this project to estimate the impact of varying the termination 
cutpoint to seven days.  
 The outcome, miscarriage, was coded as a binary variable. The time at which 
a miscarriage occurs was also incorporated into survival models for Aim 2. 
 Covariates of interest and their potential categorization schemes are outlined 
in Table 3.7. Continuous variables, such as age, body mass index, and percent 
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poverty threshold, were evaluated as continuous variables initially to determine the 
best way to model the covariate-outcome association. Variables were specified to 
include quadratic or cubic terms or splines. The specification that best fit the 
observed relationship was used to model the variables. If appropriate, continuous 
variables were categorized. Sample category cutpoints are listed in the table. 
Categories for body mass index (BMI) were defined according to the criteria of the 
National Heart, Lung, and Blood Institute (Underweight <18.5; Healthy weight 18.5-
24.9; Overweight 25.0-29.9; Obese ≥30.0). Percent poverty threshold was calculated 
according to the 2008 Poverty Guidelines, as determined by the Department of 
Health and Human Services, accounting for the size of family unit. These guidelines 
are used in determining financial eligibility for federal programs, and are informally 
referred to as the “federal poverty level.” Data for all other covariates were based on 
self-reported information obtained from the intake and the first trimester interview, or 
from the first trimester ultrasound. 
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Aim 1 
 
Determine the usual patterns and characteristics of vaginal bleeding and 
spotting in pregnancy. Identify the maternal characteristics that predict vaginal 
bleeding and spotting in early pregnancy. 
Description  
 This aim had two components: a descriptive analysis (Sub-aim 1.1) and 
identification of maternal predictors of bleeding (Sub-aim 1.2). These components 
are discussed separately. 
 Sub-aim 1.1: To begin the process of analyzing the data, a descriptive 
analysis of first trimester bleeding, was undertaken. This characterization was 
essential for subsequent analysis steps. Bleeding data was obtained from the first 
trimester interview questions and follow-up interview (RFTS 1 only) (Appendix 1 and 
2). 
 Sub-aim 1.2: This component assessed which maternal characteristics 
predicted the presence of one or more bleeding episodes. The maternal 
characteristics that predicted the heaviness of a bleeding episode were also 
assessed. Data for all covariates and bleeding were obtained from the baseline and 
first trimester interviews and follow-up interview (RFTS 1 only). 
Hypotheses 
 Sub-aim 1.1: Because this is a descriptive analysis, no hypotheses were 
associated with this specific aim.  
 Sub-aim 1.2: Based on only one study of maternal predictors of bleeding in 
pregnancy, we hypothesized that advanced maternal age, passive smoking 
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exposure, prior preterm birth, and multiple prior miscarriages and elective 
terminations were associated with more intense bleeding episodes.1 Based on 
substantive area knowledge, we also hypothesized that overweight or obese status, 
maternal history of diabetes, menstrual cycle function (measured by the length of 
menstrual cycles), and current or previous smoking were associated with occurrence 
and heaviness of bleeding in pregnancy.  
Analytic plan 
 Sub-aim 1.1: All bleeding characteristics were fully explored (including all 
components of the questionnaire, such as timing, duration, associated pain, color, 
and heaviness) and summarized. Bleeding characteristics were stratified by 
gestational age periods and heaviness of bleeding. Crude descriptions of the 
association between bleeding, covariates, and pregnancy outcomes were also 
completed.  
 Time periods of interest included very early reports of spotting/bleeding, 
coinciding with the time of implantation and the time of expected menstrual period. 
These times were explored, accounting for the length of each woman’s menstrual 
cycle. Additionally, reports of bleeding between 8 and 12 weeks of pregnancy were 
of interest because this is the time that maternal-fetal circulation begins to develop. 
Cyclic bleeding patterns that coincide with the expected timing of the usual 
menstrual cycle were also assessed. 
 For miscarriage, careful attention was given to bleeding occurring 
immediately prior a reported pregnancy loss. These episodes of bleeding did not 
contribute to the main definition of bleeding in pregnancy, as this bleeding is likely 
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specifically related to passing of fetal products of conception. Bleeding episodes that 
terminate fewer than four days before the miscarriage were excluded from 
consideration, with sensitivity analyses conducted in later components of the project 
to determine the impact of using the four-day cutpoint. 
 Sub-aim 1.2: All covariates listed in Table 3.7 were assessed. Several 
analytic steps were followed. These steps sought to evaluate the relationship 
between maternal characteristics and occurrence of bleeding, and the association 
between maternal characteristics and heaviness of bleeding.  
First, a logistic regression model was used to evaluate these predictors in 
relation to a dichotomous outcome (bleeding versus no bleeding). The contribution 
of each predictor was evaluated on the basis of a likelihood ratio test, testing 
whether each predictor contributed substantially to the model. Decisions will be 
made based on an alpha level of 0.15, considering predictors whose likelihood ratio 
test p-values are less than 0.15 to be substantial contributors to the model, and thus, 
important predictors of the outcome. This proposed model is mathematically 
represented by Equation 3.1. 
 
Y is the outcome, denoted by presence (Y=1) or absence (Y=0) of bleeding 
symptoms for each woman, indexed by i. The xk represents all the k = 1,…, K 
predictor variables that will be included in the model, which are depicted in Table 3.7. 
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The βk represent the coefficients of these predictor variables, and the β0 represents 
the baseline log odds of the outcome in all reference categories. 
 To evaluate the association between maternal characteristics and severity of 
bleeding, additional analyses were completed. Severity of bleeding was coded as a 
four-level ordinal variable (no bleeding, spotting, light bleeding, heavy bleeding). The 
definitions for the categories of this variable come from question H10a (Appendix 1), 
and are outlined in Table 3.8. All covariates included in the first part of this analysis 
were similarly assessed for their predictive ability.  
 A multinomial logistic model was used to evaluate the relationship between 
maternal characteristics and bleeding heaviness. This model permits estimation of 
individual odds ratios for each ordinal threshold of outcome. For this analysis, each 
woman’s most severe episode was used as the outcome to avoid non-independence 
of outcomes.  
 A predictive modeling strategy was followed. The contribution of each 
covariate was assessed using a likelihood ratio test, with an alpha of 0.15.  
The proposed model is mathematically represented by Equation 3.2. 
 
Y is the outcome, denoted by the 4 levels depicted in Table 9 (j = 0, 1, 2, 3) for each 
woman, indexed by i. The x represents the k = 1, …, K predictor variables that will 
be included in the model, listed in Table 3.7. The βk are the coefficients of these 
predictor variables, representing the log odds of the outcome. The β0j represents the 
Equation 3.2 
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threshold-specific baseline log odds of the outcome for covariates in all reference 
categories. This model provides odds ratios that compare predictors of higher 
severity bleeding (Y=yj) to the baseline level of no bleeding (Y=y0) for each 
incremental change in predictor variable category.  
 Equation 3.2, as described, is a constrained form of the multinomial logistic 
model. This model assumes the coefficients for each variable to be the same across 
all threshold-specific comparisons made in the analysis. Separate coefficients for 
each threshold may be required, to identify relationships between variables and 
each level of bleeding intensity. To do this, an unconstrained version of the model 
was fit (estimating βkj), resulting in threshold-specific coefficients and odds ratios. 
Because the constrained model was nested within the unconstrained model, we 
conducted a homogeneity test of equivalence of coefficients. This test uses the 
difference in log-likelihoods of the two models, which is a chi-square statistic with 
degrees of freedom equal to the difference in number of parameters between the 
models. A p-value threshold of 0.15 was used to determine whether the separate 
estimates for each threshold were necessary. If the p-value is greater than 0.15, we 
concluded that one coefficient, describing the combined effect for several thresholds, 
was sufficient.   
 Missing values for all observations were imputed using Stata’s Imputation 
using Chained Equations (ICE) command.145 ICE imputes missing values for all 
variables in the specified model using values of beta coefficients and standard errors 
from a posterior distribution that is based on a regression of the non-missing values 
of a variable on the other predictors in the model. All predictors present in the final 
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model were included in creating the imputed dataset. Two datasets were created, 
one for the model assessing predictors of presence or absence of bleeding, and one 
for the model assessing predictors of the heaviness of bleeding. Five imputation 
cycles were used in creating the final, complete dataset of imputed observations. 
Subsequent analyses were completed across all replicates of the dataset, combining 
point estimates using simple arithmetic means and standard errors that account for 
both within- and between-imputation variation. This combining procedure was done 
by the micombine command in Stata.145 
Limitations of approach 
 Because the data are collected from the first trimester interview, differential 
recall may bias the bleeding reports of women with and without a miscarriage. 
However, the validity of first trimester reports compared to prospectively collected 
data were examined in Aim 3. The results obtained in this aim can be interpreted in 
light of the results from Aim 3. In the analysis of predictors of heaviness of bleeding, 
few women reported heavy bleeding, which resulted in less stable estimates.  
Sample size considerations 
Sub-aim 1.1: This component focused on a descriptive analysis of bleeding 
patterns in the early pregnancy period; no hypothesis testing was required to fulfill 
the objectives of this component. Thus, no power analysis was necessary. 
 Sub-aim 1.2: This component focused on maternal characteristics associated with 
vaginal bleeding. We were interested in identifying predictors of bleeding, within our 
current dataset. Because we are not seeking to determine differences in estimates 
by the status of any other variable, no sample size calculation is warranted.  
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Aim 2  
 
Evaluate the association between vaginal bleeding and spotting in early 
pregnancy and the occurrence of miscarriage. 
Description 
 This aim sought to determine whether an association existed between 
episodes of bleeding in early pregnancy and miscarriage. Although some bleeding 
episodes in early pregnancy are the direct consequence of miscarriage, many 
miscarriages occur without any symptoms of bleeding and many pregnancies that 
result in live birth have bleeding episodes during early pregnancy. This analysis 
sought to describe the association between episodes of bleeding and miscarriage, 
and to uncover whether a bleeding episode was associated with subsequent 
miscarriage after accounting for other miscarriage predictors. The conceptual 
framework for this aim was that bleeding is a marker of an underlying condition or a 
physiologic change that may be related to miscarriage. 
 Special care was taken to only consider episodes of bleeding not thought to 
be a direct consequence of miscarriage. Bleeding episodes that immediately 
precede miscarriage were removed from the analysis. Bleeding and covariate 
information were obtained from the first trimester interview. Outcome information 
was obtained from the RFTS pregnancy outcome form. Subanalyses were 
considered that utilize ultrasound data to identify pregnancies that are known to 
have slowed or arrested growth early in gestation. Additional stratification by time of 
interview with relation to miscarriage was also incorporated into the analysis. The 
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analysis was also restricted to women in their first pregnancy to account for the 
potential effect of prior pregnancy outcomes on reporting of bleeding.  
Hypotheses 
 Based on prior studies, we hypothesized that bleeding episodes that occur 
during pregnancy were associated with the occurrence of miscarriage. Specifically, 
we hypothesized that heavier episodes were associated with pregnancy loss. The 
relationship between the main exposure and outcome was considered independent 
of the effect of other known predictors of miscarriage, including maternal age, prior 
miscarriage, or smoking status. 
Analytic plan 
As a preliminary step, classification and regression tree (CART) analysis was 
used to identify important characteristics of bleeding episodes that cluster together in 
units that predict miscarriage.146 CART is a data-driven analysis approach that splits 
the data into sub-groups that differentially predict an outcome (in this case, 
miscarriage). This method categorizes the data to minimize the misclassification of 
the outcome within each group, so that each group can be categorized as 
associated or not associated with the outcome. Our CART analysis evaluated the 
relationship between miscarriage and the following characteristics of first trimester 
bleeding: heaviness, duration, color, timing, and associated pain. CART is 
implemented in four automated steps: (1) a splitting process, which maximizes the 
homogeneity of the outcome within each category and builds the best and most 
elaborate tree for the full dataset (the reference tree); (2) class assignment, which 
assigns an outcome to each category by minimizing misclassification of the 
 
 
 54
outcome; (3) cross-validation, which partitions the data into 90% samples of the total 
data and builds trees appropriate for each 90% subset. The remaining 10% data 
sample for each subset is used to calculate each tree’s outcome classification error 
rate, and this process is repeated for each 90% sample of the data. Finally, (4) a 
pruning process identifies the tree with the smallest outcome classification error rate, 
and prunes the reference tree to this optimal tree size. This method was used as an 
initial, exploratory step to identify which bleeding characteristics (heaviness, duration, 
pain, and color) are important in relation to miscarriage in the population of women 
who report bleeding. 
 A discrete-time hazard model was used to evaluate the association between 
bleeding and miscarriage. Each week in pregnancy was considered the conditional 
time unit in the analysis. This modeling strategy has the advantage of accounting for 
left truncation and right censoring. It is also able to incorporate time-dependent 
covariates. Participants were censored at twenty completed weeks of pregnancy, on 
the gestational age of miscarriage, or gestational age at loss to follow-up or 
termination. Only pregnancy weeks at risk of miscarriage were included in the 
analysis. Pregnancy weeks that took place prior to enrollment, after miscarriage, or 
after censoring were not included in the weekly risk set for analysis. In other words, 
the experience of a woman with miscarriage that occurs during the seventh week of 
pregnancy will only be compared to other pregnancies at risk of the outcome during 
the seventh week of pregnancy.  
 In order to conduct this analysis, a generalized linear model was used with a 
logit link, conditioning for each week under study. Risk sets began at week 5 of 
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pregnancy and ended at week 20. Due to sparse data, weeks 18-20 were 
constrained to have the same coefficients. Weeks of pregnancy were calculated 
beginning with the date of the last menstrual period, with the first 6 days labeled as 
week 0, the next 7 days considered week 1, the next 7 days considered week 2, and 
so forth. Odds ratios describing the association between bleeding and miscarriage, 
given that the fetus has survived up to the week in which miscarriage occurs, were 
reported. Both the presence and heaviness of bleeding were assessed. Heaviness 
categories were defined as in Table 3.8.  
 Miscarriage predictors such as maternal age, prior miscarriage, and smoking 
status were included in adjusted analyses. Time interactions were evaluated, with 
important time interactions identified using an alpha of 0.05. Specifically, time-
dependent effects were carefully examined for vaginal bleeding, to identify time-
sensitive effects of this symptom. Effect measure modification by pain and cramping 
associated with the bleeding episode was also evaluated.  
 The proposed model is mathematically presented as Equation 3.3. 
 
 Y is each woman’s time to the outcome, denoted by t = 1, … , 20 weeks of 
pregnancy in which a miscarriage can occur. Each woman is indexed by i. The x 
represent the main exposure variable, bleeding (xe), and the k = 1, …, K predictor 
variables that were included in the model, which are outlined in Figure 3.4. Bleeding 
was incorporated into the model as a dichotomous time-dependent variable and as 
Equation 3.3 
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an episode-specific four-level indicator categorical variable, representing levels of 
heaviness depicted in Table 3.8. The βe and βk are the coefficients of the bleeding 
and predictor variables, respectively, representing the log odds of the outcome for 
each variable, conditional on survival up to that point in pregnancy. The β0t represent 
the baseline, week-specific log odds of the outcome in all reference categories of 
predictor variables. Time interactions that are included in the final model take the 
form of an interaction term between bleeding and the time period of interest, s. This 
term identifies specific time periods of pregnancy that are of interest.  
 Based on the level of misclassification detected in Aim 3, we conducted 
sensitivity analyses to identify how much deviation exists between the results 
obtained in this aim and those expected under ideal exposure assessment 
conditions.   
Limitations of approach 
 As with the other aims of this analysis, the data are limited by retrospective 
recall of bleeding reports, which potentially contributed to a bias in effect estimate. 
This analysis was also limited by the fact that no data exists in RFTS to examine the 
physiologic changes that may underlie any causal relationships between bleeding 
(that does not immediately result in miscarriage) and miscarriage. However, this 
project did not seek to detect a causal relationship. We sought to identify an 
association between previous bleeding during pregnancy and miscarriage, and to 
make our estimates relevant to obstetric patients and providers who want to assess 
the overall risk of miscarriage after a bleeding episode occurs.  
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Sample size considerations 
This aim focused on the relationship between bleeding symptoms and 
miscarriage. For this aim, a dual-approach power analysis was conducted. 
Assuming a dichotomous exposure (bleeding versus no bleeding) and a 
dichotomous outcome (miscarriage versus live birth), a two-group continuity-
corrected chi-square test of equal proportions was conducted. This analysis is based 
on 3285 participants reporting no episode of bleeding (11.6% who have a 
miscarriage), and 1204 participants reporting at least one episode of bleeding, 
values that were based on the numbers of women reporting bleeding in our study. 
The results based on this approach show that, with a two-sided alpha of 0.05, there 
is over 90% power to detect an OR of 1.4.  
To supplement this approach, we also conducted a sample size calculation 
based on logistic regression with a binary covariate. Using the same values as in the 
previous paragraph to describe our population, we found that we had 90% power to 
detect an OR of 1.4. The consistency of these results is reassuring and suggests 
that there will be an adequate sample size to detect a relatively small difference in 
effect.  
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Aim 3  
 
Evaluate the extent of misclassification of retrospective reports of bleeding 
exposure compared with prospectively collected data from daily diaries. 
Description 
A validation of the bleeding assessment was conducted as part of this aim. 
For this aim, the reports of presence, heaviness, and timing of bleeding symptoms in 
the first trimester interview were compared against the prospectively collected data 
from the daily diary. The diary contains two questions related to bleeding, assessing 
the presence and severity of bleeding. Because the diary is completed on a daily 
basis and time-stamped when submitted, the timing of the bleeding is inherently 
incorporated into the daily diary assessment. 
This aim is essential for the overall analysis as it helps to quantify the 
accuracy of bleeding reports in the first trimester interview, and provides some 
insight into the extent of recall bias present in the data. 
Hypotheses 
 In this aim, we hypothesized that some episodes of early pregnancy spotting 
captured by the daily diary were not reported in the first trimester interview. The 
extent of misclassification is hypothesized to decrease with increasing severity of the 
bleeding episode, and the most severe episodes will be accurately recalled. 
Additionally, we hypothesized that episodes of bleeding that occur later in the first 
trimester are more likely to be recalled accurately.  
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Analytic plan 
 As a first step, descriptive analyses similar to those of Aim 1 were conducted 
using the daily diary data. These analyses served as the comparison point for the 
validation of the results from the first trimester interview. A comparison of maternal 
characteristics of women who provided diary data to those who did not was also 
undertaken. 
 The validity of reports of presence of bleeding was assessed by calculating 
sensitivity (Se), specificity (Sp), and kappa (κ) statistics. Data obtained from the daily 
diary was considered the reference standard.  
 Sensitivity and specificity were calculated using standard formulas. Kappas 
were calculated using StatXact. Kappas were also used to compare the severity of 
reported bleeding using the most severe episode for each woman as the episode for 
comparison. Weighted kappa was used for non-binary variables. 
 A log-linear model was used to evaluate the patterns of association between 
data obtained at recall and in the diary. This model allowed comparison of the level 
of agreement beyond chance within categories of relevant covariates. This model 
was used to examine the extent of agreement and the presence, timing, and severity 
of an episode.  
 This model is mathematically represented as Equation 3.4. 
 
µij represents the expected frequency of counts in cell ij of an I * J table cross-
classifying the diary data (D) and interview-based recalled response (R) of the n 
Equation 3.4 
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subjects for whom both sources of data is available. λ is the overall mean of the 
expected counts. λiD are the diary effects (column effects). λjR are the recalled effects 
(row effects). Both of these terms represent chance agreement. λkZ represent k 
levels of other covariates of interest in predicting agreement. The addition of these 
terms and their interactions allows agreement to be evaluated within strata of the 
covariates. δij accounts for the agreement beyond what is expected by chance. I 
equals 1 if i = j, and I equals 0 if i ≠ j. Thus, if δij > 0, more agreement occurs than is 
expected by chance, and the interaction between this variable and other covariates 
indicates whether categories of the covariate is predictive of better agreement.  
Agreement was be examined for several variables of interest, including 
bleeding severity (none, spotting, bleeding) and timing (by the week in which 
bleeding occurred, from the fourth week of pregnancy to the thirteenth, inclusive). 
Other covariates of interest, such as outcome (miscarriage or live birth), prior 
miscarriage, and maternal age, were considered for their predictive ability.  
Limitations of approach 
 In this validation study, the data obtained from the daily diary was considered 
the gold standard for bleeding reports. The diary may not be a true gold standard in 
that the data are not truly collected prospectively and may still not accurately 
represent all bleeding episodes. However, there is no superior method of collecting 
this information. Medical records and hospital reports will only report the most 
serious of the bleeding episodes; thus, the data obtained from the daily diary is an 
appropriate reference standard in this analysis. 
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 The generalizability of women enrolling in the diary component of the study is 
also a limitation of this aim. The women enrolled in the diary component of the study 
provide email addresses on enrollment and have consistent Internet access. These 
women differ from the general RFTS population in several ways, including the fact 
that they are planning their pregnancy. They are also highly motivated women who 
agree to provide daily documentation of their pregnancy-related symptoms. 
Sample size considerations 
The first part of the analysis sought to describe the sensitivity, specificity, and 
kappa statistic associated with two different methods of obtaining bleeding symptom 
data in pregnancy. No sample size calculation was required for this component. The 
log-linear component of the analysis sought to identify predictors of agreement. As 
with Aim 1, since our goal was not to obtain an effect estimate beyond a certain 
threshold, no sample size calculation was required. 
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F. SOFTWARE AND APPROVALS 
 
 Data analysis was conducted primarily in STATA, version 9.2. StatXact 
(version 6) was used for components of Aim 3. DTREG was used in classification 
and regression tree exploratory analyses for Aim 2.  
 The Institutional Review Board (IRB) at the University of North Carolina and 
the National Institutes of Health reviewed this project. IRB approval was obtained 
from the National Institutes of Health IRB, and a determination that IRB review was 
not necessary for this project was obtained from the University of North Carolina IRB. 
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Figure 3.1. Timeline of Right From the Start phases and activities. 
 
 
 
 
 
 
 
  
2000 2001 2002 2006 2007 2003 2004 2005 
Study begins (RFTS 1) 
Focus on water quality 
Recruitment in NC, TN, TX 
RFTS 2 starts, RFTS 1 ends 
Focus on fibroids 
Recruitment in NC only 
RFTS 3 starts, concurrent with RFTS 2 
Focus on NSAID exposure 
Recruitment expands to TN in Spring 2007.  
After a brief period of overlapping 
recruitment in TN and NC, NC recruitment 
ceases in Fall 2007 
Estimated end of recruitment: 2010 
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Figure 3.2. Overview of Right From the Start study activities. 
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Table 3.1. Common eligibility criteria across all phases of Right From the Start. 
 
 
 
 
 
 
 
 
 
 
 
 
Criterion Details 
Age ≥18 years at enrollment 
Language English/Spanish-speaking 
Fertility No use of assisted reproductive technologies, pre-enrolled 
women must have been attempting to conceive for ≤6 months 
Other Intent to carry pregnancy to term, intent to stay in the area for the 
next 18 months, willingness to have an ultrasound, access to a 
telephone 
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Table 3.2. Unique characteristics of each phase of Right From the Start. 
 
 
 
 
 
 
 RFTS1 RFTS2 RFTS3 
Time period 2000-2004 2004-present 2007-present 
Gestational age eligibility ≤12 6/7 weeks ≤9 6/7 weeks pre-pregnant 
Internet access required? No No Yes 
Special characteristics of study Water samples 
collected from various 
areas of water 
distribution system in 
study site 
Fibroid sub-cohort 
followed in greater 
detail with additional 
post-partum 
ultrasounds and 
questionnaires 
Daily web-based diary detailing 
symptoms (nausea, fatigue) and 
exposures (pain medications) of 
early pregnancy completed from 
time of enrollment up to the end of 
the first trimester or time of 
pregnancy loss 
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Table 3.3. Characteristics of Right From the Start 1 participants and births in the 
recruitment area. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 RFTS1 Births in Area* 
 n = 1112 n = 5172 
Maternal Age (yr ± sd) 29.7 ±  5.5 28.1 ± 6.0 
Primigravid 334 (30%)  1758 (34%)
Race/ethnicity 
  White 745 (67%) 2482 (48%)
  Black 278 (25%) 1500 (29%)
  Hispanic  33   (3%) 931 (18%)
  Other 56   (5%) 259   (5%)
Education 
  ≤ High School 189 (17%) 2017 (39%)
  Some College 200 (18%) 931 (18%)
  ≥ College 723 (65%) 2224 (43%)
* NC Vital Statistics 2001; Raleigh Births 
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Table 3.4. Median gestational age in days (interquartile range) of completion of 
study activities, stratified by phases of Right From the Start. 
 
 RFTS 1 RFTS 2 RFTS 3 
 n=2332 n=2078 n=129 
Enrollment 55 (45-66) 43 (36-53) 35 (31-39) 
Ultrasound 66 (58-78) 52 (46-62)   47.5 (44-51) 
First Trimester Interview 65 (54-78)   98 (95-104)  97 (94-103) 
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Table 3.5. Characteristics of Right From the Start participants, stratified by study site. 
 
  Galveston 
RFTS 1 
n=408 
Memphis 
RFTS 1 
n=854 
Raleigh 
RFTS 1 
n=1070 
Triangle 
RFTS 2 / 3 
n=2022 
Nashville 
RFTS 2 / 3 
n=185 
  n (%) n (%) n (%) n (%) n (%)
Age 18-27 250 (63.5) 446 (52.2) 418 (39.1) 598 (29.8) 71 (38.4)
 28-34 116 (28.4) 305 (35.7) 503 (47.0) 1060 (52.4) 99 (53.5)
 35-45 33   (8.1) 103 (12.1) 149 (13.9) 364 (18.0) 14   (8.1)
Race White/non-Hispanic 151 (37.1) 475 (55.8) 710 (66.4) 1537 (76.2) 147 (79.5)
 Black/non-Hispanic 95 (23.3) 336 (39.4) 277 (25.9) 241 (11.9) 18   (9.7)
 Hispanic 152 (37.4) 19   (2.2) 31   (2.9) 130   (6.4) 9   (4.9)
 Native American/Asian/Other 9   (2.2) 22   (2.6) 52   (4.9) 110   (5.5) 11   (6.0)
 Missing 1 2 0 4 4
Education ≤ High School 222 (54.4) 261 (30.6) 191 (17.9) 203 (10.0) 22 (11.9)
 Some college 103 (25.3) 195 (22.8) 197 (18.4) 302 (14.9) 25 (13.5)
 ≥ 4 years college 83 (20.3) 398 (46.6) 682 (63.7) 1516 (75.0) 138 (74.6)
 Missing 0 0 0 1 0
Married/cohabiting 307 (75.3) 685 (80.2) 917 (85.7) 1905 (94.2) 178 (96.2)Marital 
Status Single/divorced/not living with partner 101 (24.8) 169 (19.8) 153 (14.3) 117   (5.8) 7   (3.8)
Household ≤500% poverty level 372 (96.4) 736 (90.3) 873 (85.0) 1623 (83.3) 137 (76.1)
Income >500% poverty level 14   (3.6) 79   (9.7) 154 (15.0) 326 (16.7) 43 (23.9)
 Missing 22 39 43 73 5
Parity  Nulliparous 151 (39.3) 359 (43.9) 545 (52.0) 955 (47.3) 103 (56.3)
 1+ live births 233 (60.7) 459 (56.1) 503 (48.0) 1063 (52.7) 80 (43.7)
 Missing 24 36 22 4 2
BMI Underweight 21   (5.4) 73   (8.6) 100   (9.4) 158   (8.0) 18 (10.3)
 Normal weight 172 (42.3) 392 (46.3) 580 (54.7) 1192 (60.4) 91 (52.3)
 Overweight 71 (18.3) 132 (15.6) 149 (14.1) 248 (12.6) 24 (13.8)
 Obese 124 (32.0) 250 (29.5) 231 (21.8) 375 (19.0) 41 (23.6)
 Missing 20  7 10 49 11
Smoking No 316 (77.6) 709 (83.3) 908 (84.9) 1845 (91.7) 170 (92.9)
 Yes 91 (22.4) 142 (16.7) 162 (15.1) 168   (8.4) 13   (7.1)
 Missing 1 3 0 9 2
 
 
 
70 
   
   
   
Alcohol No 181 (44.5) 374 (44.0) 408 (38.2) 951 (47.2) 89 (48.6)
 Yes 226 (55.5) 477 (56.1) 659 (61.8) 1062 (52.8) 94 (51.4)
 Missing 1 3 3 9 2
Caffeine No 97 (23.8) 227 (26.7) 340 (31.8) 661 (32.8) 58 (31.5)
 Yes 310 (76.2) 624 (73.3) 730 (68.2) 1354 (67.2) 126 (68.5)
 Missing 1 3 0 7 1
Outcome Miscarriage 48 (12.5) 87 (10.9) 122 (11.9) 272 (13.9) 15 (13.9)
 Live birth 335 (87.5) 712 (89.1) 903 (88.1) 1687 (86.1) 93 (86.1)
 Missing 25 55 45 63 77
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Table 3.6. Overview of data sources and type of information obtained in Right From 
the Start. 
 
 
*basic information includes single questions relating to the number of previous pregnancies, 
fibroid status, and medication use, etc. 
**detailed information includes follow-up questions that provide more comprehensive data 
related to participant’s obstetric and reproductive history, dietary and supplement exposures, 
intake of caffeine or alcohol, and smoking history.
 D
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Intake Interview 3 3 3 --- --- basic* basic* --- 3 --- 
Diary 
(Pre-preg to 12 weeks) --- 3 3 3 3 --- 3 --- 3 --- 
Ultrasound 
(6 weeks, as late as 9 6/7) --- --- --- --- --- --- --- 3 --- --- 
First Trimester Interview 
(13 to 17 weeks) 3 3 3 3 3 detailed** detailed** --- 3 --- 
Follow-up call 
(20 to 24 weeks) --- --- --- --- --- --- --- --- --- 3 
Vital & medical records 3 --- 3 --- --- detailed** --- 3 --- 3 
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Table 3.7. Covariates of interest for this project, Right From the Start. 
 
 
Socioeconomic status Maternal behaviors Maternal characteristics 
   Race    Smoking status    Body mass index 
     White, non-Hispanic      No exposure      Underweight  
     Black, non-Hispanic      Exposed pre-pregnant      Healthy weight  
     Hispanic      Exposed in pregnancy      Overweight  
     Asian, Native Am, Oth       Obese  
   Education    Passive smoking    Gravidity 
     < High school      No exposure       Primigravida 
        High school      Exposed in pregnancy       Multigravida 
     > High school   
   Percent poverty threshold    Alcohol use    Parity 
     ≤ 500%      No exposure       Nulliparous 
     >  500%      Exposed pre-pregnant       Primiparous 
     Continuous      Exposed in pregnancy       2+ prior pregnancies 
   Marital status    Caffeine    Age 
     Married/cohabiting      Yes      <35 years old 
     Other      No      ≥35 years old 
      Continuous (amount)      continuous 
Current pregnancy Prior obstetric outcomes    Cycle length 
  Prenatal vitamins   Prior miscarriage*      27-33 days 
     Yes      Yes      <27 days 
     No      No      >33 days 
  Infection   Prior preterm birth*   History of diabetes 
     Yes      Yes      Yes 
     No      No      No 
  Progesterone use   Prior elective termination*  
     Yes      Yes  
     No      No  
  Fibroids   
     Yes   
     No   
*will also examine relationships with multiple occurrences of these events, as noted in the 
aims 
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Table 3.8. Categorization of bleeding severity, Right From the Start. 
 
 
 
 
 
 
Model Interview 
No bleeding (j=0) No bleeding 
Spotting (j=1) Light 
Light bleeding (j=2) Lighter than heavy flow 
Heavy bleeding (j=3) Like heavy flow 
Heavy bleeding (j=3) More than heavy flow 
  
 
 
 
 
 
CHAPTER 4 : GENERAL RESULTS 
 
This chapter outlines general results that do not belong in any manuscript, 
focusing on general characteristics of the study population, the overall hazard of 
miscarriage, and some descriptions of missing data.  
 
A. HAZARD OF MISCARRIAGE  
The hazard of miscarriage, by week of pregnancy, is depicted in Figure 4.1. 
This figure shows a general pattern that is similar to other week-specific risk of 
miscarriage estimates in large populations.147 The sample used for this figure 
includes all participants contributing to the analysis for Aim 2. Table 4.1 shows the 
raw data used for this figure. 
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B. SAMPLE COMPOSITION 
Aim 1 and Aim 2 
The original dataset contained 5017 participants. Exclusion criteria, and 
numbers of participants excluded for each criterion to obtain the final sample size, 
are listed in Table 4.2. A total of 4539 participants contributed to these analyses. 
However, for Aim 2, the analysis required fetal survival to at least week 5 of 
pregnancy and to the beginning of the week following enrollment for inclusion in risk 
sets for analysis. Twenty-nine participants were excluded due to this requirement, 
leaving 4510 total participants for the Aim 2 analysis. 
 
Aim 3 
Participants eligible for this analysis were required to have completed the 
daily diary throughout the first trimester as well as complete the first trimester 
interview. A total of 153 participants contributed to this analysis.  
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C. PARTICIPANT CHARACTERISTICS 
Overall participant characteristics are outlined in Table 3.5 (Chapter 3). 
Overall, RFTS women are highly educated, married, and about slightly less than half 
are nulliparous. Comparison of the overall study population used in this analysis with 
two interesting sub-groups is outlined in Table 4.3 (Primigravida women), and Table 
4.4 (Comparison of women enrolling prior to pregnancy with women enrolling during 
early pregnancy). 
 Women in their first pregnancy are generally more highly educated and 
younger than women with a pregnancy history. Women who enrolled prior to 
pregnancy were characterized by being, on average, older, non-smokers, white, and 
highly educated. 
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D. MISSING DATA  
Vaginal bleeding 
Vaginal bleeding data was missing for 149 women who did not complete the 
first trimester interview. An additional 21 women who completed the interview did not 
provide information on bleeding. A comparison of general characteristics of women 
who did not provide data on bleeding (n=170) with the rest of the study population is 
found in Table 4.5. In general, women with missing data on vaginal bleeding were 
more likely to be younger, less educated, and not living with their partners. 
 
Miscarriage 
Pregnancy outcome information is missing on 5.8% of women in the study 
(n=269). Sixty-nine of these women had LMPs in 2008 and were not known to have 
delivered by the time the data for this analysis was obtained. A comparison of 
women with missing outcome information and women without missing outcome is 
found in Table 4.6. In general, women with missing outcomes were more likely to be 
younger, less educated, and non-white. 
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Figure 4.1. Conditional probability (95% CI) of miscarriage by week of pregnancy, 
Right From the Start (n=517 miscarriages, n=4510 total population), 2000-2008.  
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Table 4.1. Conditional probability of miscarriage in the first 20 weeks of pregnancy, 
Right From the Start, 2000-2008.  
 
Week 
Conditional 
probability 95% CI 
5 0.024 0.015, 0.038 
6 0.021 0.014, 0.029 
7 0.020 0.015, 0.026 
8 0.024 0.019, 0.030 
9 0.018 0.014, 0.023 
10 0.020 0.016, 0.025 
11 0.019 0.015, 0.024 
12 0.012 0.009, 0.016 
13 0.005 0.003, 0.008 
14 0.004 0.002, 0.006 
15 0.003 0.002, 0.006 
16 0.003 0.002, 0.005 
17 0.002 0.001, 0.004 
18 0.001 0.001, 0.002 
19 0.001 0.001, 0.002 
20 0.001 0.001, 0.002 
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Table 4.2. Aim 1 and Aim 2 basic exclusion criteria, Right From the Start, 2000-2008 
(total n=4539). 
 
Criterion n excluded Total n 
Original dataset 5017 
LMP after 14 July 2008 57 4960 
No first trimester interview 170 4790 
No LMP 2 4788 
Outcome reported on or before day of enrollment 6 4782 
Ectopic pregnancy 5 4777 
2nd or greater enrollment by same woman 238 4539 
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Table 4.3. Comparison of participants in their first pregnancy with participants in 
subsequent pregnancy, Right From the Start (n=4539), 2000-2008. 
 
 Primigravida  
(n=1527) 
Multigravida 
(n=3000) 
 Freq (%) Freq (%) 
Age 
18-27 years 742 (48.6) 1042 (34.7)
28-34 years 687 (45.0) 1393 (46.4)
35-45 years 98   (6.4) 565 (18.8)
Race/ethnicity 
White, non-Hispanic 1084 (71.1) 1930 (64.4)
Black, non-Hispanic 259 (17.0) 702 (23.4)
Hispanic 94   (6.2) 247 (8.3)
Other 88   (5.8) 116 (3.9)
Missing 2 5
Marital status 
Married/cohabiting 1323 (86.6) 2663 (88.8)
Other 204 (13.4) 337 (11.2)
Education 
  High School or less 240 (15.7) 654 (21.8)
Some college 206 (13.5) 615 (20.5)
College or more 1080 (70.8) 1731 (57.7)
Missing 1 0
Smoking status 
No 1344 (88.4) 2601 (86.7)
Yes 177 (11.6) 399 (13.3)
Missing 5 0
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Table 4.4. Comparison of participants enrolled prior to pregnancy with women 
enrolled during pregnancy, Right From the Start (n=4539), 2000-2008. 
 
   
 
Enrolled prior  
to pregnancy 
(n=958) 
Enrolled  
during pregnancy
(n=3581) 
 Freq (%) Freq (%) 
Age 
18-27 years 257 (26.8) 1535 (42.9)
28-34 years 548 (57.2) 1535 (42.9)
35-45 years 153 (16.0) 511 (14.3)
Race/ethnicity 
White, non-Hispanic 764 (79.8) 2256 (63.1)
Black, non-Hispanic 96 (10.0) 871 (24.4)
Hispanic 51   (5.3) 290 (8.1)
Other 46   (4.8) 158 (4.4)
Missing 1 6
Marital status 
Married/cohabiting 932 (97.3) 3060 (85.5)
Other 26   (2.7) 521 (14.6)
Education 
  High School or less 68   (7.1) 831 (23.2)
Some college 97 (10.1) 725 (20.3)
College or more 793 (82.8) 2024 (56.5)
Missing 0 1
Parity 
Nulliparous 496 (52.0) 1617 (46.2)
Parous 458 (48.0) 1880 (53.8)
Missing 4 84
Prior miscarriage 
None 741 (77.7) 2716 (77.7)
One 172 (18.0) 623 (17.8)
Two or more 41   (4.3) 158   (4.5)
Missing 4 84
Smoking status 
No 913 (95.5) 3035 (85.1)
Yes 43   (4.5) 533 (14.9)
Missing 1 13
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Table 4.5. Women missing information on vaginal bleeding compared to women who 
are not missing data on vaginal bleeding, Right From the Start (n=4688), 2000-2008. 
 
   
 No missing data 
(n=4518) 
Missing data 
(n=170)* 
 Freq (%) Freq (%) 
Age  
18-27 years 1780 (39.4) 101 (50.4) 
28-34 years 2077 (46.0) 55 (32.4) 
35-45 years 661 (14.6) 14   (8.2) 
Race/ethnicity  
White, non-Hispanic 3007 (66.7) 101 (60.1) 
Black, non-Hispanic 961 (21.3) 40 (23.8) 
Hispanic 339   (7.5) 19 (11.3) 
Other 204   (4.5) 8   (4.8) 
Missing 7 2 
Marital status  
Married/cohabiting 3980 (88.1) 94 (54.3) 
Other 538 (11.9) 76 (44.7) 
Education  
  High School or less 892 (19.8) 63 (37.1) 
Some college 819 (18.2) 42 (24.7) 
College or more 2806 (62.1) 65 (38.2) 
Missing 1 0 
Parity  
Nulliparous 2104 (47.4) 9 (100.0) 
Parous 2338 (52.6) 0 (0) 
Missing 76 161 
Prior miscarriage  
None 3448 (77.6) 9 (100.0) 
One 795 (17.9) 0 (0) 
Two or more 199 (4.5) 0 (0) 
Missing 76 161 
Smoking status  
No 3942 (87.3) 6 (100.0) 
Yes 576 (12.8) 0 (0) 
Missing 0 164 
*after all other exclusions of the data 
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Table 4.6. Women missing information on pregnancy outcome compared to women 
who are not missing data on pregnancy outcome, Right From the Start (n=4539), 
2000-2008. 
 
   
 No missing data 
(n=4274) 
Missing data 
(n=265) 
 Freq (%) Freq (%) 
Age 
18-27 years 1634 (38.2) 158 (59.6)
28-34 years 1988 (46.5) 95 (35.9)
35-45 years 652 (15.3) 12   (4.5)
Race/ethnicity 
White, non-Hispanic 2887 (67.7) 133 (50.2)
Black, non-Hispanic 887 (20.8) 80 (30.2)
Hispanic 306   (7.2) 35 (13.2)
Other 187   (4.4) 17   (6.4)
Missing 7 0
Marital status 
Married/cohabiting 3784 (88.5) 208 (78.5)
Other 490 (11.5) 57 (21.5)
Education 
  High School or less 806 (18.9) 93 (35.1)
Some college 759 (17.8) 63 (23.8)
College or more 2708 (63.4) 109 (41.1)
Missing 1 0
Parity 
Nulliparous 1982 (47.1) 131 (54.1)
Parous 2227 (52.9) 111 (45.9)
Missing 65 23
Prior miscarriage 
None 3266 (77.6) 191 (78.9)
One 758 (18.0) 37 (15.3)
Two or more 185   (4.4) 14   (5.8)
Missing 65 23
Smoking status 
No 3738 (87.7) 210 (80.5)
Yes 525 (12.3) 51 (19.5)
Missing 11 4
 
 
 
  
 
 
 
 
 
CHAPTER 5 : PATTERNS AND PREDICTORS OF VAGINAL BLEEDING IN THE 
FIRST TRIMESTER OF PREGNANCY 
 
 
A. ABSTRACT 
 
Background 
Although first-trimester vaginal bleeding is commonly considered a marker of an at-
risk pregnancy, few studies have investigated the prevalence and predictors of early 
bleeding. This study characterizes early pregnancy bleeding and identifies maternal 
characteristics associated with bleeding.  
Methods 
Participants (n=4539) were women ages 18-45 enrolled in Right From the Start, a 
community-based pregnancy study conducted in three states (2000-2008). Bleeding 
information included timing, heaviness, duration, color, and associated pain. Life 
table analyses were used to describe gestational timing of bleeding. Predictors of 
bleeding were investigated using multiple logistic regression, and multiple imputation 
was used for missing data. 
Results 
Approximately one-fourth of participants (n=1207) reported bleeding (n=1656 
episodes), but only 8% of participants reported heavy bleeding. Of the episodes with 
only spotting or light bleeding (n=1555), 28% were associated with pain. Among 
heavy episodes, 54% were associated with pain. Most episodes lasted less than 
three days, and most occurred between gestational weeks 5-8. Twelve percent of 
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women with bleeding and 13% of those without experienced miscarriage. Predictors 
of bleeding were age (particularly between 28 and 34), increasing education, 
nulliparity, and either short or long menstrual cycle length. Maternal conditions 
(diabetes, fibroids), prior pregnancy outcomes (miscarriage, induced abortion), 
reproductive tract infections, smoking, and alcohol intake were also predictive of 
bleeding.  
Conclusions 
Consistent with the hypothesis that bleeding is a marker for placental dysfunction, 
bleeding is most likely to be seen around the time of the luteal-placental shift. 
Further analyses will examine the association between bleeding and adverse 
pregnancy outcomes.  
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B. INTRODUCTION 
 
 Although first-trimester vaginal bleeding is commonly considered a marker of 
a pregnancy at risk for adverse outcomes,4,5,75,109 few studies have rigorously 
investigated the prevalence and predictors of bleeding. Estimates of bleeding 
prevalence in early pregnancy are imprecise and range from 7 to 24%.1-3,114,132  
 Only three reports have attempted to systematically describe early pregnancy 
bleeding patterns.1,3,71 One collected data only through the eighth gestational week 
on a small sample.71 The other two studies recruited participants and collected data 
during the second trimester, focusing on bleeding that occurs among women who 
deliver after twenty weeks,1 or among women with live births.3 These studies 
exclude pregnant women whose pregnancies result in miscarriage. 
 One previous study has investigated the maternal predictors of vaginal 
bleeding; however, it focused on preterm birth and excluded all losses prior to 20 
weeks.1 This study found that women of advanced maternal age, with passive 
smoking exposure, prior preterm birth, multiple prior elective terminations or with 
prior miscarriages were more likely to experience “intense” vaginal bleeding, 
measured by heaviness, duration, and an index of total blood loss. Unadjusted 
analyses from other studies suggest associations with increasing maternal age, 
minority race/ethnicity, prior obstetric outcomes (induced abortion, miscarriage, 
stillbirth, preterm delivery), or use of assisted reproductive technologies.5,75,76  
 To better characterize and understand the patterns and predictors of early 
pregnancy bleeding, we conducted this analysis using data from Right From the 
Start, a community-based early pregnancy cohort. Participants are recruited early in 
 
 
88
pregnancy and provide detailed information about first-trimester bleeding. We 
describe the timing and heaviness of bleeding episodes in the first trimester of 
pregnancy, excluding bleeding immediately prior to a miscarriage event. We also 
report maternal characteristics associated with the occurrence and heaviness of 
bleeding episodes. 
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C. METHODS 
 
Study Population 
Right From the Start (RFTS) is an ongoing cohort that began enrollment of 
pregnant women in 2000. Over time, the study has included three phases (RFTS 1, 
2, and 3) and has been active in Galveston, TX, Memphis and Nashville, TN, and 
the Triangle region (including Raleigh, Durham, and Chapel Hill), NC, USA. 
Participants were at least 18 years old, spoke English or Spanish, had not used 
assisted reproductive technologies to conceive, and intended to carry the pregnancy 
to term. Women who were not yet pregnant but attempting to conceive could pre-
enroll prior to pregnancy and were considered enrolled once they reported a positive 
pregnancy test. Pre-enrolled women must have been attempting pregnancy for 
fewer than six months (RFTS 1 and 2) or fewer than three months (RFTS 3) to be 
eligible. Women entered the study prior to twelve completed weeks of gestation 
(RFTS 1), prior to nine completed weeks of gestation (RFTS 2), or only pre-enrolled 
(RFTS 3). Formal enrollment occurred, on average, at 53 days of gestation for 
women who enrolled while pregnant (n=3581), and at 38 days of gestation for 
women who pre-enrolled in the study (n=958). Informed, signed consent was 
obtained from each study subject in compliance with all Institutional Review Board 
procedures. 
Participants had an early pregnancy ultrasound to assess fetal viability and 
document the gestational age of the fetus. Gestational age was calculated using 
self-reported last menstrual period (LMP). If self-reported LMP was unavailable, 
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ultrasound-based LMP was used (n=15). Seventy-five percent of ultrasounds were 
completed by the end of the ninth week of gestation. 
Participants completed a short intake interview. Additional telephone 
interviews were conducted to collect more detailed information about the first 
trimester, including information about personal medical history, reproductive history, 
and pregnancy-related behaviors. All women, regardless of pregnancy outcome, 
provided this detailed information. In the first phase of the study (RFTS 1), two 
additional interviews were conducted: one shortly after enrollment during the first 
trimester, followed by a second interview around 20 weeks of pregnancy. Data from 
both of these interviews were compiled to reflect all first trimester events and 
conditions occurring during the entire first trimester. Later phases of RFTS (RFTS 2, 
RFTS 3) included only one additional interview, conducted at the end of the first 
trimester, no later than the 16th week of pregnancy. Average time of completion of 
this interview was during the fourteenth week of pregnancy. If miscarriage occurred 
before the scheduled interview, the interview occurred as soon as possible after 
pregnancy loss. We refer to these interviews as the ‘first trimester interview’. 
Women who had their last menstrual period before July 14, 2008 were 
included in this analysis. Exclusions from the analysis sample include: women who 
did not complete the first trimester interview (n=170), participants missing both LMP 
and ultrasound (n=2), women with inconsistent enrollment or pregnancy end dates 
(n=6), and women with ectopic pregnancies (n=5). Women could enroll during more 
than one pregnancy, but only the first was included (n=238 subsequent pregnancies 
excluded). A total of 4539 pregnancies contributed to this analysis. 
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A separate sub-analysis was conducted among women for whom bleeding 
data was available for at least two enrollments in the study. Using this restricted 
sample, we calculated the relative risk of bleeding in a subsequent pregnancy, given 
that the woman reported bleeding in a prior pregnancy. 
 
Variable definitions 
Bleeding information 
Bleeding was self-reported by each participant in the first trimester interview 
(Appendix 1). Participants reported the total number of episodes experienced during 
the first trimester and detailed information about the timing, heaviness, color, 
duration, and pain associated with the first three episodes. If bleeding stopped for at 
least two days and then started again, this was considered two separate episodes of 
bleeding. Participants provided the exact date on which an episode began; if this 
was unavailable, the week and month in which the episode occurred was recorded. 
The duration of the episode was reported in days. The heaviness of each episode 
was defined according to the heaviest flow in an episode, and was compared to a 
participant’s usual flow during a menstrual period. A ‘spotting’ episode was one that 
was only noticed when wiping, a ‘light bleeding’ episode was defined as having the 
heaviest day(s) of flow being lighter than the heavy flow of a usual menstrual period, 
and a ‘heavy bleeding’ episode was defined as having the heaviest day(s) of flow as 
heavy or heavier than the heavy flow of a usual menstrual period. Participants could 
describe the color of each episode as ‘pink,’ ‘red,’ or ‘brown.’ If participants reported 
bleeding-associated pain, they were asked to characterize the pain as mild, 
moderate, or severe. 
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This analysis focuses on bleeding episodes that occur during the first 
trimester, regardless of whether a miscarriage occurs. To exclude bleeding that 
occurs at the time of miscarriage, we do not include any bleeding episodes that 
ended within 4 days of a miscarriage. This cutpoint was chosen after exploring 
several meaningful cutpoints based on the distribution of episodes in the data. We 
chose 4 days to maximize our use of the data and varied this cutpoint in later 
sensitivity analyses to identify whether the choice of cutpoint affected results. 
 
Other characteristics 
Data collected at the first trimester interview included demographic factors 
(age, race/ethnicity, education, marital status, percent of poverty level [according to 
the 2008 poverty guidelines, accounting for number of persons in household]), pre-
pregnancy weight and height from which we calculated body mass index, usual 
menstrual cycle length in days, maternal morbidities (reproductive tract infections 
during pregnancy and diabetes), maternal behaviors (active and passive smoking, 
prenatal vitamin use, alcohol intake, caffeine intake), and prior obstetric history 
(parity, gravidity, history of miscarriage, induced abortion, or preterm birth). The 
early pregnancy ultrasound included systematic screening for uterine fibroids.148 We 
created a dichotomous variable for presence or absence of fibroids. 
Women were classified according to whether or not they were treated for one 
or more of the following infections at any time from LMP to the end of the first 
trimester: yeast infection, urinary tract infection, bacterial vaginosis, pelvic 
inflammatory disease, chlamydia, trichomonas, gonorrhea, syphilis, genital warts, or 
outbreaks of genital herpes. Women with pre-existing diabetes or who had 
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gestational diabetes in a previous pregnancy were classified as having diabetes. 
Women who smoked cigarettes at any point during pregnancy were identified as 
smokers. Passive smoking was defined according to whether an individual in the 
participant’s household was a regular smoker. Women who reported drinking any 
alcoholic beverages during the pregnancy were classified as being exposed to 
alcohol.  
Coding and categorization decisions for covariates were based on evaluation 
of the association between the presence of bleeding and various covariate 
specifications. Where appropriate, different coding schemes were compared using 
Akaike’s information criterion (AIC) to choose the best variable specification. 
Categorical, indicator specification was favored due to ease of interpretation of 
results. Categories showing similar magnitude of association with bleeding were 
combined. Age, percent poverty level, caffeine intake, and cycle length were 
originally continuous variables that were categorized, with cutpoints chosen based 
on knots identified from use of smoothing splines. Gravidity, parity, and the other 
prior obstetric history variables were initially assessed as ordinal variables and 
categorized based on sparse data in higher-order categories and similarity of 
estimates in combined categories. Prior induced abortion was specified as a three-
level categorical indicator variable when the outcome was presence of any bleeding 
and as a dichotomous variable when the heaviness of bleeding was modeled due to 
sparse data. Active smoking, prenatal vitamin use, and alcohol intake were 
converted from nominal categorical variables to dichotomous variables representing 
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any or no intake because of sparse data and similarities of category-specific 
estimates. 
 
Data Analysis 
All analyses were conducted in Stata, version 9.2 (College Station, TX). 
 
Descriptive analyses 
Episodes were categorized into weeks of pregnancy based on the day in 
which an episode began. Weeks of pregnancy were defined with the first 6 days 
after LMP labeled as week 0, the next 7 days considered week 1, the next 7 days 
considered week 2, and so forth. We used life table analyses to calculate the 
percent of pregnancies with bleeding for each week of gestation during the first 
trimester. The same was repeated for heavy bleeding only. Participants were 
censored at time of miscarriage (n=464), induced abortion (n=14), or interview when 
it occurred before the end of the first trimester (n=114). Miscarriage and induced 
abortion dates were based on participant self-report. The distribution of episodes by 
heaviness, duration, color, and associated pain were examined descriptively for all 
bleeding episodes. The same analyses were repeated using only the woman’s 
heaviest episode (based on heaviest bleed), but patterns were substantially 
unchanged; thus, only analyses based on all episodes are shown. 
 
Predictive modeling 
Maternal characteristics predicting the presence/absence of bleeding were 
evaluated using a logistic model. All covariates were included in the model and the 
least important (highest p-value) was sequentially removed if the p-value from the 
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likelihood ratio test was greater than 0.15. The final reduced model consisted of only 
variables with an associated p-value less than 0.15.  
Predictors of the heaviness of bleeding (based on each woman’s heaviest 
episode) were evaluated using a multinomial logistic model, with a reference group 
of “no bleeding” and index categories of “spotting,” “light bleeding,” and “heavy 
bleeding.” We followed the same strategy previously described to identify variables 
predicting the heaviness of bleeding, while requiring the previously identified 
predictors of any bleeding to remain in the model. For the multinomial logistic model, 
likelihood ratio tests were conducted to determine whether categories of heaviness 
could be combined. If heaviness levels were not different from each other at an a 
priori p-value of 0.15, the categories were combined.  
 
Sensitivity analyses 
Multiple imputation procedures (Stata, Imputation with Chained Equations145) were 
used so that participants with missing covariate data could be included. This method 
imputes missing values of a variable from a posterior distribution based on a 
regression of the non-missing values of the variable on all other predictors in the 
model. Five imputation cycles were used. Most variables were missing for less than 
3% of the sample, but poverty level, fibroid status, and cycle length were missing for 
4.0%, 6.9% and 16.9% of the sample, respectively. A sensitivity analysis was 
conducted that dropped women with missing data on any covariates in the final 
model (n=1082). A second sensitivity analysis was conducted, restricting the sample 
to primigravidae (n=1527), to eliminate potential bias associated with prior 
pregnancy outcomes. 
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D. RESULTS 
The 4539 women in this study ranged in age from 18 to 45. Most self-
identified as white, black, or Hispanic and were generally of high educational 
attainment (Table 5.1). About half of all women were nulliparous. In total, about two-
thirds of women with miscarriage reported some bleeding during pregnancy. After 
excluding bleeding episodes that occurred within 4 days of miscarriage, 24.6% of 
women with miscarriage reported at least one episode of bleeding during the first 
trimester, similar to the proportion of women without miscarriage who reported 
bleeding during pregnancy (26.8%). Of those reporting bleeding, 70.9% reported 
only one episode (n=856); 20.0% reported two episodes (n=241); and 9.1%, three or 
more (n=110).  
Bleeding episodes occurred during all weeks of the first trimester, peaking 
around the sixth and seventh week of pregnancy (Figure 5.1). Heavy episodes 
showed a similar pattern, and the peak extended throughout a longer period of the 
first trimester.  
Most episodes were characterized as ‘spotting only’ (75.6%), and the majority 
were painless (70.7%) (Table 5.2). Heavy episodes comprised fewer than 10% of 
reported episodes. Half of all episodes persisted for only one day, 30% were of two 
or three days duration, and approximately 20% of episodes continued for more than 
3 days. Heavy episodes were more likely to be painful, of longer duration, and red in 
color (Table 5.2). 
Of the women who reported bleeding, about 15% reported an episode that 
occurred around the time of their expected menstrual period. Women who reported 
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more than one episode (n=351) had variable intervals between episodes. More than 
half of all multiple episodes occurred less than two weeks apart. Fewer than 3% of 
women (n=10) with multiple episodes reported episode intervals consistent with the 
timing and length of their usual menstrual cycles, and none of these had heaviness 
similar to usual menses.  
Women who enrolled in the study more than once and reported bleeding in 
their first enrollment were 1.9 (95% CI 1.2, 2.9) times as likely to report bleeding in a 
subsequent pregnancy, compared to women who did not report bleeding in the prior 
pregnancy. We were unable to assess whether the heaviness of prior pregnancy 
bleeding was associated with heaviness in a subsequent pregnancy due to sparse 
data. 
Table 5.3 shows the factors predictive of bleeding. Maternal age (particularly 
between 28 and 34 years), more years of education, long (≥34 days) and short (<27 
days) cycle length, fibroids, infection, pre-existing or prior gestational diabetes, 
nulliparity, history of prior miscarriage, and history of induced abortion were strong 
predictors of bleeding. Reproductive tract infection during pregnancy was found to 
be a predictor, but had only a weakly elevated association with bleeding. The 
strongest predictor based on strength of association was history of miscarriage. 
Body mass index, race/ethnicity, marital status, percent poverty level, active or 
passive smoking, prenatal vitamin use, alcohol intake, caffeine intake, gravidity, and 
prior preterm birth, were not strong predictors. Estimates from the fully adjusted 
model are found in Appendix 3. 
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When assessing heaviness of bleeding, likelihood ratio tests indicated that 
the categories of spotting and light bleeding could be constrained to have the same 
coefficients (X2=14.7, df=13, p=0.32), whereas the coefficients for the light and 
heavy bleeding categories were substantially different and could not be constrained 
to be the same (X2=25.6, df=13, p=0.02). Because of this, the spotting and light 
bleeding categories were combined for the multinomial analysis. 
Table 5.4 shows the important predictors of bleeding heaviness: maternal age, 
long/short menstrual cycle length, fibroids, infection, pre-existing or prior gestational 
diabetes, smoking, alcohol intake, nulliparity, and history of miscarriage and induced 
abortion. Estimates for some categories are highly imprecise due to the small 
number of observations within some strata of heavy bleeding. Most factors showed a 
stronger relationship with heavy bleeding compared with light bleeding, but 
education, parity, and induced abortion history appeared to be associated primarily 
with light bleeding. Of note, active smoking in pregnancy was inversely associated 
with spotting/light bleeding (OR 0.84, 95% CI 0.66, 1.05) and associated with heavy 
bleeding (OR 1.42, 95% CI 0.81, 2.47). Alcohol exposure was predictive of heavy 
bleeding only (OR 1.60, 95% CI 1.03, 2.48). These variables were not important 
predictors of ‘any’ bleeding. Estimates from the models including all tested 
covariates can be found in Appendix 3. 
Comparing the results of the model with multiple imputation to the model with 
no missing data for any covariates, the results did not change substantially, though 
confidence intervals around estimates were wider for the model without missing data, 
which was expected given the reduced sample size. Restriction of the population to 
 
 
99
participants without prior pregnancy history (n=1527) and removal of pregnancy 
history variables did not meaningfully change the estimates of the variables 
remaining in the model. Stratification of the main model by participant education 
provided some evidence that women with more years of education were more likely 
to report spotting and light bleeding episodes (Appendix 4). 
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E. DISCUSSION 
 
We provide new evidence that bleeding episodes occur throughout the first 
trimester, peaking during the sixth and seventh weeks. Different characteristics of 
bleeding tend to cluster together. Heavy bleeding episodes (similar or heavier than 
those of a woman’s normal menses) are more likely to be associated with pain, 
longer duration, bright red color, and presence of multiple episodes, while spotting 
episodes are more likely to occur in isolation and be of shorter duration and without 
pain. This suggests that heavy bleeding may arise from different underlying biologic 
events than spotting. 
Though the causes of bleeding in later pregnancy have been investigated 
(due to placenta previa, abruption, or infection), there has been little investigation of 
first trimester bleeding.132,134,149 It is interesting that the peak in bleeding episodes 
coincides with the development of a hormonally functional placenta. In very early 
pregnancy, the corpus luteum produces progesterone. The shift to placental 
production of progesterone occurs by the 7th week of pregnancy.82 If the decrease in 
progesterone during this transition period is substantial enough to mimic the 
progesterone drop at the end of the luteal phase of the menstrual cycle, this might 
trigger an episode of bleeding. Such an episode may suggest that the early placenta 
is not performing its functions adequately.  
The maternal spiral arteries are blocked by a trophoblastic shell during most 
of the first trimester, maintaining a low oxygen environment for fetal development.121 
The onset of maternal-fetal circulation usually begins in the periphery of the placenta 
around the ninth or tenth week of gestation.16,121 Vaginal bleeding around this time 
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may be the external expression of internal uterine bleeding that occurs during the 
premature onset of maternal-fetal circulation or abnormal formation of placental 
membranes.121 The peak in vaginal bleeding episodes observed in the middle of the 
first trimester may serve as an important marker of the developing placenta’s 
function. It has been suggested that improper placentation may play a causal role in 
later adverse pregnancy outcomes.16 Our future analyses will focus on the 
relationship between bleeding and pregnancy outcomes, including miscarriage. 
 Our results show that early pregnancy bleeding rarely mimics the bleeding of 
menses. Although some women reported bleeding at the time of expected menses, 
this bleeding was light, of short duration, and did not resemble bleeding of a usual 
menstrual cycle. Gestational age dating was verified by ultrasound, and a validation 
substudy of ongoing pregnancies in RFTS 1 found that the average difference 
between gestational age based on self-reported LMP and ultrasound was less than 
one day.150 Based on these results, it is unlikely that many women misdate their 
pregnancy by mistaking early pregnancy bleeding for their LMP, consistent with the 
results of a previous study.71 We found little evidence that cyclic, menstrual-like 
bleeding occurs during the first trimester. Few women reported intervals between 
episodes consistent with menstrual cycling, and none of these reported heaviness 
similar to their menses.  
 Several maternal characteristics emerged as important predictors of the 
presence of bleeding, including maternal age (especially women 28-34), higher 
education level, nulliparity, prior miscarriage or induced abortion, the presence of 
fibroids, pre-existing diabetes or history of gestational diabetes, reproductive tract 
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infection in pregnancy, and either long or short menstrual cycles. Education, 
nulliparity, and previous induced abortion may be important as measures of 
reporting sensitivity because they were associated with increased reporting of 
spotting or light bleeding but not heavy bleeding.  
History of prior miscarriage was an important independent predictor of 
bleeding, consistent with the results of a previous study.1 Prior obstetric outcomes 
that involve vaginal bleeding may make a woman more concerned and more likely to 
remember the bleeding episodes of a current pregnancy. Women who miscarried in 
the past may also have recurring problems that cause bleeding and/or loss.  
Maternal conditions such as diabetes and reproductive tract infections may be 
associated with bleeding due to related biological processes, such as inflammation 
or placental infarction and hemorrhage. Fibroids have been associated with 
abnormal bleeding outside of pregnancy, and the same mechanisms may increase 
risk of bleeding during pregnancy, but those mechanisms are not yet understood.151 
Maternal behaviors, such as active smoking and alcohol intake during 
pregnancy, were important predictors of heavy, but not light, bleeding. It is important 
to investigate what mechanisms underlie these relationships. Smoking was also 
inversely associated with light bleeding, likely related to decreased reporting of 
spotting and light bleeding episodes among smokers. 
 We acknowledge several important limitations. Our results are based on 
retrospective reporting of bleeding. Participants were asked to define an entire 
episode as spotting, light, or heavy; we did not have data on the number of days 
within an episode that were associated with heavy bleeding. Our study is also limited 
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by small sample size for some predictors, such as diabetes. However, unlike other 
studies, our results are based on a pregnant population recruited from the 
community that does not exclude participants whose pregnancies terminated prior to 
twenty weeks of gestation. Timing of gestational age was verified with ultrasound, 
which gave us confidence in our gestational age dating and also provided unique 
information about uterine fibroids not available to other perinatal researchers. Our 
study is also strengthened by detailed assessment of bleeding characteristics, 
including data on the timing, heaviness, duration, color, and overall number of 
episodes. 
 In conclusion, spotting and light bleeding are common symptoms of early 
pregnancy. Heavy bleeding is much less common. Whether both light and heavy 
bleeding arise from the same mechanisms or have different etiologies is an 
important question for future research. Future steps include investigating the 
relationship between bleeding episodes, early pregnancy biology, placental 
pathophysiology, and pregnancy outcomes such as miscarriage and preterm birth. 
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Table 5.1. Participants of Right From the Start, 2000-2008 (n=4539). 
 
 Frequency (%) 
Age 
  18-27 years 1792 (39.5)
  28-34 years 2083 (45.9)
  35-45 years 664 (14.6)
Missing 0
Race/ethnicity 
  White, non-Hispanic 3020 (66.6)
  Black, non-Hispanic 967 (21.3)
  Hispanic ethnicity 341 (7.5)
  Other 204 (4.5)
  Missing 7
Education 
  High school or less 899 (19.8)
  Some college 822 (18.1)
  College or more 2817 (62.1)
  Missing 1
Smoking 
  No 3948 (87.3)
  Yes 576 (12.7)
  Missing 15
Parity 
  Nulliparous 2113 (47.5)
  Primiparous 1549 (34.8)
  Multiparous 789 (17.7)
  Missing 88
Bleeding 
  None 3311 (73.3)
  Any bleeding 1207 (26.7)
  Missing 21
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Figure 5.1. Percent with bleeding among all pregnancies that reach each gestational 
week through the first trimester, Right From the Start, 2000-2008 (n=4539). 
All bleeding: 1656 episodes of spotting, light, or heavy bleeding reported by 1207 
women. 
Heavy bleeding: 100 heavy bleeding episodes reported by 97 women.  
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Table 5.2. Descriptive characterization of all bleeding episodes (n=1656 episodes 
from 1207 women) and episodes of heavy bleeding (n=100 episodes from 97 
women) of participants in Right From the Start, 2000-2008.  
 
 
  
 
 
  
 
  
 All episodes 
Heavy bleeding 
episodes 
Bleeding characteristic (n=1656) (n=100) 
Heaviness Freq (%) Freq (%)
Spotting 1,251 (75.6) -- --
Light bleeding 304 (18.4) -- --
Heavy bleeding 100 (6.1) -- --
Missing 1
 
Color 
Pink 511 (31.0) 4 (4.0)
Red 419 (25.4) 84 (84.0)
Brown 717 (43.5) 12 (12.0)
Missing 9
 
Pain 
None 1,168 (70.7) 46 (46.0)
Mild 350 (21.1) 19 (19.0)
Moderate 100 (6.0) 19 (19.0)
Severe 35 (2.1) 16 (16.0)
Missing 3
 
Duration 
1 day 852 (51.5) 38 (38.0)
2 days 285 (17.2) 16 (16.0)
3 days 195 (11.8) 7 (7.0)
4-6 days 161 (9.7) 14 (14.0)
7+ days 160 (9.7) 25 (25.0)
Missing 3
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Table 5.3. Predictors of the occurrence of bleeding, Right From the Start, (2000-2008). 
 
 
 
 n %  Unadjusted OR 95% CI p Adjusted OR* 95% CI p 
Age      <0.01   <0.01
18-27 years 1792 39.5  1.00  1.00 
28-34 years 2083 45.9  1.39 (1.20, 1.61)  1.34 (1.14, 1.58)  
35-45 years 664 14.6  1.23 (1.00, 1.51)  1.13 (0.90, 1.42)  
Education      <0.01  0.11
≤High school 899 19.8  1.00  1.00 
Some college 822 18.1  1.27 (1.02, 1.59)  1.19 (0.94, 1.49)  
College or more 2817 62.1  1.37 (1.15, 1.64)  1.24 (1.01, 1.52)  
Cycle length      <0.01   <0.01
<27 days 667 17.7  1.33 (1.12, 1.57)  1.35 (1.14, 1.61)  
27-33 days 2793 74.1  1.00   1.00  
≥34 days 312 8.3  1.27 (0.99, 1.63)  1.27 (0.98, 1.64)  
Infection      0.11   0.06
No 3442 76.2  1.00   1.00   
Yes 1076 23.8  1.13 (0.97, 1.32)  1.17 (1.00, 1.36)  
Fibroids      <0.01   0.01
No 3753 88.8  1.00   1.00   
Yes 472 11.2  1.42 (1.15, 1.76)  1.29 (1.04, 1.61)  
Diabetes      0.15   0.07
None 4381 97.0  1.00   1.00   
Pre-existing/prior  137 3.0  1.32 (0.91, 1.90)  1.43 (0.98, 2.07)  
Parity      <0.01   <0.01
≥1 live birth 2338 52.5  1.00   1.00   
Nulliparous 2113 47.5  1.23 (1.08, 1.40)  1.33 (1.16, 1.54)  
Miscarriage history      0.03   0.01
None 3457 77.7  1.00   1.00   
One 795 17.9  1.16 (0.97, 1.37) 1.20 (1.01, 1.43)
Multiple 199 4.5  1.41 (1.04, 1.91)  1.50 (1.09, 2.05)
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Induced abortion history      <0.01   <0.01
None 3729 83.7  1.00   1.00   
One 546 12.3  1.35 (1.11, 1.63) 1.34 (1.10, 1.64)
Multiple 179 4.0  1.37 (1.00, 1.88)  1.39 (1.01, 1.92)
*Factors are adjusted for all other variables in the table. 
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Table 5.4. Predictors of bleeding heaviness, Right from the Start, (2000-2008). 
 
 
 
                 
    Unadjusted model  Adjusted model* 
 
 
No bleeding  Spotting/Light Bleeding Heavy Bleeding  
Spotting/Light 
Bleeding Heavy Bleeding 
 
  n OR  n OR 95% CI n OR 95% CI p OR 95% CI OR 95% CI p
Age        <0.01 0.01
18-27 years  1367 1.00  372 1.00 40 1.00  1.00 1.00
28-34 years  1462 1.00  570 1.43 (1.23, 1.67) 45 1.05 (0.68, 1.62)  1.35 (1.14, 1.61) 1.14 (0.69, 1.88)
35-45 years  482 1.00  167 1.28 (1.04, 1.58) 12 0.86 (0.45, 1.66)  1.16 (0.91, 1.47) 0.80 (0.37, 1.62)
Education        <0.01     0.20
≤High school  693 1.00  173 1.00 25 1.00  1.00 1.00
Some college  601 1.00  197 1.32 (1.05, 1.66) 21 0.97 (0.54, 1.75)  1.21 (0.95, 1.53) 0.96 (0.52, 1.75)
College or more  2016 1.00  739 1.47 (1.22, 1.78) 51 0.70 (0.43, 1.14)  1.27 (1.02, 1.57) 0.77 (0.42, 1.38)
Cycle length        <0.01     <0.01
<27 days  457 1.00  195 1.34 (1.11, 1.62) 15 1.32 (0.78, 2.22)  1.38 (1.14, 1.67) 1.30 (0.77, 2.22)
27-33 days  2085 1.00  651 1.00  55 1.00  1.00 1.00
   ≥34 days  217 1.00  89 1.34 (1.02, 1.76) 5 1.09 (0.44, 2.73)  1.34 (1.01, 1.77) 1.18 (0.47, 2.98)
Infection        0.24     0.18 
No  2542 1.00  831 1.00  69 1.00   1.00 1.00
Yes  769 1.00  278 1.10 (0.94, 1.29) 28 1.34 (0.86, 2.10)  1.15 (0.99, 1.36) 1.22 (0.77, 1.93)
Fibroids        <0.01   0.07
No  2765 1.00  895 1.00  73 1.00   1.00 1.00  
Yes  316 1.00  143 1.39 (1.13, 1.72) 13 1.46 (0.80, 2.69)  1.24 (1.00, 1.54) 1.54 (0.83, 2.88)
Diabetes        0.27 0.19
None  3218 1.00  1070 1.00  92 1.00   1.00 1.00
Prior diabetes  93 1.00  39 1.26 (0.86, 1.84) 5 1.88 (0.75, 4.73)  1.37 (0.93, 2.02) 1.79 (0.70, 4.59)
Parity        <0.01 <0.01
≥1 live birth  1752 1.00  530 1.00  56 1.00   1.00 1.00
Nulliparous  1496 1.00  567 1.26 (1.10, 1.45) 40 0.85 (0.56, 1.29)  1.37 (1.18, 1.59) 0.92 (0.59, 1.43)
Miscarriage history        0.02 0.01
None  2552 1.00  831 1.00  64 1.00   1.00 1.00
One  564 1.00  207 1.12 (0.94, 1.33) 24 1.68 (1.04, 2.73) 1.17 (0.98, 1.40) 1.64 (1.00, 2.68)
Two or more  132 1.00  59 1.39 (1.02, 1.90) 8 2.46 (1.16, 5.23) 1.48 (1.02, 2.04) 2.45 (1.13, 5.35)
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Induced abortion  
   history 
    
 
 
 <0.01
  
<0.01
None  2757 1.00  880 1.00  79 1.00   1.00 1.00
One or more  491 1.00  217 1.38 (1.16, 1.65) 17 1.21 (0.71, 2.06)  1.42 (1.18, 1.71) 1.02 (0.59, 1.77)
Smoking         0.01   0.12
No  2876 1.00  989 1.00  77 1.00   1.00 1.00
Yes  435 1.00  120 0.80 (0.64, 0.99) 20 1.70 (1.03, 2.80)  0.84 (0.66, 1.05) 1.42 (0.81, 2.47)
Alcohol exposure         0.14 0.09
No  1483 1.00  483 1.00  34 1.00   1.00 1.00
Yes  1826 1.00  625 1.05 (0.92, 1.21) 63 1.49 (0.98, 2.27) 0.98 (0.85, 1.13) 1.60 (1.03, 2.48)
*Factors are adjusted for all other variables in the table. 
 
 
 
 
 
  
 
 
 
 
 
CHAPTER 6 : THE ASSOCIATION BETWEEN FIRST TRIMESTER VAGINAL 
BLEEDING AND MISCARRIAGE 
 
A. ABSTRACT 
Background 
Miscarriage is often recognized by vaginal bleeding, but many women experience 
first trimester bleeding that does not immediately precede miscarriage. Though this 
is a common, potentially alarming symptom, no previous study has estimated the 
risk of miscarriage in these women.  
 
Objective 
To evaluate the association between miscarriage and first trimester bleeding that is 
temporally remote from the loss. 
 
Methods 
Women enrolled before pregnancy or during early gestation in Right from the Start, a 
community-based pregnancy study designed to identify miscarriage risk factors. 
Detailed bleeding data for the first trimester were collected by telephone interview. 
Bleeding episodes proximal to miscarriage (within 4 days) were excluded. We used 
discrete-time hazard models to evaluate the association between gestational-age 
specific bleeding and miscarriage. The effect of the presence and heaviness of 
bleeding was modeled, both with and without adjustment for covariates (maternal 
age, prior miscarriage, and smoking). Exploratory regression tree analysis was used 
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to evaluate the relative importance of other bleeding characteristics (duration, 
associated pain, color, gestational timing). 
 
Results 
Of the 4510 participants, 1204 (26.8%) reported first-trimester vaginal bleeding or 
spotting, and 517 miscarriages were observed. Eight percent of participants reported 
heavy bleeding episodes. When we evaluated any bleeding, including episodes of 
only spotting, the unadjusted relative odds (OR) of miscarriage for women with 
bleeding was 1.1 (95% confidence interval [CI] 0.9, 1.3). However, women who 
reported heavy bleeding (as heavy or heavier than heaviest flow during menses) had 
nearly three times the risk of miscarriage compared to women without bleeding 
during the first trimester (OR 3.0, 95% CI 1.9, 4.6). Adjustment for covariates did not 
change estimates. Exploratory analyses suggested that women with heavy bleeding 
accompanied by pain were the group accounting for most of the elevated risk.  
 
Conclusion 
Heavy bleeding in the first trimester, particularly when accompanied by pain, is 
associated with higher risk of miscarriage. Spotting and light episodes, especially if 
only lasting 1-2 days, do not predict pregnancy loss. 
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B. INTRODUCTION 
 
Vaginal bleeding is a common first trimester complication, often considered to 
be a sign of a problem in pregnancy. Bleeding has been related to preterm birth, low 
birthweight, and small-for-gestational age infants.4,75,108,109 Inconsistent results have 
also been found relating bleeding and congenital malformations.112,114,152 These 
studies are limited by focusing on bleeding episodes that come to clinical attention or 
bleeding episodes that are reported later in pregnancy or after delivery. Such 
methodologic differences result in widely varying baseline bleeding prevalences in 
these studies (7 to 24%), making it difficult to compare their results. 
Studies that have looked specifically at the relationship between bleeding and 
miscarriage are usually conducted in populations recruited from hospital clinics or 
emergency departments.91,98,101,104,105 Many of these bleeding episodes that require 
immediate medical attention mark the actual miscarriage event; thus, these studies 
do not provide useful information about the risk of miscarriage for women who 
experience bleeding that does not directly precede miscarriage. Only two studies 
have evaluated bleeding that is temporally separated from miscarriage. Both studies 
evaluated first-trimester bleeding in relation to second-trimester miscarriage, and 
both reported increased risk of late loss, especially for heavy bleeding (odds ratios 
for heavy bleeding were 3.6 and 4.9).5,76  
However, most miscarriage occurs during the first trimester, and study of this 
outcome requires enrollment early in pregnancy so that early miscarriages can be 
identified. We collected detailed data about the timing and characteristics of first 
trimester bleeding from a large, community-based study that enrolled early in 
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pregnancy or prior to pregnancy in order to examine the association between 
bleeding and miscarriage, including first-trimester miscarriage.  
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C. METHODS 
 
Study Population 
Right From the Start (RFTS) is an ongoing pregnancy cohort that began 
enrollment of pregnant women in 2000. Over time, the study has included three 
phases (RFTS 1, 2, and 3) and has been active in Galveston, TX, Memphis and 
Nashville, TN, and the Triangle region of NC (including Raleigh, Durham, and 
Chapel Hill, NC). Participants were at least 18 years old, spoke English or Spanish, 
had not used assisted reproductive technologies to conceive, and intended to carry 
the pregnancy to term. Women who were not yet pregnant but attempting to 
conceive could pre-enroll prior to pregnancy and were followed until formal 
enrollment at the time of a positive pregnancy test. Pre-enrolled women must have 
been attempting pregnancy for fewer than six months (RFTS 1 and 2) or fewer than 
three months (RFTS 3). Women entered the study prior to twelve completed weeks 
of gestation (RFTS 1), prior to nine completed weeks of gestation (RFTS 2), or only 
pre-enrolled (RFTS 3). Formal enrollment occurred, on average, at 53 days of 
gestation for women who enrolled while pregnant (n=3581), and at 38 days of 
gestation for women who pre-enrolled in the study (n=958). Informed, signed 
consent was obtained from each study participant in compliance with all Institutional 
Review Board procedures. 
Participants had an early pregnancy ultrasound to assess fetal viability and 
document the gestational age of the fetus. Gestational age was calculated based on 
self-reported last menstrual period (LMP). If self-reported LMP was unavailable, 
ultrasound-based LMP was used (n=15). Seventy-five percent of ultrasounds were 
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completed by the end of the ninth week of gestation, and the average difference 
between LMP- and ultrasound-based gestational age for ongoing pregnancies was 
less than one day in a RFTS 1 validation substudy.140 
Participants completed an intake interview. Additional interviews were 
conducted to collect more detailed information about each participant, including 
demographic information such as race/ethnicity and education, reproductive history, 
and pregnancy-related behaviors such as smoking and symptoms, including 
bleeding. Women who smoked cigarettes at any point during pregnancy were 
identified as smokers. All women, regardless of outcome, provided this detailed 
information. In the first phase of the study, two interviews were conducted after 
intake: one occurred shortly after enrollment during the first trimester, followed by a 
second interview around 20 weeks of pregnancy. Data from both of these interviews 
were compiled to obtain an assessment of events and conditions occurring during 
the entire first trimester. Later phases of RFTS included only one interview after 
intake, conducted at the end of the first trimester, no later than the sixteenth week of 
pregnancy. Average time of completion of this interview was during the fourteenth 
week of pregnancy. Participants who experienced pregnancy loss before the 
scheduled interview were interviewed as soon as possible after miscarriage. We 
refer to the interviews that provide our data as the ‘first trimester interview’. 
Women who had their last menstrual period before July 14, 2008 were 
included in this analysis. Exclusions from the analysis sample include: women who 
did not complete the first trimester interview (n=170), participants missing both LMP 
and ultrasound (n=2), women with inconsistent enrollment or pregnancy end dates 
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(n=6), and women with ectopic pregnancies (n=5). Women could enroll during more 
than one pregnancy, but only the first was included (n=238 subsequent pregnancies 
excluded). An additional 26 women were excluded from this analysis because they 
had immediate losses or were lost to follow-up prior to the beginning of the 
gestational week following their enrollment. A total of 4510 pregnancies contributed 
to this analysis. 
 
Bleeding information  
Bleeding was self-reported by each participant in the first trimester interview. 
Participants reported the total number of episodes experienced during the first 
trimester, and detailed information was collected about the timing, heaviness, color, 
duration, and pain associated with the first three reported episodes. If bleeding 
stopped for at least two days and then started again, this was considered two 
separate episodes of bleeding. Participants provided the exact date on which an 
episode began; if this was unavailable, the week and month in which the episode 
occurred was recorded. The duration of the episode was reported in days of 
bleeding. The heaviness of each episode was defined according to the heaviest flow 
in an episode. A ‘spotting’ episode was one that was only noticed when wiping, a 
‘light bleeding’ episode was defined as being lighter than the heavy flow of a usual 
menstrual period, and a ‘heavy bleeding’ episode had at least one day when flow 
was as heavy or heavier than the heavy flow of a usual menstrual period. 
Participants could describe the color of each episode as ‘red,’ ‘brown,’ or ‘pink.’ 
Participants were also asked if bleeding was associated with pain, and if so, to 
characterize the pain as mild, moderate, or severe. 
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This analysis focused on bleeding episodes that occurred during the first 
trimester, regardless of pregnancy outcome. To exclude bleeding that occured at the 
time of miscarriage, we did not include any episodes that terminated less than 4 
days before a miscarriage, and conducted a sensitivity analysis in which this cutpoint 
was extended to 7 days prior to miscarriage. These cutpoints were chosen after 
exploring several meaningful cutpoints based on the distribution of episodes in the 
data. 
 
Pregnancy outcomes 
Pregnancy was verified by ultrasound or pregnancy test. Miscarriage was 
defined as loss of a recognized pregnancy prior to twenty completed weeks of 
gestation. Outcomes were self-reported by participants, and prenatal records were 
obtained to verify the outcome. The date of a miscarriage was self-reported as the 
date of dilatation and evacuation or as the day of most severe bleeding. Women with 
induced abortions (n=14) were censored at the time of the induced abortion. 
 
Statistical Analysis 
All analyses were conducted in Stata, version 9.2 (College Station, TX) and 
DTREG (Brentwood, TN). We used discrete-time hazard models to evaluate the 
relationship between first trimester bleeding episodes and miscarriage and 
calculated week-specific odds ratios for the probability of having a miscarriage in a 
given gestational week, conditional on a woman still being pregnant at the beginning 
of that week. Due to the rarity of week-specific miscarriage in our sample, the 
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conditional odds ratios obtained from this model closely approximate the risk ratio. 
Thus, we refer to our results using ‘risk’ terminology.  
Weeks of pregnancy were calculated beginning with the date of the last 
menstrual period, with the first 6 days labeled as week 0, the next 7 days considered 
week 1, the next 7 days considered week 2, and so forth. Analysis began at 
gestational week 5, and women entered analysis at the gestational week following 
their enrollment (e.g. a woman who entered on day 2 of gestational week 5 would 
enter analysis at gestational week 6). Participants contributed to analysis risk sets 
until an outcome occurred or loss to follow-up. All participants were censored at 
week 20 if an outcome or loss to follow-up had not yet occurred. 
 Because bleeding episodes are considered a marker of a pregnancy at risk, 
the effect of a bleeding episode was considered to extend indefinitely during the 
pregnancy (e.g., if bleeding occurred at week 5, a woman was entered as having 
bleeding in all subsequent weeks).  
We conducted both unadjusted and adjusted analyses. In adjusted analyses, 
we controlled for maternal age, prior miscarriage, and maternal smoking status, prior 
predictors of miscarriage. Estimates for any bleeding and heaviness of bleeding 
(none, spotting, light, heavy) were calculated. In the hazard model, the heaviest 
episode prior to each analysis week was used to define heaviness (e.g., if a woman 
had light bleeding in week 6, heavy bleeding in week 8, and light bleeding in week 
10, she would be initially coded none, then light, then heavy which would remain 
despite the subsequent light bleed).  
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We evaluated whether the effects of any bleeding or bleeding heaviness 
differed across weeks of pregnancy and assessed the proportional hazards 
assumption using linear and categorical time interactions and separate estimates for 
bleeding per week.  
Other characteristics of bleeding episodes, such as duration, color, and 
associated pain, were evaluated using a two-phase approach that involved 
preliminary descriptive assessment of characteristics associated with miscarriage 
using classification and regression tree (CART) analysis, followed by an analysis of 
interactions with bleeding characteristics in the main model.146 CART is a data-
driven analysis approach that splits the data into sub-groups that differentially predict 
an outcome (in this case, miscarriage). This method categorizes the data to 
minimize the misclassification of the outcome within each group, so that each group 
can be categorized as associated or not associated with the outcome. Our CART 
analysis evaluated the relationship between miscarriage and the following 
characteristics of first trimester bleeding: heaviness, duration, color, timing, and 
associated pain. We restricted this analysis to women who experienced any 
bleeding. CART is implemented in four automated steps: (1) a splitting process, 
which maximizes the homogeneity of the outcome within each category and builds 
the best and most elaborate tree for the full dataset (the reference tree); (2) class 
assignment, which assigns an outcome to each category by minimizing 
misclassification of the outcome; (3) cross-validation, which partitions the data into 
10 subsets and builds 10 trees appropriate for 10 different 90% samples of the data 
(9 of the subsets) and uses the 10% remaining sample (1 subset) to calculate each 
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tree’s outcome classification error rate, and (4) a pruning process, which identifies 
the tree with the smallest outcome classification error rate, and prunes the reference 
tree to this optimal tree size.  
After using CART to identify bleeding episode characteristics that were 
important predictors of miscarriage, we conducted a conditional logistic analysis of 
interactions between these characteristics and the main effect of bleeding. Several 
specifications of each variable were considered, informed by patterns observed in 
the CART analysis. Heaviness was specified as either a binary variable (heavy or 
not heavy) or as a three-level variable (spotting, light, or heavy bleeding). Pain was 
coded as a binary variable (present, absent) or as a four-level variable including pain 
severity (none, mild, moderate, severe pain). Duration was coded as a binary (<3 
days, 3+ days) and as a three-level variable (1 day, 2 days, 3+ days). The 
contribution of interaction terms for episode characteristics to the main models was 
evaluated using Akaike’s information criterion and likelihood ratio tests for nested 
models (p=0.10).  
Because previous studies have evaluated the relationship between bleeding 
and second trimester miscarriage, we used logistic regression models to replicate 
these analyses, obtaining estimates for any bleeding and heaviness of bleeding. 
 Sensitivity analyses were conducted to assess the consistency of our results 
under various scenarios. (1) We re-analyzed our data using a 7-day rather than 4-
day cutpoint for eliminating bleeding episodes that are proximate in time to the 
miscarriage. (2) We restricted our study population to participants for whom 
gestational age by ultrasound and by last menstrual period differed by no more than 
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3 or 7 days. This eliminates women whose reporting of early pregnancy events and 
symptoms may be inaccurate (potentially confusing an episode of early bleeding 
with the last menstrual period) and fetuses which may display early signs of 
abnormal development and growth. (3) We stratified our analysis by whether 
participants completed their interview before or after the time of miscarriage. (4) We 
restricted our analyses to women in their first pregnancy to eliminate the potential 
effect of prior pregnancy outcomes on reporting. (5) Finally, we applied the 
estimates of sensitivity and specificity obtained from a validation sub-study 
comparing recalled interview data and daily diary data to our results using both a 
deterministic and probabilistic framework to evaluate the potential effect of recall 
error on bleeding episode reporting. Sensitivities and specificities were drawn from a 
trapezoidal distribution for the probabilistic analysis.153 
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D. RESULTS 
The 4510 women in this study ranged in age from 18 to 45. Most were white, 
but substantial numbers of blacks and Hispanics also participated. Eighty percent 
had more than a high school education (Table 6.1). About half were nulliparous. 
Twenty-seven percent reported at least one episode of bleeding during the first 
trimester. Of those reporting bleeding, 70.9% reported only one episode (n=854); 
20.0% reported two episodes (n=241); and 9.1%, three or more (n=109). About eight 
percent of women with bleeding reported heavy episodes.  
The association between bleeding and miscarriage is shown in Table 6.2. 
Overall, twelve percent of participants experienced a miscarriage, and bleeding in 
pregnancy was not associated with a significantly increased risk of miscarriage (OR 
1.10, 95% CI: 0.90, 1.34). However, 24% of women with heavy bleeding 
experienced miscarriage (n=23) and this represented a significantly elevated risk 
(OR 2.97, 95% CI: 1.93, 4.56). Adjustment of our results for age, prior miscarriage 
history, and smoking status had little effect on the estimates. 
Figure 6.1 shows the probability of miscarriage, conditional on survival to that 
week of pregnancy, for women who had experienced different levels of bleeding 
heaviness. Given the small number of losses in any given week by heaviness of 
bleeding, confidence intervals are broad (Appendix 5). Data were not sufficient to 
estimate miscarriage risk for some weeks where outcomes occurred only among 
those with bleeding (light bleeding: weeks 11, 16, 18-20; heavy bleeding: weeks 5, 
13, 15, 17). However, women who experienced heavy bleeding were at increased 
risk of both first and second trimester miscarriage, while the risk for women with less 
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severe bleeding (spotting, light bleeding) was similar to those for women who did not 
bleed.  
Because previous studies of bleeding and miscarriage looked only at second 
trimester miscarriage, we also formally examined that outcome. The risk of second-
trimester miscarriage (n=61) for women reporting first trimester bleeding compared 
to those who reported none was 1.6 (95% CI: 1.0, 2.8), while the risk among women 
reporting heavy bleeding was 7.1 (95% CI: 3.1, 16.5); these values were similar 
range to previous results.5,76 
To assure that bleeding episodes for women who miscarried were not all 
clustered near the time of loss, we examined the time from bleeding episodes to 
time of miscarriage for both heavy and spotting/light episodes. For heavy episodes, 
the median time from the end of the index episode to the time of miscarriage was 13 
days (interquartile range (IQR) 6, 46), and for spotting and light episodes, the 
median time for the end of the index episode to time of miscarriage was 20 days 
(IQR 10, 33). 
 Of the characteristics of bleeding evaluated in the exploratory CART analysis, 
heaviness and pain associated with bleeding appeared to be the two most important 
characteristics predicting miscarriage, followed by duration (data not shown). The 
total number of episodes and color of bleeding appeared to have little importance. 
Because of these results, we evaluated the risk of miscarriage associated with 
combinations of heaviness, pain, and duration by including subgroups of these 
characteristics in the overall unadjusted hazard model. Figure 6.2 shows the 
relationship between specific types of bleeding episodes and miscarriage. Women 
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with heavy bleeding and pain had the highest risk of miscarriage (OR 4.79, 95% CI: 
2.97, 7.73). 
The finding that miscarriage was associated with heavy bleeding but not less 
severe bleeding was robust to sensitivity tests, including changes in our definition of 
bleeding episodes (Appendix 6). In all cases the risk of miscarriage was low for 
spotting and light bleeding (unadjusted odds ratios all below 1.5) but moderate to 
high for heavy bleeding (unadjusted odds ratios varied from 2.1 to 4.5). Furthermore, 
because the specificity of bleeding reporting was 100% in our validation sub-study, 
and sensitivity was non-differential by outcome near 0.8, there was no substantial 
change in the estimates after accounting for low sensitivity in both deterministic and 
probabilistic sensitivity analyses. 
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E. DISCUSSION 
 
Vaginal bleeding is a common, and potentially alarming, symptom in early 
pregnancy. Yet, its relationship with miscarriage has not been carefully studied. We 
found that heavy bleeding (similar or greater than that seen during a woman’s 
normal menses) was strongly associated with miscarriage, associated with three 
times the risk compared to women without bleeding. Further exploratory analyses 
suggested that women who had heavy bleeding that was accompanied by pain were 
at the greatest risk. Women with spotting or light bleeding that was associated with 
pain and continued for several days may also be at increased risk, though 
confidence intervals were wide.  
Adjustment for maternal age, prior miscarriage, and smoking status did not 
affect our results, suggesting that bleeding is not merely a mediator of adverse 
effects on pregnancy reflected in these factors. We emphasize the unadjusted 
results because they are applicable to clinical care. If a pregnant woman informs her 
obstetrician of a prior episode of bleeding or spotting during a prenatal visit and 
inquires about the potential impact of such an episode on the health of her 
pregnancy, our results provide risk estimates. 
Our main results showed no substantial differences when subjected to 
several sensitivity analyses. Results were similar when analysis was restricted to 
women in their first pregnancy, to women whose gestational dating by LMP was 
consistent with ultrasound, and to women whose time of interview occurred either 
before or after the loss. Little changed when we excluded bleeding episodes within 7 
days of a loss instead of within 4 days as in the main analysis. A diary sub-study 
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provided estimates of the quality of the bleeding data and adjusting for 
misclassification did not change the results.  
Many previous studies estimated the risk of miscarriage for women 
presenting to emergency or hospital care.98,104,105 Many in such a sample are 
presenting with a current miscarriage, and such a study excludes many pregnant 
women, including those who experience bleeding but do not seek emergency care. 
Two population-based previous studies examined the relationship between first-
trimester bleeding and second-trimester miscarriage.5,76  We replicated these 
analyses, and obtained similar results.  
In the Right From the Start sample, bleeding prevalence is highest around 
gestational weeks 5-8 (Chapter 5). The timing of this peak coincides with the timing 
of important phases of placental development. A hormonally functional placenta is 
required for the luteal to placental shift in progesterone production that occurs 
around gestational week 7.82 Additionally, around the 10th week of pregnancy, the 
trophoblast blockage of the spiral arteries breaks down, remodeling of the arteries 
occurs, and the resulting blood flow to the developing placenta dramatically 
increases the oxygen tension.121 Premature onset of maternal-fetal circulation may 
expose the placenta and fetus to harmful levels of oxidative stress. Heavy bleeding 
during this time in pregnancy may be indicative of an underlying defect in placental 
development. Early placental insufficiency has been implicated in several adverse 
pregnancy outcomes, including miscarriage.16 Additionally, our observation that the 
most substantial increase in risk occurs for heavy, painful bleeding episodes 
suggests the presence of uterine contractions, which may occur due to low 
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progesterone levels. Presence of contractions may facilitate the transfer of 
pathogens from the vagina to the uterus,154 further jeopardizing pregnancy. A 
pregnancy study that prospectively monitors hormone levels and placental blood 
flow could provide valuable insights on potential mechanisms. 
Importantly, our study provides evidence that spotting or light bleeding 
episodes, especially those without pain and lasting only a day or two, do not 
increase the risk of miscarriage. Pregnant patients reporting these symptoms can be 
reassured that their risk of miscarriage is not higher than the general population. 
Most previous studies have been unable to assess the effect of light bleeding or 
spotting because most were conducted in hospital or clinic-based populations, or 
based entirely on medical records, and such episodes come to clinical attention less 
frequently.91,98,99,104,105 To our knowledge, this is the first study to rigorously evaluate 
the relationship between early pregnancy bleeding and both first and second-
trimester miscarriage in a community-based early pregnancy study. 
Our study is also strengthened by several factors. The incorporation of early 
pregnancy ultrasound in our study protocol allows assessment of fetal viability and 
verification of gestational dating early during pregnancy. Our participants are a 
highly motivated group of women who have demonstrated their ability to provide 
accurate data on the presence and timing of early pregnancy events, such as timing 
of last menses.140  
Limitations of this analysis include our inability to know the exact time of fetal 
demise. Although we have removed those bleeding episodes that directly result in 
miscarriage from our analysis, we may be including some loss-specific episodes in 
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our bleeding definition, especially if miscarriage does not result within 4 days of the 
end of the episode. Additionally, despite our relatively large study population, few 
women reported heavy bleeding episodes, yielding imprecise estimates. 
To conclude, we found that painful bleeding episodes with heaviness similar 
to or greater than usual menses were associated with risk of miscarriage. Although 
only about 2% of pregnant women in our sample report heavy bleeding, reports of 
such episodes warrant greater concern for the health of the pregnancy. Among 
intrauterine pregnancies, light bleeding or spotting of short duration does not 
increase the risk of miscarriage. 
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Table 6.1. Participants of Right From the Start, 2000-2008 (n=4510). 
 
 Frequency (%) 
Age 
  18-28 years 1783 (39.5)
  28-34 years 2068 (45.9)
  34-45 years 659 (14.6)
Missing 0
Race/ethnicity 
  White, non-Hispanic 3002 (66.7)
  Black, non-Hispanic 960 (21.3)
  Hispanic ethnicity 340 (7.6)
  Other 201 (4.5)
  Missing 7
Education 
  High school or less 895 (19.9)
  Some college 819 (18.2)
  College or more 2795 (62.0)
  Missing 1
Smoking 
  No 3921 (87.2)
  Yes 574 (12.8)
  Missing 15
Parity 
  Nulliparous 2095 (47.4)
  Primiparous 1542 (34.9)
  Multiparous 786 (17.8)
  Missing 87
Bleeding 
  None 3285 (73.2)
  Any bleeding 1204 (26.8)
  Missing 21
Heaviness of bleeding 
No bleeding 3285 (73.2)
Spotting 866 (19.3)
Light 240 (5.4)
Heavy 97 (2.2)
Missing 22
Outcome 
  Miscarriage 517 (11.5)
  Live birth 3690 (81.8)
  Other 40 (0.9)
  Missing* 263 (5.8)
*Missing includes 69 women who are known to be beyond 20 weeks of pregnancy but had 
not reported deliveries at the time of this analysis. The remaining missing observations were 
censored at the last time of contact with the study. 
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Table 6.2. Association between bleeding and miscarriage, Right From the Start, 
2000-2008 (n=4510). 
 
 Total n (%) 
Miscarriage 
(% of total) 
Unadjusted 
OR 95% CI 
Adjusted 
OR* 95% CI 
Presence of bleeding    
  None 3285 (73.2) 381 (11.6) 1.00  1.00 
  Any  1204 (26.8) 131 (10.9) 1.10 0.90, 1.34 1.10 0.90, 1.35
Heaviness of bleeding    
  None 3285 (73.2) 381 (11.6) 1.00  1.00 
  Spotting 866 (19.3) 80   (9.2) 0.91 0.72, 1.17 0.93 0.73, 1.19
  Light  240   (5.3) 28 (11.7) 1.18 0.80, 1.74 1.16 0.78, 1.71
  Heavy  97   (2.2) 23 (23.7) 2.97 1.93, 4.56 2.84 1.82, 4.43
*Adjusted for maternal age, smoking, prior miscarriage 
 
 
 
 
 
 132
Figure 6.1. Week-specific probability of miscarriage by bleeding status, Right From 
the Start, 2000-2008 (n=4510).  
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Figure 6.2. Relationship between bleeding episodes, characterized by levels of 
heaviness, pain, and duration, and miscarriage, Right From the Start, 2000-2008 
(Total n=4510). Heavy bleeding categories could not be subdivided by duration 
because of small numbers. N refers to the number of miscarriages in each category. 
 
 
 
 
 
  
 
 
 
 
 
CHAPTER 7 : ACCURACY OF INTERVIEW REPORTING OF BLEEDING DURING 
CURRENT PREGNANCY: COMPARISON WITH FIRST TRIMESTER DAILY 
DIARY 
 
 
A. ABSTRACT 
 
Background/Significance 
Vaginal bleeding during pregnancy has been considered a marker of an at-risk 
pregnancy, but the accuracy of reported bleeding has not been assessed.  
 
Objective 
To evaluate the agreement in vaginal bleeding reports based on prospective daily 
diary and retrospective recall at first trimester interview and to investigate predictors 
of reporting accuracy.  
 
Methods 
Participants recruited prior to pregnancy for a community-based pregnancy cohort 
(n=153) completed web-based daily diaries beginning prior to pregnancy up through 
the end of the first trimester. A comprehensive first-trimester interview was 
conducted, and the bleeding data from diary and interview were compared. Kappa 
statistics were used to quantify agreement, and agreement was examined visually, 
using individual bleeding patterns reported in the diary and interview. Log-linear 
models were used to investigate maternal age, prior miscarriage, and current 
pregnancy outcome as potential predictors of agreement. 
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Results 
Bleeding episodes and characteristics from the diary and interview were reported 
with high levels of agreement, with kappas ranging from 0.77-0.84. Sensitivity of any 
bleeding reports was 0.80, and specificity was 1.0. No important predictors of 
agreement were identified in this analysis, but the sample is small. 
 
Conclusion 
The presence of vaginal bleeding, a common and potentially alarming symptom of 
early pregnancy, may be assessed retrospectively with reasonable accuracy in a 
pregnancy study. 
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B. INTRODUCTION 
Vaginal bleeding is common in early pregnancy, and has been previously 
associated with adverse pregnancy outcomes.4,5,75,108 Many studies of vaginal 
bleeding rely on maternal self-report during late pregnancy or after delivery. Prior 
studies have found that recalled data may be influenced by outcome and other 
events in pregnancy.53,155 No studies have evaluated the accuracy of reports of 
vaginal bleeding in pregnancy.  
This analysis was undertaken to compare retrospective bleeding data 
collected from interview with prospective data obtained from daily, web-based 
diaries in a population of pregnant women in their first trimester. We assessed the 
extent of agreement of vaginal bleeding reports between interview and diary. We 
also investigated characteristics predictive of increased agreement.
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C. METHODS 
Study Population 
Right From the Start (RFTS) is an ongoing community-based pregnancy 
cohort that began enrollment of pregnant women in several states of the United 
States (US) in 2000.156 Briefly, participants were at least 18 years old, English- or 
Spanish-speaking, had not used assisted reproductive technologies to conceive, and 
intended to carry the pregnancy to term. Women who were not yet pregnant but 
attempting to conceive could pre-enroll prior to pregnancy and were followed until 
formal enrollment at the time of a positive pregnancy test. Formal enrollment 
occurred, on average, at 36 days of gestation for women who pre-enrolled in the 
study. Starting with the third phase of the study, pre-enrolled women completed a 
web-based daily diary during the pre-enrolled period and throughout the first 
trimester. The diary included information about common symptoms and signs of 
pregnancy, including vaginal bleeding and spotting. A comprehensive telephone 
interview was completed (median gestational week 13) which collected detailed 
information about the first trimester, including information about personal medical 
history, reproductive history, and pregnancy-related behaviors. If miscarriage 
occurred before the scheduled interview, the interview occurred as soon as possible 
after pregnancy loss. Informed, signed consent was obtained from each study 
participant in compliance with all Institutional Review Board procedures. 
This analysis focuses on the 153 participants enrolled in RFTS who 
completed the daily diary during the first trimester and completed the first trimester 
interview. Although all participants included in this analysis provided diary data and 
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completed the first trimester interview, some participants included in the analysis 
sample had not yet reported a pregnancy outcome at the time of the analysis. 
 
Bleeding Episodes 
This analysis focuses on bleeding episodes that occurred during the first 
trimester, regardless of pregnancy outcome. We do not seek to describe the 
patterns or characteristics of bleeding episodes that occur at the time of a 
miscarriage event. Because of this, bleeding episodes that terminate within four 
days of miscarriage are not included in this analysis. 
 
Bleeding episodes from interview 
Bleeding was self-reported by each participant in the first trimester interview. 
Participants reported the total number of episodes experienced during the first 
trimester, and detailed information was collected about the timing, heaviness, color, 
duration, and pain associated with the first three reported episodes. If bleeding 
stopped for at least two days and then started again, this was considered two 
separate episodes of bleeding. Participants provided the exact date on which an 
episode began; if this was unavailable, the week and month in which the episode 
occurred was recorded. Episode duration was reported in days of bleeding. The 
heaviness of each episode was defined according to the heaviest flow in an episode. 
A ‘spotting’ episode was one that was only noticed when wiping; a ‘bleeding’ episode 
included at least one day of light or heavy bleeding.  
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Bleeding episodes from diary 
In the daily diary, bleeding and spotting were queried separately. From these 
daily data, episodes were defined in a manner similar to that in the interview, i.e., 
episodes were separated by at least two days without any spotting or bleeding. All 
episodes were classified according to their timing (date began), duration (number of 
days with any bleeding or spotting), and heaviness (bleeding or spotting).  
 
Statistical Analysis 
Episodes of bleeding and spotting from the diary and the interview were 
compared. We first visually examined the individual bleeding patterns (including the 
timing, heaviness, and duration of bleeding episodes) for all women reporting 
bleeding in this study. This was followed by a quantitative comparison of the reports 
of the occurrence of any episode, the total number of episodes (no report, 1 episode, 
or 2+ episodes), the total duration of all episodes combined (no report, 1 day, or 2+ 
days), the timing of the first episode (no report, before 7 weeks gestation, 7-9 weeks 
gestation, 10+ weeks gestation), and the heaviness of the heaviest episode (no 
report, spotting only, bleeding) for all women. Sensitivity, specificity, and kappa for 
presence of any episode were calculated, and a weighted kappa statistic was 
calculated for all other comparisons. For the weighted kappa, the default in StatXact 
was used so that adjacent categories were given greater weight. Sensitivity and 
specificity were also calculated for episodes reported in the diary and the interview, 
in one- and two-week intervals of the first trimester.  
Log-linear models were used to determine predictors of agreement for the 
number of episodes reported and heaviness of bleeding. This method models the 
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distribution of observations in a contingency table, accounting for agreement due to 
chance and beyond-chance agreement in the data.157-159 Further cross-classification 
by predictor variables of interest (maternal age, prior miscarriage, current pregnancy 
outcome) was evaluated by including each variable and its interactions with other 
variables in the model to assess whether it predicted agreement in the diary and 
interview. Potential predictors were evaluated separately from each other due to 
small sample size. The coefficient for the interaction of the predictor with the 
beyond-chance agreement term indicates which group has better agreement. A 
positive coefficient indicates that agreement is greater than expected due to chance, 
and a negative coefficient indicates that agreement is less than expected due to 
chance in the index category. Although education level would be an interesting 
variable to examine due to its association with reporting accuracy in other 
studies,160,161 examination of this variable as a predictor was limited by the 
homogeneity of our sample.  
Stata (version 9.2) and StatXact (version 6) were used for all analyses. 
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D. RESULTS 
 
 The majority of participants were white, married, and had at least a college 
education (Table 7.1). About half of all women with prior pregnancies reported 
having had a miscarriage, consistent with other women enrolled in this phase of the 
study. Of the women whose current pregnancy resulted in a miscarriage (n=19), 
16% reported bleeding at some point during their pregnancy (n=3). Sixty-five women 
(42%) reported at least one episode of bleeding or spotting in the diary; fifty-two of 
these women reported episodes in the first-trimester interview (sensitivity=0.80). No 
participants reported episodes in the interview without reporting some episodes in 
the diary (specificity=1.0). More spotting episodes were reported in the diary 
compared to interview. The thirteen women who had diary episodes but did not 
report any episodes in interview all reported only spotting episodes in the diary. All 
participants who reported bleeding episodes in the diary reported at least one 
episode (spotting or bleeding) in the interview, although some misclassification in 
heaviness was present (Table 7.2).  
Figure 7.1a shows the distribution of women reporting episodes in the diary 
and the corresponding reports of bleeding in the interview, by week of pregnancy. 
Specificity remained high throughout the first trimester (≥0.94 for all weeks), while 
sensitivity was lower and more variable. Sensitivity increased when we examined 
sensitivity within two-week intervals (Figure 7.1b). 
 The extent of agreement between information reported in the diary and 
interview was evaluated by calculating Cohen’s kappa and weighted kappa statistics. 
The kappa for agreement of overall bleeding reports (not including bleeding 
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characteristics) was 0.82 (95% CI 0.73, 0.91). Results from the diary and interview 
were also reported with high levels of agreement for specific bleeding characteristics, 
with all kappas greater than 0.75 (Table 7.2). 
 None of the factors that we examined as potential predictors of agreement 
(maternal age, prior miscarriage, or miscarriage in current pregnancy) were 
important predictors of agreement. Estimates were imprecise with wide confidence 
intervals, due to the small sample size (Table 7.3). 
Visual comparisons of diary and interview reports found that bleeding episode 
information obtained from the diary was more detailed compared to interview data. 
The number, duration, and heaviness of episodes reported in the diary were often 
attenuated when reported in the interview (Appendix 7). 
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E. DISCUSSION 
Overall, more episodes were reported in the diary compared to the interview, 
but these were only spotting episodes, suggesting that spotting is more easily 
forgotten than bleeding. Despite these errors in recall, our overall measures of 
agreement were high. Kappas suggested that recall of bleeding episodes and 
characteristics is accurate at the end of the first trimester. Although some of the 
bleeding characteristics were analyzed in broad categories (e.g., categories of total 
duration defined by no report, one day, two or more days), similar kappas were 
obtained when more detailed categories were used to classify variables. Both the 
presence and characteristics of bleeding episodes were similarly reported in the 
diary and interview. The high level of agreement between diary-based collection of 
data and retrospective interview data supports the use of recalled data from the first 
trimester interview, though exact timing is not well reported. The increase in 
sensitivity of episode reports based on two-week intervals compared to one-week 
intervals suggests if precise timing of bleeding is required, more frequent or 
prospective data collection may provide more accurate information than recalled 
data.  
The major limitation of this analysis is the homogeneity of our study 
population. Participants were highly educated women who not only planned their 
pregnancy but also enrolled in a community-based pregnancy cohort study that was 
not directly affiliated with their prenatal care provider. A third had had a prior 
miscarriage. These participants are likely to be highly aware of their pregnancy-
related symptoms and accurately report bleeding episodes, both in the daily diary 
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and in the first trimester interview. The proportion of women reporting any bleeding 
in interview (approximately 34%) was higher in this analysis compared to a related 
analysis of the entire cohort, in which approximately 26% of participants reported 
any bleeding. The act of filling out the diary may result in higher levels of reporting in 
the interview for this subgroup of women. Thus, our results may be viewed as a 
best-case scenario, based on a select population of women whose recall may be 
better than the general population.  
 To conclude, we found a relatively high level of agreement for reports of 
vaginal bleeding episodes obtained from daily diary and recalled interview. No 
important predictors of agreement were identified, although our results are limited by 
small sample size.  
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Table 7.1. Participants who completed the daily diary and first trimester interview 
(n=153), Right From the Start (2000-2008). 
 
 
 Freq (%) 
Maternal age 
  ≤ 30  95 (62.1)
  >30 58 (37.9)
Race 
  White 132 (86.8)
  Other 20 (13.2)
  Missing 1
Education 
  Less than college 16 (10.4)
  College or more 137 (89.5)
Marital status 
  Married, cohabiting 152 (99.3)
  Single 1 (0.7)
Smoking in pregnancy 
  No 148 (96.7)
  Yes 5 (3.3)
Gravidity 
  Primigravida 54 (35.3)
  1 or more prior pregnancy 99 (64.7)
History of miscarriage* 
  No 50 (50.5)
  Yes 49 (49.4)
History of induced abortion* 
  No 85 (85.8)
  Yes 14 (14.1)
Outcome 
  Miscarriage 19 (15.4)
  Live birth/stillbirth 104 (84.6)
  Missing 30
*among women with previous pregnancies  
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Table 7.2. Comparison of bleeding characteristics reported in diary and interview 
(n=153), Right From the Start, (2000-2008). 
 
 Interview Diary      
Percent 
agreement Kappa (95% CI) 
 None Spot Bleed Total     
None 88 13 0 101   0.84 0.82 (0.75, 0.88) 
Heaviness of 
heaviest 
episode Spot 0 33 5 38     
 Bleed 0 6 8 14     
 Total 88 52 13 153     
       
 None 1 2+ Total   0.84 0.83 (0.76, 0.91) Number of 
episodes None 88 11 2 101     
 1 0 20 9 29     
 2+ 0 3 20 23     
 Total 88 34 31 153     
       
 None 1 2+ Total   0.86 0.84 (0.76, 0.92) 
None 88 8 5 101     
1 0 9 7 16     
Total duration 
of all 
episodes 
(days) 2+ 0 2 34 36     
 Total 88 20 46 153     
        
 None ≤6 7-9 10+ Total  0.84 0.77 (0.65, 0.89) 
None 88 7 4 2 101    
Timing of first 
episode 
(weeks) ≤6 0 26 3 2 31    
 7-9 0 4 7 0 11    
 10+ 0 0 3 7 10    
 Total 88 37 17 11 153    
          
 
 
 
 147
Figure 7.1a. Number of participants reporting at least one episode in a given 
gestational week  via diary (black); among participants reporting episodes via diary, 
number also reporting episodes during that week during interview (white). Numbers 
above bars represent the week-specific sensitivity, Right From the Start (n=153) 
(2000-2008). 
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Figure 7.1b. Number of participants reporting at least one episode in a given two-
week interval  via diary (black); among participants reporting episodes via diary, 
number also reporting episodes during those two weeks during interview (white). 
Numbers above bars represent the category-specific sensitivity, Right From the Start 
(n=153) (2000-2008). 
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Table 7.3. Predictors of agreement in the number and heaviness of episodes, Right 
From the Start (2000-2008). 
 
 Coefficient 95% CI p 
Number of episodes    
  Prior miscarriage 0.52 (-0.60, 1.65) 0.35
  Current miscarriage 0.31 (-1.85, 2.46) 0.77
  Age ≥30 -0.001 (-1.06, 1.06) 0.99
 
Heaviness of episodes 
  Prior miscarriage -0.07 (-1.06, 0.91) 0.89
  Current miscarriage 0.55 (-1.54, 2.65) 0.58
  Age ≥30 -0.73 (-1.70, 0.25) 0.14
    
 
 
 
 
  
 
 
 
 
 
CHAPTER 8 : DISCUSSION 
 
Pregnancy loss is a common and poorly understood pregnancy outcome. 
Few modifiable miscarriage risk factors are known and the two most common risk 
factors – advanced maternal age and prior miscarriage – do not clarify biological 
mechanisms to explain why miscarriage occurs so commonly, even among young 
women or those without a history of miscarriage. Because miscarriage occurs early 
in pregnancy, its study has been limited by the challenges of recruiting a study 
sample in early pregnancy whose results apply to a general obstetric population. As 
a beginning step, characterizing and understanding common early pregnancy 
symptoms and their association with miscarriage may provide clues about biological 
mechanisms that underlie miscarriage. 
Few studies of a large, generalizable population have examined the course of 
early pregnancy symptoms and their association with early pregnancy outcomes. 
This project focused on vaginal bleeding, a common and potentially alarming 
symptom of early pregnancy. We described the patterns of bleeding, identified 
predictors of bleeding, and evaluated the association between bleeding and 
miscarriage. To determine the extent of misclassification associated with the 
assessment of bleeding in this study, we compared bleeding reports in the standard 
interview questionnaire with reports obtained from a daily, web-based diary. In all 
analyses, we exclude bleeding episodes that immediately precede miscarriage.  
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A. SUMMARY OF FINDINGS 
About one-fourth of participants reported bleeding in the first trimester. This 
proportion was similar whether or not participants ultimately had a miscarriage. We 
found that over 90% of bleeding episodes were spotting or light bleeding episodes. 
The small number of heavy episodes were more often characterized as painful, of 
longer duration, and red in color, compared to spotting or light episodes. The 
distribution of bleeding in the first trimester had a peak in bleeding episodes in the 
mid-first trimester, around the time of the luteal-placental shift.  
Identification of predictors of first trimester bleeding included maternal 
characteristics such as fibroids, diabetes, reproductive tract infections, long and 
short cycle length, maternal age (primarily between 28 and 34), and prior 
miscarriage or induced abortion. Increasing education level and nulliparity also 
predicted bleeding, and we believe that these covariates likely served as reporting 
variables, due to their association with spotting and light bleeding episodes. More 
detailed analysis of predictors of bleeding heaviness found that the strength of 
association between predictors for spotting episodes and light bleeding episodes 
were similar, so they were collapsed in the analysis. This additional analysis 
revealed that alcohol intake and smoking were also predictors of heavy bleeding.  
We conducted an analysis to compare the agreement of bleeding reports in 
the first trimester interview with episodes reported in a prospective, web-based daily 
diary (gold standard). We found high kappas for agreement for reports of various 
episode characteristics, including total duration and heaviness. However, the use of 
kappa necessarily required categorization of episodes. When examining the week-
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specific sensitivity and specificity of episode reports, we found that specificity 
remained high, while sensitivity was lower and more variable during the first 
trimester. Sensitivity increased when broader categories were used, and an overall 
analysis of the sensitivity and specificity of any episode reports found that overall 
sensitivity was 0.8 and specificity was 1.0. These results were applied to the 
evaluation of the relationship between bleeding and miscarriage. 
We evaluated the association between bleeding and miscarriage and found 
that heavy episodes were associated with a three-fold increased risk of miscarriage. 
An exploratory analysis further identified that heavy bleeding episodes associated 
with pain accounted for the majority of this increased risk of pregnancy loss. The 
week-specific risk of miscarriage for spotting and light bleeding episodes closely 
mirrored the baseline risk of miscarriage for women without bleeding, providing 
further evidence that these most-common episodes do not confer increased risk for 
early pregnancy loss. Under the conditions of several sensitivity analyses, including 
application of the results of the sensitivity and specificity obtained previously, we 
obtained consistent results. 
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B. STRENGTHS AND LIMITATIONS 
 
This project has several strengths. Right From the Start (RFTS) is a rigorous 
early pregnancy study whose participants have demonstrated their ability to provide 
accurate information, both in the timing of their last menstrual period and in the 
presence or absence of bleeding episodes and their characteristics. The first 
trimester interview collects detailed information on first trimester bleeding episodes. 
After eight years of recruiting participants, RFTS has accrued a large sample size. 
RFTS is a community-based study, allowing recruitment during very early pregnancy, 
often prior to the initiation of prenatal care. Some participants enroll prior to 
pregnancy. Because of this, the study ascertains a large number of miscarriages. 
Our analytic approach is also a strength of this project. The evaluation of the 
relationship between bleeding and miscarriage used survival analysis, allowing 
incorporation of information about participant time of entry into the study and loss to 
follow-up. We were also able to precisely specify the week in which bleeding 
episodes were first reported and account for the changes in heaviness of episodes 
reported during the first trimester if multiple episodes were reported. 
We also subjected our results to a wide range of sensitivity analyses. Our results 
were consistent under many restrictions of the data. 
 Several limitations of this project should also be noted. Miscarriage was 
defined based on participant self-report, based on the day of dilatation and 
evacuation or the day of heaviest bleeding for each woman. Although this was the 
best measure for time of miscarriage available for this project, this was not a proxy 
for exact time of fetal demise. We were unable to know the exact time of fetal 
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demise from the available data. We attempted to minimize the possibility of 
misclassification of miscarriage-related bleeding from other bleeding episodes that 
occur during pregnancy by removing episodes that ended immediately before 
miscarriage (within four or seven days). However, fetal demise may have occurred 
several weeks before a miscarriage becomes symptomatic or detected at ultrasound, 
and bleeding episodes reported earlier during pregnancy may actually be a direct 
result. Such episodes should not be included in an analysis of the relationship 
between bleeding and miscarriage because the bleeding episodes would be 
differentially reported by women with symptomatic miscarriage. However, our results 
are applicable to women who experience pregnancy bleeding that does not result in 
immediate miscarriage, regardless of whether that episode is known to be symptom 
or direct component of miscarriage.  
 Although our sample size was sufficient to conduct most of the analyses in 
this project, some sub-analyses were limited by small sample size. Because heavy 
episodes were infrequent compared to spotting or light episodes, our analysis did 
not permit more detailed evaluation of heavy bleeding stratified by multiple 
characteristics, such as duration or associated pain. Few miscarriages were 
reported among women in some categories, resulting in imprecise estimates. Few 
participants reported some covariates, such as diabetes. 
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C. PUBLIC HEALTH IMPLICATIONS 
 Clinically, any research that gives insight to the processes and 
mechanisms operating during early pregnancy is useful. This time period in 
pregnancy is not well understood, despite the fact that the most common adverse 
outcome of pregnancy, miscarriage, frequently occurs during this time. Our 
results provide reassurance to many pregnant women who experience spotting 
or light bleeding episode during pregnancy. Our results also suggest that more 
careful, prolonged follow-up of women with heavy bleeding may be warranted, as 
a heavy bleeding episode may suggest an underlying problem with fetal or 
placental development. Mechanisms involving early abnormalities in placental 
development are hypothesized to underlie various later pregnancy outcomes, 
including pre-eclampsia.  
 Our epidemiologic data also provide supporting details that may be 
important for clarification of biologic processes occurring in early pregnancy. The 
peak of bleeding episode reports occurs during the mid-first trimester, around the 
same time as the luteal to placental shift in production of progesterone. 
Progesterone plays a vital role in the preservation of early pregnancy, promoting 
maintenance of the endometrium, inhibiting uterine contractions and altering 
maternal immunity to prevent rejection of the fetus. If the placenta is not 
sufficiently developed to produce adequate amounts of progesterone to maintain 
pregnancy when the corpus luteum regresses, bleeding may occur through 
mechanisms involving decreased progesterone levels, similar to those which 
promote the onset of menses. Heavier bleeding may be suggestive of greater 
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placental dysfunction, associated with a greater decrease in progesterone, 
leading to uterine contractions and pain. As a marker of placental dysfunction, 
this may explain why women with heavy episodes and pain have the greatest risk 
of miscarriage, since such episodes are presumably associated with a greater 
drop in progesterone and uterine contractions.  
 Presence of early pregnancy bleeding may also increase risk to fetal well-
being through a mechanism that reflects the premature onset of maternal-fetal 
circulation. Evidence suggests that the early maternal spiral arteries are blocked 
until the last few weeks of the first trimester, allowing the fetus to develop in an 
environment of low oxygen tension. Factors associated with the onset of 
circulation prior to the development of defense mechanisms against excess 
oxidative stress have been associated with pregnancies that continue to 
miscarriage. Further studies that include collection of biologic samples are 
necessary to increase our understanding of these early pregnancy processes in 
relation to miscarriage. 
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D. CONCLUSIONS 
To summarize, our analysis found that early pregnancy bleeding was a 
relatively common occurrence in pregnancy. Over one-fourth of participants in our 
study reported some bleeding during the first trimester, and the majority of episodes 
were spotting or light bleeding episodes. Women with such bleeding episodes can 
be reassured that there is little evidence to suggest that these episodes are 
associated with miscarriage. 
 Our results do suggest that the minority of women who report heavy episodes 
may be at higher risk of miscarriage. The hypothesized mechanisms that underlie 
these relationships need to be confirmed in a pregnancy study that collects 
longitudinal data on progesterone levels and other early pregnancy factors, monitors 
placental blood flow, and obtains products of conception, when available, to identify 
associations between reported symptoms and biologic markers that are related to 
early pregnancy maintenance and loss. Clarification of these biologic mechanisms 
will increase our knowledge of the pathophysiology of miscarriage and allow for 
identification of at-risk pregnancies. Such information is also essential for eventual 
development of appropriate and effective interventions that may help prevent 
miscarriage. 
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Appendix 1: Bleeding questionnaire  in the first trimester interview, Right From the Start. 
 
H8a. Since you got pregnant, have you had any bleeding or spotting with blood? 
 
H8b. Did the bleeding or spotting start at the time you expected your menstrual 
period? 
 
H9a. As best as you can remember when did you start to bleed or spot for the 
first/2nd/3rd time?  (month/day/year) 
 
H9b. (if H9a ‘don’t know’) Do you remember what week that was (1st, 2nd, 3rd, 4th, 
etc.) 
 
H10a. Compare this spotting/bleeding to amount of bleeding you usually have: on 
the day of your heaviest spotting or bleeding in the 1st/2nd/3rd episode, would you 
describe the bleeding as light, lighter than heavy flow, like heavy flow, more than 
heavy flow 
 
H10b. What color was the blood, was it generally red, pink, or brown? 
 
H10c. How many days did it last? If it stopped for at least 2 days and started again, 
consider this a separate episode. 
 
H11a. Did you have any pain during the time you had spotting or bleeding? 
 
H11b. Overall, would you describe the pain as mild, moderate, or severe? 
 
H12. Did you have a 2nd/3rd time when you had spotting or bleeding? (start back at 
H9a) 
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Appendix 2: Additional questions about bleeding asked of women who report a 
miscarriage (Right From the Start 2 and 3 only). 
 
A10f. Did you first suspect you might be having a miscarriage because  
 You noticed symptoms such as bleeding or pain? 
 Your health care provider found a problem during a physical exam? 
 Your health care provider found a problem during an ultrasound? 
 Or something else? _______________ 
 
A10g. What, if any, symptoms or problems did you notice? 
 Bleeding or spotting? __yes  __no 
 Pain? __yes  __no 
 Something else? Specify ___________ 
 
A10h. What was the first day that you noticed any of those symptoms?  
 Month, Day, Year 
 
A10i. (if don’t know for 10h) Do you remember what week that was? 
 Week, Month 
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Appendix 3: All predictors included in Aim 1 models. 
Table 1. All potential predictors of bleeding in the first trimester, Right From the Start, 2000-2008 (n=4539). 
 
 n Unadjusted OR 95% CI Adjusted OR 95% CI 
Age  
18-28 years 1792 1.00 1.00 
28-34 years 2083 1.39 (1.20, 1.61) 1.33 (1.12, 1.57)
34-45 years 664 1.23 (1.00, 1.51) 1.12 (0.88, 1.42)
Missing 0   
Race/ethnicity   
White 3020 1.00 1.00 
Black 967 1.01 (0.86, 1.20) 1.08 (0.88, 1.32)
Hispanic 341 1.17 (0.91, 1.49) 1.38 (1.06, 1.80)
Other 204 1.09 (0.80, 1.50) 1.03 (0.74, 1.42)
Missing 7   
Education   
High school or less 899 1.00 1.00 
Some college 822 1.27 (1.02, 1.59) 1.23 (0.98, 1.56)
College or more 2817 1.37 (1.15, 1.64) 1.28 (1.01, 1.61)
Missing 1   
Marital status   
Married/cohabiting 3992 1.00 1.00 
Other 547 0.95 (0.77, 1.17) 1.01 (0.79, 1.29)
Missing 0   
Percent poverty level   
≤500%  3741 1.00 1.00 
>500% 616 1.31 (1.09, 1.57) 1.09 (0.88, 1.36)
Missing 182   
Body mass index   
Underweight 370 0.99 (0.77, 1.27) 1.05 (0.82, 1.36)
Healthy weight 2427 1.00 1.00 
Overweight 624 0.91 (0.75, 1.11) 0.89 (0.73, 1.09)
Obese 1021 0.89 (0.76, 1.06) 0.91 (0.75, 1.09)
Missing 97   
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Cycle length   
<27 days 667 1.33 (1.12, 1.57) 1.35 (1.13, 1.61)
27-33 days 2793 1.00 1.00 
>33 days 312 1.27 (0.99, 1.63) 1.27 (0.98, 1.65)
Missing 767   
Infection   
No 3442 1.00 1.00 
Yes 1076 1.13 (0.97, 1.32) 1.17 (1.00, 1.38)
Missing 21   
Fibroid   
No  3753 1.00 1.00 
Yes 472 1.42 (1.15, 1.76) 1.30 (1.04, 1.63)
Missing 314   
Diabetes   
No 4381 1.00 1.00 
Prior diabetes* 137 1.32 (0.91, 1.90) 1.46 (1.00, 2.12)
Missing 21   
Vitamin use   
Yes 4083 1.00 1.00 
No 373 1.00 (0.79, 1.27) 1.10 (0.86, 1.41)
Missing 83   
Alcohol intake   
No 2003 1.00 1.00 
Yes 2518 1.08 (0.95, 1.24) 1.01 (0.88, 1.17)
Missing 18   
Caffeine intake   
None 1383 1.00 1.00 
1st quintile (<76.7 mgs) 429 0.85 (0.66, 1.09) 0.85 (0.65, 1.09)
2nd quintile (76.8-207.4 mgs) 830 0.99 (0.82, 1.20) 1.03 (0.84, 1.26)
3rd quintile (207.5-386.3 mgs) 618 0.98 (0.79, 1.22) 0.99 (0.79, 1.23)
4th quintile (386.4-698.9 mgs) 638 1.03 (0.83, 1.27) 1.03 (0.83, 1.29)
5th quintile (>699.0 mgs) 629 1.04 (0.84, 1.29) 1.07 (0.85, 1.33)
Missing 12   
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Active smoking   
No 3948 1.00 1.00 
Yes 576 0.88 (0.72, 1.07) 0.91 (0.72, 1.15)
Missing 15   
Passive smoking   
No 4011 1.00 1.00 
Yes 512 0.88 (0.71, 1.10) 0.98 (0.77, 1.26)
Missing 16   
Gravidity   
First pregnancy 1527 1.00 1.00 
Second pregnancy 1424 0.87 (0.74, 1.03) 0.95 (0.73, 1.22)
Third or greater 1576 1.00 (0.85, 1.17) 0.97 (0.67, 1.41)
Missing 12   
Parity   
One or more previous birth 2338 1.00 1.00 
Nulliparous 2113 1.23 (1.08, 1.40) 1.28 (0.99, 1.65)
Missing 88   
Miscarriage history   
None 3457 1.00 1.00 
One 795 1.16 (0.97, 1.37) 1.21 (0.98, 1.51)
Multiple 199 1.41 (1.04, 1.91) 1.49 (1.05, 2.12)
Missing 88   
Induced abortion history   
None 3726 1.00 1.00 
One 546 1.35 (1.11, 1.63) 1.37 (1.08, 1.74)
Multiple 179 1.37 (1.00, 1.88) 1.40 (1.96, 2.04)
Missing 88   
Preterm birth history   
None 4070 1.00 1.00 
One or more 381 0.93 (0.74, 1.18) 1.03 (0.80, 1.33)
Missing 88  
*pre-existing diabetes, or gestational diabetes in a previous pregnancy 
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Table 2. All potential predictors of light and heavy bleeding in the first trimester, Right From the Start, 2000-2008 (n=4524). 
 
 Spotting or light bleeding Heavy bleeding 
 
Unadjusted 
OR 95% CI 
Adjusted 
OR 95% CI 
Unadjusted 
OR 95% CI 
Adjusted 
OR 95% CI 
Age 
18-28 years 1.00 1.00 1.00 1.00 
28-34 years 1.43 (1.23, 1.67) 1.36 (1.14, 1.62) 1.05 (0.68, 1.62) 1.03 (0.61, 1.73)
34-45 years 1.28 (1.04, 1.58) 1.17 (0.92, 1.49) 0.86 (0.45, 1.66) 0.72 (0.33, 1.53)
Race/ethnicity     
White 1.00 1.00 1.00 1.00 
Black 1.00 (0.85, 1.19) 1.09 (0.88, 1.35) 1.05 (0.63, 1.75) 0.87 (0.46, 1.63)
Hispanic 1.09 (0.84, 1.41) 1.30 (0.99, 1.72) 1.99 (1.07, 3.67) 2.03 (1.04, 3.95)
Other 1.09 (0.79, 1.51) 1.01 (0.73, 1.41) 1.01 (0.36, 2.81) 1.08 (0.38, 3.05)
Education     
High school or less 1.00 1.00 1.00 1.00 
Some college 1.32 (1.05, 1.66) 1.25 (0.98, 1.59) 0.97 (0.54, 1.75) 1.10 (0.59, 2.06) 
College or more 1.47 (1.22, 1.78) 1.30 (1.02, 1.66) 0.70 (0.43, 1.14) 0.96 (0.49, 1.89)
Marital status     
Married/cohabiting 1.00 1.00 1.00 1.00 
Other 0.90 (0.73, 1.11) 1.00 (0.77, 1.28) 1.35 (0.77, 2.36) 1.17 (0.60, 2.27)
Percent poverty level     
≤500%  1.00 1.00 1.00 1.00 
>500% 1.33 (1.10, 1.61) 1.06 (0.85, 1.33) 1.14 (0.64, 2.04) 1.73 (0.85, 3.54)
Body mass index     
Underweight 0.98 (0.76, 1.26) 1.04 (0.81, 1.34) 1.10 (0.52, 2.36) 1.23 (0.57, 2.66)
Healthy weight 1.00 1.00 1.00 1.00 
Overweight 0.93 (0.76, 1.14) 0.91 (0.73, 1.12) 0.82 (0.41, 1.63) 0.78 (0.38, 1.58)
Obese 0.85 (0.71, 1.01) 0.87 (0.72, 1.05) 1.43 (0.90, 2.28) 1.30 (0.78, 2.17)
Cycle length     
<27 days 1.34 (1.11, 1.62) 1.37 (1.13, 1.66) 1.32 (0.78, 2.22) 1.28 (0.74, 2.21)
27-33 days 1.00 1.00 1.00 1.00 
>33 days 1.34 (1.02, 1.76) 1.34 (1.02, 1.78) 1.09 (0.44, 2.73) 1.21 (0.48, 3.05)
Infection     
No 1.00 1.00 1.00 1.00 
Yes 1.10 (0.94, 1.29) 1.16 (0.98, 1.36) 1.34 (0.86, 2.10) 1.26 (0.79, 2.00)
     
     
 
 
 
164 
     
Fibroid     
No  1.00 1.00 1.00 1.00 
Yes 1.39 (1.13, 1.72) 1.25 (1.00, 1.57) 1.46 (0.80, 2.69) 1.55 (0.82, 2.98)
Diabetes     
No 1.00 1.00 1.00 1.00 
Prior diabetes* 1.26 (0.86, 1.84) 1.41 (0.95, 2.10) 1.88 (0.75, 4.73) 1.71 (0.65, 4.48)
Vitamin use     
Yes 1.00 1.00 1.00 1.00 
No 0.98 (0.77, 1.26) 1.11 (0.85, 1.43) 1.29 (0.66, 2.51) 1.22 (0.61, 2.46)
Alcohol intake     
No 1.00 1.00 1.00 1.00 
Yes 1.05 (0.92, 1.21) 0.98 (0.84, 1.13) 1.49 (0.98, 2.27) 1.46 (0.93, 2.29)
Caffeine intake     
None 1.00 1.00 1.00 1.00 
1st quintile (<76.7 mgs) 0.86 (0.67, 1.12) 0.86 (0.66, 1.12) 0.63 (0.24, 1.67) 0.60 (0.23, 1.60)
2nd quintile (76.8-207.4 mgs) 1.00 (0.82, 1.22) 1.05 (0.85, 1.29) 0.89 (0.45, 1.75) 0.79 (0.40, 1.59)
3rd quintile (207.5-386.3 mgs) 0.93 (0.75, 1.17) 0.96 (0.76, 1.20) 1.64 (0.88, 3.05) 1.46 (0.77, 2.75)
4th quintile (386.4-698.9 mgs) 0.99 (0.79, 1.23) 1.00 (0.80, 1.26) 1.52 (0.81, 2.85) 1.33 (0.70, 2.55)
5th quintile (>699.0 mgs) 0.99 (0.79, 1.23) 1.03 (0.82, 1.30) 1.82 (1.00, 3.33) 1.58 (0.83, 3.00)
Active smoking     
No 1.00 1.00 1.00 1.00 
Yes 0.80 (0.64, 0.99) 0.85 (0.67, 1.08) 1.70 (1.03, 2.80) 1.21 (0.67, 2.19)
Passive smoking     
No 1.00 1.00 1.00 1.00 
Yes 0.82 (0.65, 1.03) 0.95 (0.73, 1.23) 1.62 (0.95, 2.77) 1.33 (0.71, 2.51)
Gravidity     
First pregnancy 1.00 1.00 1.00 1.00 
Second pregnancy 0.85 (0.72, 1.01) 0.92 (0.69, 1.23) 1.22 (0.73, 2.05) 0.71 (0.31, 1.64)
Third or greater 0.97 (0.83, 1.15) 0.95 (0.62, 1.45) 1.36 (0.83, 2.25) 0.43 (0.12, 1.50)
Parity     
One or more previous birt 1.00 1.00 1.00 1.00 
Nulliparous 1.26 (1.10, 1.45) 1.31 (0.98, 1.75) 0.85 (0.56, 1.29) 0.50 (0.21, 1.19)
Miscarriage history     
None 1.00 1.00 1.00 1.00 
One 1.12 (0.94, 1.33) 1.19 (0.94, 1.50) 1.68 (1.04, 2.73) 2.28 (1.16, 4.47)
Multiple 1.39 (1.02, 1.90) 1.48 (1.03, 2.13) 2.46 (1.16, 5.23) 3.44 (1.34, 8.79)
     
     
 
 
 
165 
     
Induced abortion history     
None 1.00 1.00 1.00 1.00 
One or more 1.38 (1.16, 1.65) 1.45 (1.13, 1.86) 1.21 (0.71, 2.06) 1.41 (0.72, 2.77)
Preterm birth history     
None 1.00 1.00 1.00 1.00 
One or more 0.91 (0.71, 1.17) 1.02 (0.78, 1.34) 1.24 (0.63, 2.43) 1.06 (0.51, 2.20)
*pre-existing diabetes, or gestational diabetes in a previous pregnancy 
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Appendix 4: Stratification of Aim 1 results by education level. 
 
Less than college College or more
 OR 95% CI OR 95% CI 
Age     
18-28 years 1.00 1.00 
28-34 years 1.49 (1.14, 1.95) 1.29 (1.04, 1.59)
35-45 years 1.11 (0.72, 1.71) 1.15 (0.86, 1.53)
Cycle length     
<27 days 1.32 (1.00, 1.75) 1.39 (1.10, 1.75)
27-33 days 1.00  1.00  
≥34 days 1.47 (0.89, 1.75) 1.20 (0.90, 1.60)
Infection     
No 1.00  1.00  
Yes 1.29 (1.02, 1.64) 1.06 (0.87, 1.32)
Fibroids     
No 1.00  1.00  
Yes 1.16 (0.78, 1.73) 1.36 (1.04, 1.77)
Diabetes    
None 1.00  1.00  
Pre-existing/prior  1.40 (0.81, 2.41) 1.44 (0.86, 2.41)
Parity     
≥1 live birth 1.00  1.00  
Nulliparous 1.31 (1.10, 1.57) 1.35 (1.06, 1.72)
Miscarriage history    
None 1.00  1.00  
One 1.85 (1.40, 2.44) 0.88 (0.70, 1.11)
Multiple 1.92 (1.20, 3.06) 1.24 (0.81, 1.89)
Induced abortion history    
None 1.00  1.00  
One 1.62 (1.21, 2.19) 1.16 (0.89, 1.51)
Multiple 1.16 (0.73, 1.84) 1.70 (1.06, 2.72)
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Appendix 5: Risk of miscarriage by week of pregnancy, including error bars around estimates. 
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Appendix 6: Further analyses and restrictions to evaluate the association between bleeding and miscarriage, Right From 
the Start (2000-2008). 
 
 No bleeding  Any bleeding  Spotting/Light  Heavy 
 n 
n  
SAB*** OR  n 
n  
SAB*** 
OR* 
(95% CI)  n 
n  
SAB*** 
OR* 
(95% CI)  n 
n  
SAB*** 
OR* 
(95% CI) 
Changing episode definition                
  4 days (overall analysis results) 3285 381 1.0  1204 131 1.1 (0.9, 1.3)  1106 108 1.0 (0.8, 1.2)  97 23 3.0 (1.9, 4.6) 
  7 days 3306 402 1.0  1183 110 0.9 (0.7, 1.1)  1091 93 0.8 (0.6, 1.0)  91 17 2.1 (1.3, 3.5) 
Gestational age**                
  3 days 1408 53 1.0  532 21 1.2 (0.7, 2.0)  495 18 1.1 (0.6, 1.8)  37 3 2.5 (0.8, 8.2) 
  7 days 2124 82 1.0  797 33 1.2 (0.8, 1.8)  743 29 1.1 (0.7, 1.7)  54 4 2.4 (0.9, 6.5) 
Loss and interview timing                
  Loss before interview 2904 244 1.0  1073 61 0.9 (0.6, 1.1)  998 52 0.8 (0.6, 1.0)  74 9 2.1 (1.1, 4.1) 
  Interview before loss 2904 135 1.0  1073 67 1.5 (1.1, 2.0)  998 54 1.3 (0.9, 1.8)  74 13 4.5 (2.5, 8.0) 
Restriction                
  Women in first pregnancy 1087 98 1.0  419 46 1.4 (1.0, 2.0)  391 41 1.4 (0.9, 2.0)  27 5 2.7 (1.1, 6.8) 
*unadjusted odds ratio 
**only including pregnancies whose gestational age calculated by last menstrual period and by ultrasound agree within the specified amount (3 days or 7 days) 
***SAB: spontaneous abortion, or miscarriage 
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Appendix 7: Comparison of bleeding patterns reported in the diary and in the interview for a select number of participants (labeled A-
H). The top line represents episodes reported in the diary, the bottom line represents episodes reported in the interview, gestational 
days 20-76, Right From the Start (2000-2008). 
A 
B 
C 
D 
E 
F 
G 
H 
S: spotting  
L: light bleeding 
H: heavy bleeding 
 
The length of the associated line represents episode duration
 
 
 170
 
REFERENCES 
1. Yang J, Savitz DA, Dole N, Hartmann KE, Herring AH, Olshan AF, Thorp JM, 
Jr. Predictors of vaginal bleeding during the first two trimesters of pregnancy. 
Paediatr Perinat Epidemiol 2005;19:276-83. 
2. Batzofin JH, Fielding WL, Friedman EA. Effect of vaginal bleeding in early 
pregnancy on outcome. Obstet Gynecol 1984;63:515-8. 
3. Axelsen SM, Henriksen TB, Hedegaard M, Secher NJ. Characteristics of 
vaginal bleeding during pregnancy. Eur J Obstet Gynecol Reprod Biol 
1995;63:131-4. 
4. Ananth CV, Savitz DA. Vaginal bleeding and adverse reproductive outcomes: 
a meta-analysis. Paediatr Perinat Epidemiol 1994;8:62-78. 
5. Weiss JL, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock CH, 
Hankins GD, Berkowitz RL, Gross SJ, Dugoff L, Timor-Tritsch IE, D'Alton ME. 
Threatened abortion: A risk factor for poor pregnancy outcome, a population-
based screening study. Am J Obstet Gynecol 2004;190:745-50. 
6. Strobino B, Pantel-Silverman J. Gestational vaginal bleeding and pregnancy 
outcome. Am J Epidemiol 1989;129:806-15. 
7. Macklon NS, Geraedts JP, Fauser BC. Conception to ongoing pregnancy: the 
'black box' of early pregnancy loss. Hum Reprod Update 2002;8:333-43. 
8. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, 
Armstrong EG, Nisula BC. Incidence of early loss of pregnancy. N Engl J Med 
1988;319:189-94. 
9. Zinaman MJ, Clegg ED, Brown CC, O'Connor J, Selevan SG. Estimates of 
human fertility and pregnancy loss. Fertil Steril 1996;65:503-9. 
10. Exalto N, Christiansen OB, Farquarhson RG, Jauniaux E. Early pregnancy 
failure: a review. Eur Clinics Obstet Gynaecol 2007;2:171-179. 
11. Rai R, Regan L. Recurrent miscarriage. Lancet 2006;368:601-11. 
12. Goddijn M, Leschot NJ. Genetic aspects of miscarriage. Baillieres Best Pract 
Res Clin Obstet Gynaecol 2000;14:855-65. 
 
 
 171
13. Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early 
pregnancy. N Engl J Med 2001;345:1400-8. 
14. Puscheck EE, Jeyendran RS. The impact of male factor on recurrent 
pregnancy loss. Curr Opin Obstet Gynecol 2007;19:222-8. 
15. Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus 
and loss of pregnancy. N Engl J Med 1999;340:1796-9. 
16. Jauniaux E, Poston L, Burton GJ. Placental-related diseases of pregnancy: 
Involvement of oxidative stress and implications in human evolution. Hum 
Reprod Update 2006;12:747-55. 
17. Minami S, Ishihara K, Araki T. Determination of blastocyst implantation site in 
spontaneous pregnancies using three-dimensional transvaginal ultrasound. J 
Nippon Med Sch 2003;70:250-4. 
18. George L, Granath F, Johansson AL, Olander B, Cnattingius S. Risks of 
repeated miscarriage. Paediatr Perinat Epidemiol 2006;20:119-26. 
19. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal 
age and fetal loss: population based register linkage study. BMJ 
2000;320:1708-12. 
20. Regan L, Braude PR, Trembath PL. Influence of past reproductive 
performance on risk of spontaneous abortion. BMJ 1989;299:541-5. 
21. Bajekal N, Li TC. Fibroids, infertility and pregnancy wastage. Hum Reprod 
Update 2000;6:614-20. 
22. Devi Wold AS, Pham N, Arici A. Anatomic factors in recurrent pregnancy loss. 
Semin Reprod Med 2006;24:25-32. 
23. Kavalier F. Investigation of recurrent miscarriages. BMJ 2005;331:121-2. 
24. Regan L, Rai R. Epidemiology and the medical causes of miscarriage. 
Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:839-54. 
25. Metwally M, Li TC, Ledger WL. The impact of obesity on female reproductive 
function. Obes Rev 2007;8:515-23. 
26. Gesink Law DC, Maclehose RF, Longnecker MP. Obesity and time to 
pregnancy. Hum Reprod 2007;22:414-20. 
 
 
 172
27. Dunne F. Type 2 diabetes and pregnancy. Semin Fetal Neonatal Med 
2005;10:333-9. 
28. Greene MF. Spontaneous abortions and major malformations in women with 
diabetes mellitus. Semin Reprod Endocrinol 1999;17:127-36. 
29. Hirahara F, Andoh N, Sawai K, Hirabuki T, Uemura T, Minaguchi H. 
Hyperprolactinemic recurrent miscarriage and results of randomized 
bromocriptine treatment trials. Fertil Steril 1998;70:246-52. 
30. Venners SA, Liu X, Perry MJ, Korrick SA, Li Z, Yang F, Yang J, Lasley BL, Xu 
X, Wang X. Urinary estrogen and progesterone metabolite concentrations in 
menstrual cycles of fertile women with non-conception, early pregnancy loss 
or clinical pregnancy. Hum Reprod 2006;21:2272-80. 
31. Szekeres-Bartho J, Balasch J. Progestagen therapy for recurrent miscarriage. 
Hum Reprod Update 2008;14:27-35. 
32. Nardo LG, Sallam HN. Progesterone supplementation to prevent recurrent 
miscarriage and to reduce implantation failure in assisted reproduction cycles. 
Reprod Biomed Online 2006;13:47-57. 
33. Bukulmez O, Arici A. Luteal phase defect: myth or reality. Obstet Gynecol Clin 
North Am 2004;31:727-44, ix. 
34. Rowland AS, Baird DD, Long S, Wegienka G, Harlow SD, Alavanja M, 
Sandler DP. Influence of medical conditions and lifestyle factors on the 
menstrual cycle. Epidemiology 2002;13:668-74. 
35. Small CM, Manatunga AK, Klein M, Feigelson HS, Dominguez CE, 
McChesney R, Marcus M. Menstrual cycle characteristics: associations with 
fertility and spontaneous abortion. Epidemiology 2006;17:52-60. 
36. Hjollund NH, Jensen TK, Bonde JP, Henriksen TB, Andersson AM, Kolstad 
HA, Ernst E, Giwercman A, Skakkebaek NE, Olsen J. Distress and reduced 
fertility: a follow-up study of first-pregnancy planners. Fertil Steril 1999;72:47-
53. 
37. Steiner MJ, Hertz-Picciotto I, Raymond E, Trussell J, Wheeless A, 
Schoenbach V. Influence of cycle variability and coital frequency on the risk of 
pregnancy. Contraception 1999;60:137-43. 
 
 
 173
38. Jensen TK, Scheike T, Keiding N, Schaumburg I, Grandjean P. Fecundability 
in relation to body mass and menstrual cycle patterns. Epidemiology 
1999;10:422-8. 
39. Nelson DB, Bellamy S, Nachamkin I, Ness RB, Macones GA, Allen-Taylor L. 
First trimester bacterial vaginosis, individual microorganism levels, and risk of 
second trimester pregnancy loss among urban women. Fertil Steril 
2007;88:1396-403. 
40. Leitich H, Kiss H. Asymptomatic bacterial vaginosis and intermediate flora as 
risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet 
Gynaecol 2007;21:375-90. 
41. Farrell S, Ide M, Wilson RF. The relationship between maternal periodontitis, 
adverse pregnancy outcome and miscarriage in never smokers. J Clin 
Periodontol 2006;33:115-20. 
42. Srinivas SK, Ma Y, Sammel MD, Chou D, McGrath C, Parry S, Elovitz MA. 
Placental inflammation and viral infection are implicated in second trimester 
pregnancy loss. Am J Obstet Gynecol 2006;195:797-802. 
43. Whelan EA, Lawson CC, Grajewski B, Hibert EN, Spiegelman D, Rich-
Edwards JW. Work schedule during pregnancy and spontaneous abortion. 
Epidemiology 2007;18:350-5. 
44. Maconochie N, Doyle P, Prior S, Simmons R. Risk factors for first trimester 
miscarriage--results from a UK-population-based case-control study. BJoG 
2007;114:170-86. 
45. Schenker MB, Eaton M, Green R, Samuels S. Self-reported stress and 
reproductive health of female lawyers. J Occup Environ Med 1997;39:556-68. 
46. Fenster L, Schaefer C, Mathur A, Hiatt RA, Pieper C, Hubbard AE, Von 
Behren J, Swan SH. Psychologic stress in the workplace and spontaneous 
abortion. Am J Epidemiol 1995;142:1176-83. 
47. Neugebauer R, Kline J, Stein Z, Shrout P, Warburton D, Susser M. 
Association of stressful life events with chromosomally normal spontaneous 
abortion. Am J Epidemiol 1996;143:588-96. 
48. O'Hare T, Creed F. Life events and miscarriage. Br J Psychiatry 
1995;167:799-805. 
 
 
 174
49. George L, Granath F, Johansson AL, Anneren G, Cnattingius S. 
Environmental tobacco smoke and risk of spontaneous abortion. 
Epidemiology 2006;17:500-5. 
50. Nielsen A, Hannibal CG, Lindekilde BE, Tolstrup J, Frederiksen K, Munk C, 
Bergholt T, Buss L, Ottesen B, Gronbaek M, Kjaer SK. Maternal smoking 
predicts the risk of spontaneous abortion. Acta Obstet Gynecol Scand 
2006;85:1057-65. 
51. Soares SR, Simon C, Remohi J, Pellicer A. Cigarette smoking affects uterine 
receptiveness. Hum Reprod 2007;22:543-7. 
52. Weng X, Odouli R, Li DK. Maternal caffeine consumption during pregnancy 
and the risk of miscarriage: a prospective cohort study. Am J Obstet Gynecol 
2008;198:279 e1-8. 
53. Savitz DA, Chan RL, Herring AH, Howards PP, Hartmann KE. Caffeine and 
miscarriage risk. Epidemiology 2008;19:55-62. 
54. Rasch V. Cigarette, alcohol, and caffeine consumption: risk factors for 
spontaneous abortion. Acta Obstet Gynecol Scand 2003;82:182-8. 
55. Kesmodel U, Wisborg K, Olsen SF, Henriksen TB, Secher NJ. Moderate 
alcohol intake in pregnancy and the risk of spontaneous abortion. Alcohol 
Alcohol 2002;37:87-92. 
56. Henriksen TB, Hjollund NH, Jensen TK, Bonde JP, Andersson AM, Kolstad H, 
Ernst E, Giwercman A, Skakkebaek NE, Olsen J. Alcohol consumption at the 
time of conception and spontaneous abortion. Am J Epidemiol 2004;160:661-
7. 
57. Tolstrup JS, Kjaer SK, Munk C, Madsen LB, Ottesen B, Bergholt T, Gronbaek 
M. Does caffeine and alcohol intake before pregnancy predict the occurrence 
of spontaneous abortion? Hum Reprod 2003;18:2704-10. 
58. Nielsen GL, Sorensen HT, Larsen H, Pedersen L. Risk of adverse birth 
outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory 
drugs: population based observational study and case-control study. BMJ 
2001;322:266-70. 
59. Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs 
during pregnancy and risk of miscarriage: population based cohort study. 
BMJ 2003;327:368. 
 
 
 175
60. Djulus J, Koren G, Einarson TR, Wilton L, Shakir S, Diav-Citrin O, Kennedy D, 
Voyer Lavigne S, De Santis M, Einarson A. Exposure to mirtazapine during 
pregnancy: a prospective, comparative study of birth outcomes. J Clin 
Psychiatry 2006;67:1280-4. 
61. Hemels ME, Einarson A, Koren G, Lanctot KL, Einarson TR. Antidepressant 
use during pregnancy and the rates of spontaneous abortions: a meta-
analysis. Ann Pharmacother 2005;39:803-9. 
62. Kleinhaus K, Perrin M, Friedlander Y, Paltiel O, Malaspina D, Harlap S. 
Paternal age and spontaneous abortion. Obstet Gynecol 2006;108:369-77. 
63. Cordier S. Evidence for a role of paternal exposures in developmental toxicity. 
Basic Clin Pharmacol Toxicol 2008;102:176-81. 
64. Ananth CV, Smulian JC, Vintzileos AM. The effect of placenta previa on 
neonatal mortality: a population-based study in the United States, 1989 
through 1997. Am J Obstet Gynecol 2003;188:1299-304. 
65. Ananth CV, Wilcox AJ, Savitz DA, Bowes WA, Jr., Luther ER. Effect of 
maternal age and parity on the risk of uteroplacental bleeding disorders in 
pregnancy. Obstet Gynecol 1996;88:511-6. 
66. Faiz AS, Ananth CV. Etiology and risk factors for placenta previa: an overview 
and meta-analysis of observational studies. J Matern Fetal Neonatal Med 
2003;13:175-90. 
67. Ananth CV, Oyelese Y, Yeo L, Pradhan A, Vintzileos AM. Placental abruption 
in the United States, 1979 through 2001: temporal trends and potential 
determinants. Am J Obstet Gynecol 2005;192:191-8. 
68. Koifman A, Levy A, Zaulan Y, Harlev A, Mazor M, Wiznitzer A, Sheiner E. The 
clinical significance of bleeding during the second trimester of pregnancy. 
Arch Gynecol Obstet 2008;278:47-51. 
69. Jouppila P. Vaginal bleeding in the last two trimesters of pregnancy. A clinical 
and ultrasonic study. Acta Obstet Gynecol Scand 1979;58:461-7. 
70. Signore CC, Sood AK, Richards DS. Second-trimester vaginal bleeding: 
correlation of ultrasonographic findings with perinatal outcome. Am J Obstet 
Gynecol 1998;178:336-40. 
 
 
 176
71. Harville EW, Wilcox AJ, Baird DD, Weinberg CR. Vaginal bleeding in very 
early pregnancy. Hum Reprod 2003;18:1944-7. 
72. Peckham CH. Uterine bleeding during pregnancy. II. Factors relating to its 
incidence. Obstet Gynecol 1972;39:48-51. 
73. Hammouda AA. Bleeding in the first two trimesters of pregnancy. Review of 
1000 cases. Int Surg 1966;45:447-9. 
74. Wittels KA, Pelletier AJ, Brown DF, Camargo CA, Jr. United States 
emergency department visits for vaginal bleeding during early pregnancy, 
1993-2003. Am J Obstet Gynecol 2008;198:523 e1-6. 
75. Williams MA, Mittendorf R, Lieberman E, Monson RR. Adverse infant 
outcomes associated with first-trimester vaginal bleeding. Obstet Gynecol 
1991;78:14-8. 
76. Strobino BA, Pantel-Silverman J. First-trimester vaginal bleeding and the loss 
of chromosomally normal and abnormal conceptions. Am J Obstet Gynecol 
1987;157:1150-4. 
77. Chamberlain G. ABC of antenatal care, Vaginal bleeding in early pregnancy--I. 
BMJ 1991;302:1141-3. 
78. Allan A. Vaginal bleeding in early pregnancy. Practitioner 1994;238:310-5. 
79. Ouyang DW, Economy KE, Norwitz ER. Obstetric complications of fibroids. 
Obstet Gynecol Clin North Am 2006;33:153-69. 
80. Paspulati RM, Bhatt S, Nour S. Sonographic evaluation of first-trimester 
bleeding. Radiol Clin North Am 2004;42:297-314. 
81. Wessel J, Endrikat J. Cyclic menstruation-like bleeding during denied 
pregnancy. Is there a particular hormonal cause? Gynecol Endocrinol 
2005;21:353-9. 
82. Csapo AI, Pulkkinen M. Indispensability of the human corpus luteum in the 
maintenance of early pregnancy. Luteectomy evidence. Obstet Gynecol Surv 
1978;33:69-81. 
83. Pedersen JF, Mantoni M. Prevalence and significance of subchorionic 
hemorrhage in threatened abortion: a sonographic study. Am J Roentgenol 
1990;154:535-7. 
 
 
 177
84. Dogra V, Paspulati RM, Bhatt S. First trimester bleeding evaluation. 
Ultrasound Q 2005;21:69-85; quiz 149-50, 153-4. 
85. Ball RH, Ade CM, Schoenborn JA, Crane JP. The clinical significance of 
ultransonographically detected subchorionic hemorrhages. Am J Obstet 
Gynecol 1996;174:996-1002. 
86. Fleischer AC, Kurtz AB, Wapner RJ, Ruch D, Sacks GA, Jeanty P, Shah DM, 
Boehm FH. Elevated alpha-fetoprotein and a normal fetal sonogram: 
association with placental abnormalities. Am J Roentgenol 1988;150:881-3. 
87. Abu-Yousef MM, Bleicher JJ, Williamson RA, Weiner CP. Subchorionic 
hemorrhage: sonographic diagnosis and clinical significance. Am J 
Roentgenol 1987;149:737-40. 
88. Maso G, D'Ottavio G, De Seta F, Sartore A, Piccoli M, Mandruzzato G. First-
trimester intrauterine hematoma and outcome of pregnancy. Obstet Gynecol 
2005;105:339-44. 
89. Nagy S, Bush M, Stone J, Lapinski RH, Gardo S. Clinical significance of 
subchorionic and retroplacental hematomas detected in the first trimester of 
pregnancy. Obstet Gynecol 2003;102:94-100. 
90. Kurjak A, Schulman H, Zudenigo D, Kupesic S, Kos M, Goldenberg M. 
Subchorionic hematomas in early pregnancy: clinical outcome and blood flow 
patterns. J Matern Fetal Med 1996;5:41-4. 
91. Bennett GL, Bromley B, Lieberman E, Benacerraf BR. Subchorionic 
hemorrhage in first-trimester pregnancies: prediction of pregnancy outcome 
with sonography. Radiology 1996;200:803-6. 
92. Pearlstone M, Baxi L. Subchorionic hematoma: a review. Obstet Gynecol 
Surv 1993;48:65-8. 
93. Tower CL, Regan L. Intrauterine haematomas in a recurrent miscarriage 
population. Hum Reprod 2001;16:2005-7. 
94. Dickey RP, Olar TT, Curole DN, Taylor SN, Matulich EM. Relationship of first-
trimester subchorionic bleeding detected by color Doppler ultrasound to 
subchorionic fluid, clinical bleeding, and pregnancy outcome. Obstet Gynecol 
1992;80:415-20. 
 
 
 178
95. Stabile I, Campbell S, Grudzinskas JG. Threatened miscarriage and 
intrauterine hematomas. Sonographic and biochemical studies. J Ultrasound 
Med 1989;8:289-92. 
96. Sauerbrei EE, Pham DH. Placental abruption and subchorionic hemorrhage 
in the first half of pregnancy: US appearance and clinical outcome. Radiology 
1986;160:109-12. 
97. Schauberger CW, Mathiason MA, Rooney BL. Ultrasound assessment of first-
trimester bleeding. Obstet Gynecol 2005;105:333-8. 
98. Chung TK, Sahota DS, Lau TK, Mongelli JM, Spencer JA, Haines CJ. 
Threatened abortion: prediction of viability based on signs and symptoms. 
Aust N Z J Obstet Gynaecol 1999;39:443-7. 
99. Everett C. Incidence and outcome of bleeding before the 20th week of 
pregnancy: prospective study from general practice. BMJ 1997;315:32-4. 
100. Coppola PT, Coppola M. Vaginal bleeding in the first 20 weeks of pregnancy. 
Emerg Med Clin North Am 2003;21:667-77. 
101. Basama FM, Crosfill F. The outcome of pregnancies in 182 women with 
threatened miscarriage. Arch Gynecol Obstet 2004;270:86-90. 
102. Laufer MR, Ecker JL, Hill JA. Pregnancy outcome following ultrasound-
detected fetal cardiac activity in women with a history of multiple spontaneous 
abortions. J Soc Gynecol Investig 1994;1:138-42. 
103. Deaton JL, Honore GM, Huffman CS, Bauguess P. Early transvaginal 
ultrasound following an accurately dated pregnancy: the importance of finding 
a yolk sac or fetal heart motion. Hum Reprod 1997;12:2820-3. 
104. Gracia CR, Sammel MD, Chittams J, Hummel AC, Shaunik A, Barnhart KT. 
Risk factors for spontaneous abortion in early symptomatic first-trimester 
pregnancies. Obstet Gynecol 2005;106:993-9. 
105. Tongsong T, Srisomboon J, Wanapirak C, Sirichotiyakul S, Pongsatha S, 
Polsrisuthikul T. Pregnancy outcome of threatened abortion with 
demonstrable fetal cardiac activity: a cohort study. J Obstet Gynaecol 
1995;21:331-5. 
106. Johannsen A. The prognosis of threatened abortion. Acta Obstet Gynecol 
Scand 1970;49:89-93. 
 
 
 179
107. Evans JH, Beischer NA. The prognosis of threatened abortion. Med J Aust 
1970;2:165-8. 
108. Yang J, Hartmann KE, Savitz DA, Herring AH, Dole N, Olshan AF, Thorp JM, 
Jr. Vaginal bleeding during pregnancy and preterm birth. Am J Epidemiol 
2004;160:118-25. 
109. Berkowitz GS, Harlap S, Beck GJ, Freeman DH, Baras M. Early gestational 
bleeding and pregnancy outcome: a multivariable analysis. Int J Epidemiol 
1983;12:165-73. 
110. Johns J, Jauniaux E. Threatened miscarriage as a predictor of obstetric 
outcome. Obstet Gynecol 2006;107:845-50. 
111. Yang J, Savitz DA. The effect of vaginal bleeding during pregnancy on 
preterm and small-for-gestational-age births: US National Maternal and Infant 
Health Survey, 1988. Paediatr Perinat Epidemiol 2001;15:34-9. 
112. South J, Naldrett J. The effect of vaginal bleeding in early pregnancy on the 
infant born after the 28th week of pregnancy. J Obstet Gynaecol Br 
Commonw 1973;80:236-41. 
113. Mulik V, Bethel J, Bhal K. A retrospective population-based study of 
primigravid women on the potential effect of threatened miscarriage on 
obstetric outcome. J Obstet Gynaecol 2004;24:249-53. 
114. Sipila P, Hartikainen-Sorri AL, Oja H, Von Wendt L. Perinatal outcome of 
pregnancies complicated by vaginal bleeding. Br J Obstet Gynaecol 
1992;99:959-63. 
115. Wijesiriwardana A, Bhattacharya S, Shetty A, Smith N, Bhattacharya S. 
Obstetric outcome in women with threatened miscarriage in the first trimester. 
Obstet Gynecol 2006;107:557-62. 
116. Cunningham F, Gant NF, Leveno KJ, GilstrapLC, Hauth JC, Wenstrom KD. 
Williams Obstetrics. 21st ed. New York: McGraw-Hill, 2001. 
117. Walch KT, Huber JC. Progesterone for recurrent miscarriage: truth and 
deceptions. Best Pract Res Clin Obstet Gynaecol 2008;22:375-89. 
118. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ. 
Onset of maternal arterial blood flow and placental oxidative stress. A 
 
 
 180
possible factor in human early pregnancy failure. Am J Pathol 2000;157:2111-
22. 
119. Rodesch F, Simon P, Donner C, Jauniaux E. Oxygen measurements in 
endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol 
1992;80:283-5. 
120. Jauniaux E, Gulbis B, Burton GJ. The human first trimester gestational sac 
limits rather than facilitates oxygen transfer to the foetus--a review. Placenta 
2003;24 Suppl A:S86-93. 
121. Jauniaux E, Johns J, Burton GJ. The role of ultrasound imaging in diagnosing 
and investigating early pregnancy failure. Ultrasound Obstet Gynecol 
2005;25:613-24. 
122. Harris LK, Aplin JD. Vascular remodeling and extracellular matrix breakdown 
in the uterine spiral arteries during pregnancy. Reprod Sci 2007;14:28-34. 
123. Jauniaux E, Gulbis B, Burton GJ. Physiological implications of the materno-
fetal oxygen gradient in human early pregnancy. Reprod Biomed Online 
2003;7:250-3. 
124. Watson AL, Skepper JN, Jauniaux E, Burton GJ. Susceptibility of human 
placental syncytiotrophoblastic mitochondria to oxygen-mediated damage in 
relation to gestational age. J Clin Endocrinol Metab 1998;83:1697-705. 
125. Jauniaux E, Burton GJ. Pathophysiology of histological changes in early 
pregnancy loss. Placenta 2005;26:114-23. 
126. Hempstock J, Jauniaux E, Greenwold N, Burton GJ. The contribution of 
placental oxidative stress to early pregnancy failure. Hum Pathol 
2003;34:1265-75. 
127. Johns J, Jauniaux E. Placental haematomas in early pregnancy. Br J Hosp 
Med (Lond) 2007;68:32-5. 
128. Raghupathy R, Kalinka J. Cytokine imbalance in pregnancy complications 
and its modulation. Front Biosci 2008;13:985-94. 
129. Christiansen OB, Nielsen HS, Kolte AM. Inflammation and miscarriage. 
Semin Fetal Neonatal Med 2006;11:302-8. 
 
 
 181
130. Whitcomb BW, Schisterman EF, Klebanoff MA, Baumgarten M, Rhoton-
Vlasak A, Luo X, Chegini N. Circulating chemokine levels and miscarriage. 
Am J Epidemiol 2007;166:323-31. 
131. Chaouat G. The Th1/Th2 paradigm: still important in pregnancy? Semin 
Immunopathol 2007;29:95-113. 
132. French JI, McGregor JA, Draper D, Parker R, McFee J. Gestational bleeding, 
bacterial vaginosis, and common reproductive tract infections: risk for preterm 
birth and benefit of treatment. Obstet Gynecol 1999;93:715-24. 
133. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S. The 
role of inflammation and infection in preterm birth. Semin Reprod Med 
2007;25:21-39. 
134. Gomez R, Romero R, Nien JK, Medina L, Carstens M, Kim YM, 
Chaiworapongsa T, Espinoza J, Gonzalez R. Idiopathic vaginal bleeding 
during pregnancy as the only clinical manifestation of intrauterine infection. J 
Matern Fetal Neonatal Med 2005;18:31-7. 
135. Johns J, Muttukrishna S, Lygnos M, Groome N, Jauniaux E. Maternal serum 
hormone concentrations for prediction of adverse outcome in threatened 
miscarriage. Reprod Biomed Online 2007;15:413-21. 
136. la Marca A, Morgante G, De Leo V. Human chorionic gonadotropin, thyroid 
function, and immunological indices in threatened abortion. Obstet Gynecol 
1998;92:206-11. 
137. Habayeb OM, Taylor AH, Finney M, Evans MD, Konje JC. Plasma 
anandamide concentration and pregnancy outcome in women with threatened 
miscarriage. JAMA 2008;299:1135-6. 
138. Savitz DA, Dole N, Kaczor D, Herring AH, Siega-Riz AM, Kaufman J, Thorp 
JM, Jr. Probability samples of area births versus clinic populations for 
reproductive epidemiology studies. Paediatr Perinat Epidemiol 2005;19:315-
22. 
139. Lamvu G, Lorenz C, Jonsson Funk M, Makarushka C, Hartmann K, Savitz D. 
Racial differences among reasons for participating in research of pregnancy 
outcomes: the right from the start experience. Gend Med 2005;2:166-73. 
140. Hoffman CS, Messer LC, Mendola P, Savitz DA, Herring AH, Hartmann KE. 
Comparison of gestational age at birth based on last menstrual period and 
 
 
 182
ultrasound during the first trimester. Paediatr Perinat Epidemiol 2008;22:587-
96. 
141. Mukri F, Bourne T, Bottomley C, Schoeb C, Kirk E, Papageorghiou AT. 
Evidence of early first-trimester growth restriction in pregnancies that 
subsequently end in miscarriage. BJoG 2008;115:1273-8. 
142. Slaughter JC, Herring AH, Hartmann KE. Bayesian modeling of embryonic 
growth using latent variables. Biostatistics 2008;9:373-89. 
143. Corkrey R, Parkinson L. A comparison of four computer-based telephone 
interviewing methods: getting answers to sensitive questions. Behav Res 
Methods Instrum Comput 2002;34:354-63. 
144. Kurth AE, Martin DP, Golden MR, Weiss NS, Heagerty PJ, Spielberg F, 
Handsfield HH, Holmes KK. A comparison between audio computer-assisted 
self-interviews and clinician interviews for obtaining the sexual history. Sex 
Transm Dis 2004;31:719-26. 
145. Royston P. Multiple imputation of missing values: update. The Stata Journal 
2005;5:188-201. 
146. Pawloski LR, Kitsantas P. Classification tree analysis of stunting in Malian 
adolescent girls. Am J Hum Biol 2008;20:285-91. 
147. Goldhaber MK, Fireman BH. The fetal life table revisited: spontaneous 
abortion rates in three Kaiser Permanente cohorts. Epidemiology 1991;2:33-9. 
148. Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of 
Uterine Leiomyomas in the First Trimester of Pregnancy: An ultrasound 
screening study. Obstetrics and Gynecology 2009. 
149. Williams MA, Hickok DE, Zingheim RW, Mittendorf R, Kimelman J, Mahony 
BS. Low birth weight and preterm delivery in relation to early-gestation 
vaginal bleeding and elevated maternal serum alpha-fetoprotein. Obstet 
Gynecol 1992;80:745-9. 
150. Hoffman CS, Messer LC, Mendola P, Savitz DA, Herring AH, Hartmann KE. 
Comparison of gestational age at birth based on last menstrual period and 
ultrasound during the first trimester. Paediatric and Perinatal Epidemiology 
2007. 
 
 
 183
151. Wegienka G, Baird DD, Hertz-Picciotto I, Harlow SD, Steege JF, Hill MC, 
Schectman JM, Hartmann KE. Self-reported heavy bleeding associated with 
uterine leiomyomata. Obstet Gynecol 2003;101:431-7. 
152. Hertz JB, Heisterberg L. The outcome of pregnancy after threatened abortion. 
Acta Obstet Gynecol Scand 1985;64:151-6. 
153. Orsini N BR, Bottai M, Wolk A, Greenland S. A tool for deterministic and 
probabilistic sensitivity analysis of epidemiologic studies. The Stata Journal 
2008;8:29-48. 
154. Seong HS, Lee SE, Kang JH, Romero R, Yoon BH. The frequency of 
microbial invasion of the amniotic cavity and histologic chorioamnionitis in 
women at term with intact membranes in the presence or absence of labor. 
Am J Obstet Gynecol 2008;199:375 e1-5. 
155. Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sorensen HT. Recall bias 
in a case-control surveillance system on the use of medicine during 
pregnancy. Epidemiology 2001;12:461-6. 
156. Promislow JH, Makarushka CM, Gorman JR, Howards PP, Savitz DA, 
Hartmann KE. Recruitment for a community-based study of early pregnancy: 
the Right From The Start study. Paediatr Perinat Epidemiol 2004;18:143-52. 
157. Tanner MA, Young MA. Modeling agreement among raters. J Am Stat Assoc 
1985;80:175-180. 
158. Agresti A. Modelling patterns of agreement and disagreement. Stat Methods 
Med Res 1992;1:201-18. 
159. Velema JP, Blettner M, Restrepo M, Munoz N. The evaluation of agreement 
by means of log-linear models: proxy interviews on reproductive history 
among floriculture workers in Colombia. Epidemiology 1991;2:107-15. 
160. Schieve LA, Perry GS, Cogswell ME, Scanion KS, Rosenberg D, Carmichael 
S, Ferre C. Validity of self-reported pregnancy delivery weight: an analysis of 
the 1988 National Maternal and Infant Health Survey. NMIHS Collaborative 
Working Group. Am J Epidemiol 1999;150:947-56. 
161. Tate AR, Dezateux C, Cole TJ, Davidson L. Factors affecting a mother's 
recall of her baby's birth weight. Int J Epidemiol 2005;34:688-95. 
 
 
